WCO WHO HS Classification of Active Pharmaceutical Ingredients>> HS Code HS Classification

HS Classification Opinions
683 Views

Last update : June 2022

An International Nonproprietary Name (INN) (or generic name) identifies a pharmaceutical substance or active pharmaceutical ingredient by a unique name that is globally recognized and is public property. The system of recommended INNs has been in operation since 1953 by the World Health Organization (WHO). Every year, the WHO publishes two lists of recommended new INN lists. Since 1988, the Harmonized System Committee with the assistance of the Scientific Sub-Committe, has classified nearly 5000 INNs in the Harmonized System (HS). After the publication of each INN List by the WHO, the WCO contacts all the Contracting Parties requesting their opinion for the HS classification of the INNs included in the List.

Note 1 : Lines appearing in pink colour indicate that the name or CAS number of the product has been modified by the WHO after the decision taken by the Committee.
Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
abacavir	abacavir	2933.59	42.100 Ann. O (V)	HSC/21	1998	76	136470-78-5
abafungin	abafungine	2941.90	42.100 Ann. O (III)	HSC/21	1998	74	129639-79-8
abagovomab	abagovomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	95	792921-10-9	HSC/39 (3002.10)
abaloparatide	abaloparatide	2937.19	NC2004B1b Ann. O/5	HSC/53	2014	109	247062-33-5
abametapir	abamétapir	2933.39	NC2116B1b Ann. R/4	HSC/55	2015	110	1762-34-1
abaperidone	abapéridone	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	80	183849-43-6	HSC/23 (2934.90)
abarelix	abarélix	2937.19	NC2116B1b Ann. R/7	HSC/55	2015	78	183552-38-7	HSC/22 (2933.39)
abatacept	abatacept	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	91	332348-12-6	HSC/37 (3002.10)
abciximab	abciximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	70	143653-53-6	HSC/18 (3002.10)
abdavomeran	abdavoméran	3002.41	NC2803Bc Ann. T/11	HSC/67	2021	4 COVID	2417899-75-1
abecomotide	abécomotide	3002.41	NC2803Bc Ann. T/4	HSC/67	2021	109	907596-50-3	HSC/53 (3002.20)
abediterol	abéditérol	2933.79	NC1760B1b Ann. N/7	HSC/49	2012	104	915133-65-2
abelacimab	abélacimab	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	2098724-83-3
abemaciclib	abémaciclib	2933.59	NC2237B1b Ann. S/8	HSC/57	2016	112	1231929-97-7
abequolixron	abéquolixron	2922.19	NC2930Bc Ann. P/25	HSC/69	2022	124	610318-54-2
abetimus	abétimus	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	81	167362-48-3	HSC/25 (2934.90)
abexinostat	abexinostat	2932.99	NC1760B1b Ann. N/8	HSC/49	2012	105	783355-60-2
abicipar pegol	abicipar pégol	3907.29	NC2803Bc Ann. T/4	HSC/67	2021	108	1327278-94-3	HSC/53 (3907.20)
abiraterone	abiratérone	2937.29	NC2116B1b Ann. R/7	HSC/55	2015	74	154229-19-3	HSC/21 (2933.39)
abitesartan	abitésartan	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	73	137882-98-5	HSC/18 (2933.90)
abituzumab	abituzumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	109	1105038-73-0	HSC/53 (3002.10)
abivertinib	abivertinib	2933.59	NC2626B1b Ann. O/6	HSC/63	2019	119	1557267-42-1
abrezekimab	abrézékimab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	2043952-59-4
abrilumab	abrilumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	111	1342290-43-0	HSC/55 (3002.10)
abrineurin	abrineurine	2937.19	NC0730B2 Ann. M/4	HSC/31	2003	84	178535-93-8
abrocitinib	abrocitinib	2935.90	NC2803Bc Ann. T/2	HSC/67	2021	120	1622902-68-4
abrucomstat	abrucomstat	2920.90	NC2930Bc Ann. P/25	HSC/69	2022	124	100502-66-7
acalabrutinib	acalabrutinib	2933.39	NC2237B1b Ann. S/9	HSC/57	2016	113	1420477-60-6
acalisib	acalisib	2933.59	NC2004B1b Ann. O/5	HSC/53	2014	109	870281-34-8
acapatamab	acapatamab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2314491-93-3

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
acarbose	acarbose	2932.99	NC2004B1b Ann. O/6	HSC/53	2014	40	56180-94-0	HSC/11 (2932.90)
acasunlimab	acasunlimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2253937-12-9
acavameran	acavaméran	2934.99	NC2930Bc Ann. P/25	HSC/69	2022	124	2159155-74-3
acazicolcept	acazicolcept	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2270247-50-0
acebilustat	acébilustat	2934.99	NC2373B1b Ann. O/6	HSC/59	2017	114	943764-99-6
acemannan	acémannan	3913.90	38.100 Ann. Q (No. 118)	HSC/11	1993	64	110042-95-0
acetorphine	acétorphine	2939.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	17	25333-77-1
acetylmethadol	acétylméthadol	2922.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	509-74-0
aciclovir	aciclovir	2933.59	38.100 Ann. Q (No. 119)	HSC/11	1993	42	59277-89-3
acipimox	acipimox	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	33	51037-30-0	HSC/11 (2933.90)
acitazanolast	acitazanolast	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	72	114607-46-4	HSC/18 (2933.90)
acitretin	acitrétine	2918.99	NC2373B1b Ann. O/12	HSC/59	2017	56	55079-83-9	HSC/11 (2918.90)
aclantate	aclantate	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	27	39633-62-0	HSC/11 (2934.90)
aclerastide	aclérastide	2933.29	NC2116B1b Ann. R/4	HSC/55	2015	110	227803-63-6
aclidinium bromide	bromure d’aclidinium	2934.99	NC1178B1c Ann. O/5	HSC/39	2007	95	320345-99-1
aclimostat	aclimostat	2934.99	NC2803Bc Ann. T/2	HSC/67	2021	120	2082752-83-6
acmucabtagene autoleucel	acmucabtagène autoleucel	3002.51	NC2930Bc Ann. P/27	HSC/69	2022	125	no mention
acolbifene	acolbifène	2934.99	NC0730B2 Ann. M/6	HSC/31	2003	86	182167-02-8
acorafloxacin	acorafloxacine	2933.49	NC2004B1b Ann. O/5	HSC/53	2014	111	878592-87-1
acoramidis	acoramidis	2933.19	NC2803Bc Ann. T/6	HSC/67	2021	122	1446711-81-4
acotiamide	acotiamide	2934.10	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	185106-16-5
acoziborole	acoziborole	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1266084-51-8
acreozast	acréozast	2926.90	42.100 Ann. O (VI)	HSC/21	1998	77	123548-56-1
acrisorcin	acrisorcine	2933.99	NC2116B1b Ann. R/6	HSC/55	2015	13	7527-91-5	HSC/11 (2933.90)
acrivastine	acrivastine	2933.39	38.100 Ann. Q (No. 124)	HSC/11	1993	51	87848-99-5
acrizanib	acrizanib	2933.59	NC2501B1b Ann. M/5	HSC/61	2018	116	1229453-99-9
acrocinonide	acrocinonide	2937.22	38.100 Ann. Q (No. 125)	HSC/11	1993	27	28971-58-6
acronine	acronine	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	22	7008-42-6	HSC/21 (2939.90) HSC/53 (2939.99)
actinium (225Ac) lintuzumab satetraxetan	actinium (225Ac) lintuzumab satétraxétan	2844.42	NC2803Bc Ann. T/3	HSC/67	2021	121	2209911-94-2
actoxumab	actoxumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1245634-25-6	HSC/51 (3002.10)
acumapimod	acumapimod	2933.19	NC2116B1b Ann. R/5	HSC/55	2015	111	836683-15-9
adafosbuvir	adafosbuvir	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1613589-09-5
adagrasib	adagrasib	2933.59	NC2930Bc Ann. P/25	HSC/69	2022	124	2326521-71-3
adalimumab	adalimumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	82	331731-18-1	HSC/27 (3002.10)
adalimumab beta	adalimumab bêta	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	1446410-95-2
adaprolol	adaprolol	2922.19	40.260 Ann. L/2 (No. 38)	HSC/17	1996	63	101479-70-3
adargileukin alfa	adargileukine alfa	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	89	250710-65-7	HSC/47 (3002.10)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
adarigiline	adarigiline	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1124197-79-0
adarotene	adarotène	2918.29	NC1500B1b Ann. K/6	HSC/44	2009	100	496868-77-0
adatanserin	adatansérine	2933.59	40.600 Ann. D, par. 6	HSC/18	1996	70	127266-56-2
adavivint	adavivint	2933.39	NC2501B1b Ann. M/6	HSC/61	2018	117	1467013-03-3
adavosertib	adavosertib	2933.59	NC2501B1b Ann. M/6	HSC/61	2018	117	955365-80-7
adebrelimab	adébrélimab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2247114-85-6
adecatumumab	adecatumumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	90	503605-66-1	HSC/35 (3002.10)
adefovir	adéfovir	2933.59	40.600 Ann. D, par. 6	HSC/18	1996	72	106941-25-7
adegramotide	adégramotide	3002.41	NC2803Bc Ann. T/4	HSC/67	2021	115	1252802-98-4	HSC/59 (3002.20)
adekalant	adékalant	2933.39	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	227940-00-3
adelmidrol	adelmidrol	2924.19	NC2004B1b Ann. O/6	HSC/53	2014	70	1675-66-7	HSC/18 (2924.10)
aderbasib	aderbasib	2933.59	NC1443B1b Ann. P/6	HSC/43	2009	99	791828-58-5
adezmapimod	adezmapimod	2933.39	NC2930Bc Ann. P/25	HSC/69	2022	124	152121-47-6
adibendan	adibendan	2933.79	38.100 Ann. Q (No. 126)	HSC/11	1993	57	100510-33-6
adimlecleucel	adimlecleucel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	117	no mention	HSC/61 (3002.90)
adintrevimab	adintrévimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2516243-54-0
adipiplon	adipiplon	2933.59	NC1443B1b Ann. P/5	HSC/43	2009	98	840486-93-3
adlinacogene civaparvovec	adlinacogène civaparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	120	2143579-02-4	HSC/67 (3002.90)
adomeglivant	adoméglivant	2924.29	NC2373B1b Ann. O/7	HSC/59	2017	115	1488363-78-5
adomiparin sodium	adomiparine sodique	3001.90	NC1760B1b Ann. N/7	HSC/49	2012	104	9041-08-1
adoprazine	adoprazine	2934.99	NC1443B1b Ann. P/6	HSC/43	2009	99	222551-17-9
adrenomedullin pegol	adrénomedulline pégol	2937.19	NC2803Bc Ann. T/7	HSC/67	2021	123	1432735-93-7
adriforant	adriforant	2933.59	NC2626B1b Ann. O/6	HSC/63	2019	119	943057-12-3
adrogolide	adrogolide	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	82	171752-56-0	HSC/27 (2934.90)
adrulipase alfa	adrulipase alfa	3507.90	NC2930Bc Ann. P/27	HSC/69	2022	125	2488626-93-1
aducanumab	aducanumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	110	1384260-65-4	HSC/55 (3002.10)
afabicin	afabicine	2934.99	NC2373B1b Ann. O/7	HSC/59	2017	115	1518800-35-5
afacifenacin	afacifénacine	2933.59	NC1604B1b Ann. N/5	HSC/46	2010	101	877606-63-8
afamelanotide	afamélanotide	2937.19	NC1553B1b Ann. O/7	HSC/45	2010	100	75921-69-6
afamitresgene autoleucel	afamitresgène autoleucel	3002.51	NC2803Bc Ann. T/6	HSC/67	2021	122	no mention
afasevikumab	afasévikumab	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	113	1589503-30-9	HSC/57 (3002.10) (S/9)
afatinib	afatinib	2934.99	NC1604B1b Ann. N/6	HSC/46	2010	102	850140-72-6
afegostat	afégostat	2933.39	NC1604B1b Ann. N/5	HSC/46	2010	101	169105-89-9
afeletecan	afélétécan	2939.79	NC2237B1b Ann. T/12	HSC/57	2016	85	215604-75-4	HSC/29 (2939.99)
afelimomab	afélimomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	72	156227-98-4	HSC/18 (3002.10)
aficamten	aficamtène	2934.99	NC2930Bc Ann. P/25	HSC/69	2022	124	2364554-48-1
afimetoran	afimétoran	2933.39	NC2930Bc Ann. P/25	HSC/69	2022	124	2171019-55-7
afimoxifene	afimoxifène	2922.19	NC1178B1c Ann. O/5	HSC/39	2007	95	68392-35-8

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
afizagabar	afizagabar	2934.99	NC2803Bc Ann. T/2	HSC/67	2021	120	1398496-82-6
aflibercept	aflibercept	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	95	862111-32-8	HSC/39 (3002.10)
afovirsen	afovirsen	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	70	151356-08-0	HSC/18 (2934.90)
afoxolaner	afoxolaner	2934.99	NC2004B1b Ann. O/4	HSC/53	2014	108	1093861-60-9
aftobetin	aftobétine	2933.39	NC2004B1b Ann. O/5	HSC/53	2014	109	1208971-05-4
afuresertib	afurésertib	2934.99	NC2004B1b Ann. O/4	HSC/53	2014	108	1047644-62-1
afutuzumab	afutuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	99	949142-50-1	HSC/43 (3002.10)
agalsidase alfa	agalsidase alfa	3507.90	NC0590B2 Ann. L/15	HSC/29	2002	84	104138-64-9
agalsidase beta	agalsidase beta	3507.90	NC0590B2 Ann. L/15	HSC/29	2002	84	104138-64-9
aganepag	aganépag	2934.99	NC1760B1b Ann. N/7	HSC/49	2012	104	910562-18-4
aganirsen	aganirsen	2934.99	NC1604B1b Ann. N/5	HSC/46	2010	101	1146887-67-3
agatolimod	agatolimod	2934.99	NC1443B1b Ann. P/5	HSC/43	2009	98	207623-20-9
agerafenib	agérafénib	2934.99	NC2373B1b Ann. O/7	HSC/59	2017	115	1188910-76-0
aglatimagene besadenovec	aglatimagène bésadénovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	113	1621271-62-2	HSC/57 (3002.90)
aglepristone	aglépristone	2922.50	42.100 Ann. O (VII)	HSC/21	1998	70	124478-60-0
agomelatine	agomélatine	2924.29	42.100 Ann. O (IV)	HSC/21	1998	75	138112-76-2
alacizumab pegol	alacizumab pégol	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	98	934216-54-3	HSC/43 (3002.10)
aladorian	aladorian	2934.99	NC1874B1b Ann. O/2	HSC/51	2013	107	865433-00-7
alagebrium chloride	chlorure d’alagébrium	2934.10	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	341028-37-3
alalevonadifloxacin	alalévonadifloxacine	2933.39	NC2373B1b Ann. O/6	HSC/59	2017	114	706809-20-3
alamifovir	alamifovir	2933.59	NC0938B2b Ann. O/2	HSC/35	2005	89	193681-12-8
alatrofloxacin	alatrofloxacine	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	75	157182-32-6	HSC/21 (2933.90)
albaconazole	albaconazole	2933.59	NC0845B2 Ann. M/1 (II)	HSC/33	2004	87	187949-02-6
albenatide	albénatide	3002.12	NC2237B1b Ann. T/13	HSC/57	2016	111	1031700-39-6	HSC/55 (3002.10)
albiglutide	albiglutide	2937.19	NC1310B1b Ann. N/4	HSC/41	2008	97	782500-75-8
albinterferon alfa-2b	albinterféron alfa-2b	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	97	472960-22-8	HSC/41 (3002.10)
albitiazolium bromide	bromure d’albitiazolium	2934.10	NC1604B1b Ann. N/5	HSC/46	2010	101	321915-72-4
albusomatropin	albusomatropine	2937.11	NC2373B1b Ann. O/6	HSC/59	2017	114	1636119-82-8
albutrepenonacog alfa	albutrépénonacog alfa	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	108	1357448-54-4	HSC/53 (3002.10)
alcaftadine	alcaftadine	2933.39	NC1178B1c Ann. O/3	HSC/39	2007	94	147084-10-4
alclofenac	alclofénac	2918.99	NC2373B1b Ann. O/12	HSC/59	2017	23	22131-79-9	HSC/11 (2918.90)
aldafermin	aldafermine	2937.19	NC2803Bc Ann. T/2	HSC/67	2021	120	1616639-03-2
aldesleukin	aldesleukin	3504.00	38.100 Ann. Q (No. 128)	HSC/11	1993	63	110942-02-4
aldoxorubicin	aldoxorubicine	2941.90	NC2004B1b Ann. O/4	HSC/53	2014	108	1361644-26-9
aldumastat	aldumastat	2933.59	NC2803Bc Ann. T/7	HSC/67	2021	123	1957278-93-1
alectinib	alectinib	2934.99	NC2004B1b Ann. O/4	HSC/53	2014	108	1256580-46-7
alefacept	aléfacept	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	84	222535-22-0	HSC/37 (3002.10)
aleglitazar	aléglitazar	2934.99	NC1178B1c Ann. O/5	HSC/39	2007	95	475479-34-6
alemcinal	alemcinal	2932.20	NC2004B1b Ann. O/6	HSC/53	2014	82	150785-53-8	HSC/29 (2932.29)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
alemtuzumab	alemtuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	83	216503-57-0	HSC/27 (3002.10)
aleplasinin	aléplasinine	2933.99	NC1443B1b Ann. P/5	HSC/43	2009	98	481629-87-2
alfacalcidol	alfacalcidol	2936.90	NC2004B1b Ann. O/6	HSC/53	2014	40	41294-56-8	HSC/11 (2936.10)
alfatradiol	alfatradiol	2907.29	NC0730B2 Ann. M/4	HSC/31	2003	84	57-91-0
alfentanil	alfentanil	2933.33	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	43	71195-58-9
alferminogene tadenovec	alferminogène tadénovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	95	473553-86-5	HSC/39 (3002.90)
alfimeprase	alfiméprase	3507.90	NC0590B2 Ann. L/15	HSC/29	2002	85	259074-76-5
alglucosidase alfa	alglucosidase alfa	3507.90	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	420784-05-0
alicaforsen	alicaforsen	2934.99	NC0730B2 Ann. M/4 (III)	HSC/31	2003	85	185229-68-9
alicapistat	alicapistat	2933.79	NC2373B1b Ann. O/7	HSC/59	2017	115	1254698-46-8
alicdamotide	alicdamotide	3002.41	NC2803Bc Ann. T/4	HSC/67	2021	109	1201327-17-4	HSC/53 (3002.20)
alidornase alfa	alidornase alfa	3507.90	NC2373B1b Ann. O/7	HSC/59	2017	115	1788036-49-6
aligomanuxic acid	acide aligomanuxique	3913.90	NC2803Bc Ann. T/6	HSC/67	2021	122	105280-81-7
aliloxibic acid	acide valiloxibique	2922.49	NC2803Bc Ann. T/7	HSC/67	2021	123	238401-16-6
alilusem	alilusem	2933.49	NC0590B2 Ann. L/15	HSC/29	2002	85	144506-11-6
alinastine	alinastine	2933.39	42.100 Ann. O (III)	HSC/21	1998	74	154541-72-7
alipogene tiparvovec	alipogène tiparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	99	929881-05-0	HSC/43 (3002.90)
alirinetide	alirinétide	2925.29	NC2501B1b Ann. M/6	HSC/61	2018	117	725715-18-4
alirocumab	alirocumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1245916-14-6	HSC/51 (3002.10)
alisertib	alisertib	2933.59	NC1760B1b Ann. N/7	HSC/49	2012	104	1028486-01-2
aliskiren	aliskirène	2924.29	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	173334-57-1
alisporivir	alisporivir	2933.79	NC1553B1b Ann. O/7	HSC/45	2010	100	254435-95-5
alitretinoin	alitrétinoïne	2936.21	NC0430B2 Ann. Q/1 (III)	HSC/27	2001	80	1241893
allobarbital	allobarbital	2933.53	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	1	52-43-7
allopurinol	allopurinol	2933.59	38.100 Ann. Q (No. 131)	HSC/11	1993	14	315-30-0
allylprodine	allylprodine	2933.39	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	9	25384-17-2
almagate	almagate	2842.90	38.100 Ann. Q (No. 132)	HSC/11	1993	41	66827-12-1
almorexant	almorexant	2933.49	NC1443B1b Ann. P/5	HSC/43	2009	98	871224-64-5
almotriptan	almotriptan	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	76	154323-57-6	HSC/21 (2935.00)
almurtide	almurtide	2932.99	42.100 Ann. O (III)	HSC/21	1998	74	61136-12-7
alnespirone	alnespirone	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	70	138298-79-0	HSC/18 (2934.90)
alniditan	alniditan	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	72	152317-89-0	HSC/18 (2934.90)
alnuctamab	alnuctamab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2296827-07-9
alobresib	alobrésib	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1637771-14-2
alofanib	alofanib	2935.90	NC2237B1b Ann. T/11	HSC/57	2016	113	1612888-66-0	HSC/57 (2935.00) (S/9)
alogabat	alogabat	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	2230009-48-8
alogliptin	alogliptine	2933.59	NC1248B1b Ann. P/14	HSC/40	2007	96	850649-61-5
alomfilimab	alomfilimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2378692-24-9

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
aloxistatin	aloxistatine	2924.29	38.100 Ann. Q (No. 133)	HSC/11	1993	57	88321-09-9
alpelisib	alpélisib	2934.10	NC2116B1b Ann. R/4	HSC/55	2015	110	1217486-61-7
alpertine	alpertine	2933.59	38.100 Ann. Q (No. 134)	HSC/11	1993	34	27076-46-6
alphacetylmethadol	alphacétylméthadol	2922.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	17199-58-5
alphameprodine	alphaméprodine	2933.39	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	1	468-51-9
alphamethadol	alphaméthadol	2922.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	17199-54-1
alphaprodine	alphaprodine	2933.39	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	1	77-20-3
alprafenone	alprafénone	2922.19	40.260 Ann. L/2 (No. 39)	HSC/17	1996	62	124316-02-5
alprazolam	alprazolam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	30	28981-97-7
alprenolol	alprénolol	2922.19	40.260 Ann. L/2 (No. 40)	HSC/17	1996	19	13655-52-2
alrefimotide	alréfimotide	3002.41	NC2930Bc Ann. P/27	HSC/69	2022	125	1331848-79-3
alrizomadlin	alrizomadline	2933.79	NC2930Bc Ann. P/27	HSC/69	2022	125	1818393-16-6
alsactide	alsactide	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	45	34765-96-3	HSC/21 (2937.10)
alsevalimab	alsévalimab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2254029-91-7
altapizone	altapizone	2933.59	38.100 Ann. Q (No. 135)	HSC/11	1993	55	93277-96-4
alteminostat	altéminostat	2933.59	NC2626B1b Ann. O/6	HSC/63	2019	119	1246374-97-9
altinicline	altinicline	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	82	179120-92-4	HSC/27 (2933.90)
altiratinib	altiratinib	2933.39	NC2237B1b Ann. S/9	HSC/57	2016	113	1345847-93-9
altizide	altizide	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	13	5588-16-9	HSC/11 (2935.00)
altumomab	altumomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	68	156586-92-4	HSC/16 (3002.10)
alunacedase alfa	alunacédase alfa	3507.90	NC2803Bc Ann. T/11	HSC/67	2021	4 COVID	2416824-55-8
alvameline	alvaméline	2933.39	NC0090B2 Ann. M/1 (II)	HSC/23	1999	79	120241-31-8
alvelestat	alvélestat	2933.79	NC1760B1b Ann. N/7	HSC/49	2012	104	848141-11-7
alvespimycin	alvespimycine	2941.90	NC1553B1b Ann. O/1	HSC/45	2010	96	467214-20-6
alvimopan	alvimopan	2933.39	NC0845B2 Ann. M/1 (II)	HSC/33	2004	87	156053-89-3
alvocidib	alvocidib	2934.99	NC0845B2 Ann. M/2	HSC/33	2004	88	146426-40-6
amadinone	amadinone	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	25	30781-27-2	HSC/21 (2937.92)
amatuximab	amatuximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	104	931402-35-6	HSC/49 (3002.10)
ambasilide	ambasilide	2933.39	38.100 Ann. Q (No. 137)	HSC/11	1993	59	83991-25-7
ambrisentan	ambrisentan	2933.59	NC0590B2 Ann. L/15	HSC/29	2002	85	177036-94-1
ambruticin	ambruticine	2941.90	38.100 Ann. Q (No. 138)	HSC/11	1993	39	58857-02-6
amcasertib	amcasertib	2934.10	NC2237B1b Ann. S/9	HSC/57	2016	113	1129403-56-0
amcenestrant	amcénestrant	2933.99	NC2803Bc Ann. T/6	HSC/67	2021	122	2114339-57-8
amcinafal	amcinafal	2937.22	38.100 Ann. Q (No. 139)	HSC/11	1993	25	3924-70-7
amcinafide	amcinafide	2937.22	38.100 Ann. Q (No. 140)	HSC/11	1993	25	7332-27-6
amcinonide	amcinonide	2937.22	38.100 Ann. Q (No. 141)	HSC/11	1993	33	51022-69-6
amcipatricin	amcipatricine	2941.90	NC2803Bc Ann. T/2	HSC/67	2021	120	143483-67-4
amdakefalin	amdakéfaline	2933.59	NC2803Bc Ann. T/6	HSC/67	2021	122	2253747-71-4
amdizalisib	amdizalisib	2933.59	NC2930Bc Ann. P/27	HSC/69	2022	125	1894229-05-0

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
amdoxovir	amdoxovir	2934.99	NC0590B2 Ann. L/15	HSC/29	2002	85	145514-04-1
amebucort	amébucort	2937.29	38.100 Ann. Q (No. 142)	HSC/11	1993	54	83625-35-8
amediplase	amédiplase	3507.90	NC0090B2 Ann. M/1 (II)	HSC/23	1999	79	151912-11-7
amelometasone	amélométasone	2937.22	42.100 Ann. O (III)	HSC/21	1998	74	123013-22-9
amelparib	amelparib	2934.99	NC2626B1b Ann. O/6	HSC/63	2019	119	1227156-72-0
amelubant	amélubant	2925.29	NC2004B1b Ann. O/6	HSC/53	2014	85	346735-24-8	HSC/31 (2925.20)
amenamevir	aménamévir	2934.99	NC1500B1b Ann. K/6	HSC/44	2009	100	841301-32-4
amfepramone	amfépramone	2922.31	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	13	90-84-6
amfetamine	amfétamine	2921.46	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	55	300-62-9
amfomycin	amfomycine	2941.90	38.100 Ann. Q (No. 143)	HSC/11	1993	13	1402-82-0
amibegron	amibégron	2922.50	NC1178B1c Ann. O/3	HSC/39	2007	94	121524-08-1
amifampridine	amifampridine	2933.39	NC1310B1b Ann. N/10	HSC/41	2008	96	54-96-6
amiglumide	amiglumide	2924.29	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	119363-62-1
amilintide	amilintide	2937.19	NC1760B1b Ann. N/3	HSC/49	2012	76	122384-88-7
amilomotide	amilomotide	3002.41	NC2803Bc Ann. T/4	HSC/67	2021	105	1238372-23-0	HSC/49 (3002.20)
amiloxate	amiloxate	2918.99	NC2373B1b Ann. O/12	HSC/59	2017	83	71617-10-2	HSC/27 (2918.90)
aminoethyl nitrate	nitrate d’aminoéthyle	2922.50	38.100 Ann. Q (No. 144)	HSC/11	1993	1	646-02-6
aminorex	aminorex	2934.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	14	2207-50-3
amiselimod	amisélimod	2922.50	NC2237B1b Ann. S/8	HSC/57	2016	112	942399-20-4
amitifadine	amitifadine	2933.99	NC1874B1b Ann. O/1	HSC/51	2013	106	410074-73-6
amitriptylinoxide	amitriptylinoxyde	2929.90	40.260 Ann. L/2 (No. 10)	HSC/17	1996	36	4317-14-0
amivantamab	amivantamab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2171511-58-1
amlintide	amlintide	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	76	122384-88-7	HSC/21 (2934.90)
amlitelimab	amlitélimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2378692-15-8
amlivirsen	amlivirsen	2934.99	NC2626B1b Ann. O/6	HSC/63	2019	119	1637640-12-0
amobarbital	amobarbital	2933.53	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	1	57-43-2
amolimogene bepiplasmid	amolimogène bépiplasmide	2934.99	NC1443B1b Ann. P/5	HSC/43	2009	98	870524-46-2
amopyroquine	amopyroquine	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	8	550-81-2	HSC/11 (2933.40)
amotosalen	amotosalène	2932.20	NC2004B1b Ann. O/6	HSC/53	2014	85	161262-29-9	HSC/29 (2932.29)
amoxydramine camsilate	camsilate d’amoxydramine	2929.90	40.260 Ann. L/2 (No. 11)	HSC/17	1996	15	15350-99-9
amphenidone	amphénidone	2933.79	38.100 Ann. Q (No. 146)	HSC/11	1993	10	134-37-2
ampreloxetine	ampréloxétine	2933.39	NC2626B1b Ann. O/6	HSC/63	2019	119	1227056-84-9
amprenavir	amprénavir	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	79	161814-49-9	HSC/23 (2935.00)
amsilarotene	amsilarotène	2931.90	NC2373B1b Ann. O/12	HSC/59	2017	98	125973-56-0	HSC/43 (2931.00)
amubarvimab	amubarvimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2509447-07-6
amuvatinib	amuvatinib	2934.99	NC1649B3b Ann. R/14	HSC/47	2011	103	850879-09-3
amylmetacresol	amylmétacrésol	2907.19	38.100 Ann. Q (No. 147)	HSC/11	1993	55	1300-94-3
anacetrapib	anacétrapib	2934.99	NC1443B1b Ann. P/5	HSC/43	2009	98	875446-37-0
anagestone	anagestone	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	16	2740-52-5	HSC/11 (2937.92)

t t

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
anagliptin	anagliptine	2933.59	NC1649B3b Ann. R/14	HSC/47	2011	103	739366-20-2
anakinra	anakinra	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	70	143090-92-0	HSC/18 (3002.10)
anamorelin	anamoréline	2933.39	NC1310B1b Ann. N/4	HSC/41	2008	97	249921-19-5
anaritide	anaritide	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	57	95896-08-5	HSC/11 (2934.90)
anastrozole	anastrozole	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	72	120511-73-1	HSC/18 (2933.90)
anatibant	anatibant	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	88	209733-45-9	HSC/33 (2935.00)
anatumomab mafenatox	anatumomab mafénatox	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	79	0-00-0	HSC/23 (3002.10)
anaxirone	anaxirone	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	52	77658-97-0	HSC/11 (2934.90)
anazocine	anazocine	2933.39	38.100 Ann. Q (No. 151)	HSC/11	1993	30	15378-99-1
anbenitamab	anbénitamab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2367012-88-0
ancestim	ancestim	3002.13	NC2373B1b Ann. O/8	HSC/59	2017	79	163545-26-4	HSC/23 (3002.10)
ancremonam	ancrémonam	2941.90	NC2803Bc Ann. T/7	HSC/67	2021	123	1810051-96-7
ancriviroc	ancriviroc	2933.39	NC1004B1b Ann. L/11	HSC/36	2005	92	370893-06-4
ancrod	ancrod	3507.90	38.100 Ann. Q (No. 152)	HSC/11	1993	23	9046-56-4
andecaliximab	andécaliximab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1518996-49-0
andexanet alfa	andexanet alfa	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	110	1262449-58-0	HSC/55 (3002.10)
anecortave	anécortave	2915.39	NC0430B2 Ann. Q/1 (III)	HSC/27	2001	80	7753-60-8
anetumab corixetan	anétumab corixétan	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2222980-98-3
anetumab ravtansine	anétumab ravtansine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	109	1375258-01-7	HSC/53 (3002.10)
angiotensinamide	angiotensinamide	2933.29	38.100 Ann. Q (No. 153)	HSC/11	1993	12	53-73-6
anidulafungin	anidulafungine	2941.90	NC0430B2 Ann. Q/1 (III)	HSC/27	2001	81	166663-25-8
anifrolumab	anifrolumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	109	1326232-46-5	HSC/53 (3002.10)
anileridine	aniléridine	2933.33	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	144-14-9
anisperimus	anispérimus	2925.29	NC2004B1b Ann. O/6	HSC/53	2014	82	170368-04-4	HSC/27 (2925.20)
anistreplase	anistreplase	3507.90	38.100 Ann. Q (No. 154)	HSC/11	1993	59	81669-57-0
anivamersen	anivamersen	2934.99	NC1760B1b Ann. N/8	HSC/49	2012	105	959716-29-1
anrukinzumab	anrukinzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	98	910649-32-0	HSC/43 (3002.10)
anseculin	anséculine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	75	155773-59-4	HSC/21 (2934.90)
anselamimab	ansélamimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2414866-63-8
ansuvimab	ansuvimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2375952-29-5
antazonite	antazonite	2934.10	38.100 Ann. Q (No. 155)	HSC/11	1993	15	25422-75-7
antithrombin alfa	antithrombine alfa	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	93	84720-88-7	HSC/37 (3002.10)
antithrombin gamma	antithrombine gamma	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	107	1311281-25-0	HSC/51 (3002.10)
anumigilimab	anumigilimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2416593-08-1
apabetalone	apabétalone	2933.59	NC2116B1b Ann. R/4	HSC/55	2015	110	1044870-39-4
apadamtase alfa	apadamtase alfa	3507.90	NC2626B1b Ann. O/5	HSC/63	2019	118	2086325-24-6
apadenoson	apadénoson	2934.99	NC1123B1b Ann. N/1	HSC/38	2006	94	250386-15-3
apadoline	apadoline	2934.30	42.100 Ann. O (III)	HSC/21	1998	74	135003-30-4

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
apaflurane	apaflurane	2903.46	NC2803Bc Ann. T/4	HSC/67	2021	73	431-89-0	HSC/18 (2903.30) HSC/53 (2903.39)
apalutamide	apalutamide	2933.39	NC2237B1b Ann. S/9	HSC/57	2016	113	956104-40-8
apararenone	apararénone	2935.90	NC2373B1b Ann. O/7	HSC/59	2017	115	945966-46-1
apatorsen	apatorsen	2934.99	NC2116B1b Ann. R/4	HSC/55	2015	110	1002331-21-6
apaxifylline	apaxifylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	71	151581-23-6	HSC/18 (2939.50)
apaziquone	apaziquone	2933.99	NC0730B2 Ann. M/7	HSC/31	2003	87	114560-48-4
apilimod	apilimod	2934.99	NC1178B1c Ann. O/5	HSC/39	2007	95	541550-19-0
apimostinel	apimostinel	2933.99	NC2373B1b Ann. O/7	HSC/59	2017	115	1421866-48-9
apitegromab	apitégromab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2278276-46-1
apitolisib	apitolisib	2934.99	NC2004B1b Ann. O/4	HSC/53	2014	108	1032754-93-0
apixaban	apixaban	2933.79	NC1059B2b Ann. O/5	HSC/37	2006	93	503612-47-3
aplaviroc	aplaviroc	2933.79	NC1178B1c Ann. O/3	HSC/39	2007	94	461443-59-4
aplindore	aplindore	2934.99	NC0730B2 Ann. M/7	HSC/31	2003	92	189681-70-7
apolizumab	apolizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	87	267227-08-7	HSC/31 (3002.10)
apraglutide	apraglutide	2937.19	NC2626B1b Ann. O/5	HSC/63	2019	118	1295353-98-8
apratastat	apratastat	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	93	287405-51-0	HSC/37 (2935.00)
apremilast	aprémilast	2930.90	NC1310B1b Ann. N/4	HSC/41	2008	97	608141-41-9
aprepitant	aprépitant	2934.99	NC0590B2 Ann. L/15	HSC/29	2002	84	170729-80-3
apricitabine	apricitabine	2934.99	NC1178B1c Ann. O/5	HSC/39	2007	95	160707-69-7
apricoxib	apricoxib	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	99	197904-84-0	HSC/43 (2935.00)
aprinocarsen	aprinocarsen	2934.99	NC0938B2b Ann. O/2	HSC/35	2005	89	151879-73-1
aprocitentan	aprocitentan	2933.59	NC2501B1b Ann. M/5	HSC/61	2018	116	1103522-45-7
aprutumab	aprutumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1634620-63-5
aprutumab ixadotin	aprutumab ixadotine	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1708947-48-1
aptazapine	aptazapine	2933.59	38.100 Ann. Q (No. 156)	HSC/11	1993	50	71576-40-4
aptiganel	aptiganel	2925.29	NC2004B1b Ann. O/6	HSC/53	2014	72	137159-92-3	HSC/18 (2925.20)
aramisulpride	aramisulpride	2933.99	NC2803Bc Ann. T/6	HSC/67	2021	122	71675-90-6
arasertaconazole	arasertaconazole	2934.99	NC1059B2b Ann. O/5	HSC/37	2006	93	583057-48-1
arazasetron	arazasétron	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	2025360-90-9
arbaclofen	arbaclofène	2922.49	NC1760B1b Ann. N/7	HSC/49	2012	104	69308-37-8
arbaclofen placarbil	arbaclofène placarbil	2924.29	NC1310B1b Ann. N/4	HSC/41	2008	97	847353-30-4
arbekacin	arbékacine	2941.90	38.100 Ann. Q (No. 157)	HSC/11	1993	56	51025-85-5
arcitumomab	arcitumomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	74	154361-48-5	HSC/21 (3002.10)
ardenermin	ardénermine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	88	305391-49-5	HSC/47 (3002.10)
ardeparin sodium	ardéparine sodique	3001.90	NC1553B1b Ann. O/5	HSC/45	2010	68	9041-08-1
arfalasin	arfalasine	2933.29	38.100 Ann. Q (No. 158)	HSC/11	1993	37	60173-73-1
arfolitixorin	arfolitixorine	2933.59	NC2501B1b Ann. M/6	HSC/61	2018	117	316901-11-6
arformoterol	arformotérol	2924.29	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	67346-49-0

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
arginine	arginine	2925.29	NC2004B1b Ann. O/6	HSC/53	2014	14	74-79-3	HSC/11 (2925.20)
argipressin	argipressine	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	13	113-79-1	HSC/17 (2937.99)
argiprestocin	argiprestocine	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	13	113-80-4	HSC/18 (2937.99)
arhalofenate	arhalofénate	2924.29	NC1649B3b Ann. R/12	HSC/47	2011	101	24136-23-0
arimoclomol	arimoclomol	2933.39	NC0845B2 Ann. M/2	HSC/33	2004	88	289893-25-0
aripiprazole	aripiprazole	2933.79	42.100 Ann. O (IV)	HSC/21	1998	75	129722-12-9
arlipoic acid	acide arlipoïque	2934.99	NC2803Bc Ann. T/3	HSC/67	2021	121	1200-22-2
armodafinil	armodafinil	2930.90	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	112111-43-0
arnolol	arnolol	2922.19	38.100 Ann. Q (No. 160)	HSC/11	1993	56	87129-71-3
arofylline	arofylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	75	136145-07-8	HSC/21 (2939.50)
arotinolol	arotinolol	2934.10	38.100 Ann. Q (No. 161)	HSC/11	1993	48	68377-92-4
arpraziquantel	arpraziquantel	2933.59	NC2803Bc Ann. T/3	HSC/67	2021	121	57452-98-9
arprinocid	arprinocide	2933.59	38.100 Ann. Q (No. 162)	HSC/11	1993	38	55779-18-5
artefenomel	artéfénomel	2934.99	NC2004B1b Ann. O/5	HSC/53	2014	109	1029939-86-3
arteflene	artéflène	2932.99	40.600 Ann. D, par. 6	HSC/18	1996	70	123407-36-3
artemisone	artémisone	2934.99	NC1059B2b Ann. O/4	HSC/37	2006	92	255730-18-8
artemotil	artémotil	2932.99	NC0090B2 Ann. M/5	HSC/23	1999	80	75887-54-6
artenimol	arténimol	2932.99	NC0250B2 Ann. P/1 (II)	HSC/25	2000	81	81496-81-3
arterolane	artérolane	2932.99	NC1310B1b Ann. N/4	HSC/41	2008	97	664338-39-0
arundic acid	acide arundique	2915.90	NC0845B2 Ann. M/2	HSC/33	2004	88	185517-21-9
arzoxifene	arzoxifène	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	80	182133-25-1	HSC/23 (2934.90)
asalhydromorphone	asalhydromorphone	2939.19	NC2626B1b Ann. O/6	HSC/63	2019	119	1431529-94-0
asapiprant	asapiprant	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	109	932372-01-5	HSC/53 (2935.00)
asciminib	asciminib	2933.39	NC2373B1b Ann. O/7	HSC/59	2017	115	1492952-76-7
ascorbyl gamolenate	gamolénate d’ascorbyl	2932.20	NC2004B1b Ann. O/6	HSC/53	2014	79	109791-32-4	HSC/23 (2932.29)
ascrinvacumab	ascrinvacumab	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	113	1463459-96-2	HSC/57 (3002.10) (S/9)
aselizumab	asélizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	88	395639-53-9	HSC/33 (3002.10)
asenapine	asénapine	2934.99	NC0730B2 Ann. M/7	HSC/31	2003	87	65576-45-6
aseripide	aséripide	2934.10	42.100 Ann. O (VI)	HSC/21	1998	77	153242-02-5
asfotase alfa	asfotase alfa	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	104	1174277-80-5	HSC/49 (3002.10)
asimadoline	asimadoline	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	74	153205-46-0	HSC/21 (2933.90)
asivatrep	asivatrep	2935.90	NC2501B1b Ann. M/6	HSC/61	2018	117	1005168-10-4
asobamast	asobamast	2934.10	38.100 Ann. Q (No. 163)	HSC/11	1993	63	104777-03-9
asoprisnil	asoprisnil	2937.29	NC0938B2b Ann. O/1	HSC/35	2005	86	199396-76-4
asoprisnil ecamate	ecamate d’asoprisnil	2937.29	NC0938B2b Ann. O/1	HSC/35	2005	88	222732-94-7
aspacytarabine	aspacytarabine	2934.99	NC2803Bc Ann. T/2	HSC/67	2021	120	2098942-53-9
astegolimab	astégolimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2173054-79-8
astemizole	astémizole	2933.39	38.100 Ann. Q (No. 164)	HSC/11	1993	42	68844-77-9

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
astodrimer	astodrimère	2924.29	NC2116B1b Ann. R/4	HSC/55	2015	110	1379746-42-5
asudemotide	asudémotide	3002.41	NC2803Bc Ann. T/4	HSC/67	2021	107	1018833-53-8	HSC/51 (3002.20)
asunaprevir	asunaprévir	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	105	630420-16-5	HSC/49 (2935.00)
asundexian	asundexian	2933.79	NC2803Bc Ann. T/7	HSC/67	2021	123	2064121-65-7
asunercept	asunercept	3002.13	NC2237B1b Ann. T/10	HSC/57	2016	114	1450882-18-4	(List 112 asinercept)
asvasiran	asvasiran	2934.99	NC2116B1b Ann. R/5	HSC/55	2015	111	870094-26-1
atabecestat	atabécestat	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1200493-78-2
atacicept	atacicept	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	95	845264-92-8	HSC/39 (3002.10)
ataciguat	ataciguat	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	88	254877-67-3	HSC/33 (2935.00)
atagabalin	atagabaline	2922.49	NC1604B1b Ann. N/6	HSC/46	2010	102	223445-75-8
ataluren	ataluren	2934.99	NC1604B1b Ann. N/5	HSC/46	2010	101	775304-57-9
atamestane	atamestane	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	54	96301-34-7	HSC/11 (2937.99)
atamparib	atamparib	2933.59	NC2930Bc Ann. P/25	HSC/69	2022	124	2381037-82-5
ataquimast	ataquimast	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	82	182316-31-0	HSC/27 (2933.90)
atazanavir	atazanavir	2933.39	NC0845B2 Ann. M/2	HSC/33	2004	88	198904-31-3
atecegatran	atécégatran	2933.99	NC1649B3b Ann. R/14	HSC/47	2011	103	917904-13-3
atecegatran fexenetil	atécégatran fexénétil	2933.99	NC1649B3b Ann. R/14	HSC/47	2011	103	433937-93-0
atelocantel	atélocantel	2933.39	NC2501B1b Ann. M/5	HSC/61	2018	116	1370540-16-1
atesidorsen	atésidorsen	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	872063-57-5
atexakin alfa	atexakine alfa	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	72	143631-61-2	HSC/18 (3002.10)
atezolizumab	atézolizumab	3002.13	NC2237B1b Ann. T/10	HSC/57	2016	112	1380723-44-3	HSC/57 (3002.10) (S/8)
atibeprone	atibéprone	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	72	153420-96-3	HSC/18 (2934.90)
atibuclimab	atibuclimab	3002.13	NC2803Bc Ann. T/11	HSC/67	2021	4 COVID	2417175-94-9
aticaprant	aticaprant	2933.99	NC2626B1b Ann. O/6	HSC/63	2019	119	1174130-61-0
atidarsagene autotemcel	atidarsagène autotemcel	3002.51	NC2803Bc Ann. T/7	HSC/67	2021	123	no mention
atidortoxumab	atidortoxumab	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1939108-95-8
atigliflozin	atigliflozine	2940.00	NC1553B1b Ann. O/7	HSC/45	2010	100	647834-15-9
atilmotin	atilmotine	2933.99	NC1059B2b Ann. O/4	HSC/37	2006	92	533927-56-9
atinumab	atinumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	104	1226761-65-4	HSC/49 (3002.10)
atiprimod	atiprimod	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	75	123018-47-3	HSC/21 (2933.90)
atiprosin	atiprosine	2933.59	38.100 Ann. Q (No. 166)	HSC/11	1993	54	89303-63-9
atiratecan	atiratécan	2939.79	NC2237B1b Ann. T/12	HSC/57	2016	101	867063-97-6	HSC/47 (2939.99)
atizoram	atizoram	2933.59	42.100 Ann. O (III)	HSC/21	1998	74	135637-46-6
atleradstrocel	atléradstrocel	3002.51	NC2803Bc Ann. T/3	HSC/67	2021	121	no mention
atliprofen	atliprofène	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	77	108912-17-0	HSC/21 (2934.90)
atocalcitol	atocalcitol	2909.49	NC0938B2b Ann. O/1	HSC/35	2005	88	302904-82-1
atogepant	atogépant	2933.79	NC2501B1b Ann. M/5	HSC/61	2018	116	1374248-81-3
atoltivimab	atoltivimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2135632-29-8

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
atopaxar	atopaxar	2934.99	NC1760B1b Ann. N/7	HSC/49	2012	104	751475-53-3
atorolimumab	atorolimumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	80	202833-08-7	HSC/23 (3002.10)
atorvastatin	atorvastatine	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	71	134523-00-5	HSC/18 (2933.90)
atrasentan	atrasentan	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	83	195733-43-8	HSC/27 (2934.90)
atreleuton	atréleuton	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	78	154355-76-7	HSC/22 (2934.90)
atrimustine	atrimustine	2922.49	40.260 Ann. L/2 (No. 42)	HSC/17	1996	61	75219-46-4
atromepine	atromépine	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	15	428-07-9	HSC/11 (2939.90) HSC/53 (2939.99)
atuliflapon	atuliflapon	2933.59	NC2930Bc Ann. P/27	HSC/69	2022	125	2041075-86-7
atuveciclib	atuvéciclib	2933.69	NC2373B1b Ann. O/7	HSC/59	2017	115	1414943-94-4
atuzabrutinib	atuzabrutinib	2933.59	NC2930Bc Ann. P/27	HSC/69	2022	125	1581714-49-9
atuzaginstat	atuzaginstat	2924.29	NC2930Bc Ann. P/25	HSC/69	2022	124	2211981-76-7
audencel	audencel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	115	no mention	HSC/61 (3002.90)
aumolertinib	aumolertinib	2933.59	NC2930Bc Ann. P/25	HSC/69	2022	124	1899-21-05-1
auriclosene	auriclosène	2929.90	NC1874B1b Ann. O/2	HSC/51	2013	107	846056-87-9
autogene cevumeran	autogène cévuméran	3002.41	NC2930Bc Ann. P/28	HSC/69	2022	122	2365453-34-3
avacincaptad pegol	avacincaptad pégol	3907.29	NC2803Bc Ann. T/4	HSC/67	2021	113	1613641-69-2	HSC/57 (3907.20)
avacopan	avacopan	2933.39	NC2373B1b Ann. O/6	HSC/59	2017	114	1346623-17-3
avadomide	avadomide	2933.59	NC2501B1b Ann. M/6	HSC/61	2018	117	1015474-32-4
avagacestat	avagacestat	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	104	1146699-66-2	HSC/49 (2935.00)
avalglucosidase alfa	avalglucosidase alfa	3507.90	NC2501B1b Ann. M/6	HSC/61	2018	117	1802558-87-7
avalotcagene ontaparvovec	avalotcagène ontaparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	121	2227000-30-6	HSC/67 (3002.90)
avanafil	avanafil	2933.59	NC1004B1b Ann. L/11	HSC/36	2005	92	330784-47-9
avanbulin	avanbuline	2934.99	NC2803Bc Ann. T/2	HSC/67	2021	120	798577-91-0
avapritinib	avapritinib	2933.59	NC2501B1b Ann. M/6	HSC/61	2018	117	1703793-34-3
avasimibe	avasimibe	2929.90	NC0430B2 Ann. Q/1 (III)	HSC/27	2001	80	166518-60-1
avasopasem manganese	avasopasem manganèse	2933.39	NC2626B1b Ann. O/6	HSC/63	2019	120	435327-40-5	(List 119)
avatrombopag	avatrombopag	2934.10	NC1874B1b Ann. O/2	HSC/51	2013	107	570406-98-3
avdoralimab	avdoralimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2226393-85-5
avelumab	avélumab	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	113	1537032-82-8	HSC/57 (3002.10) (S/9)
avexitide	avexitide	2937.19	NC2803Bc Ann. T/2	HSC/67	2021	120	133514-43-9
avibactam	avibactam	2933.39	NC1649B3b Ann. R/14	HSC/47	2011	103	1192500-31-4
avipendekin pegol	avipendékine pégol	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2361317-09-9
aviptadil	aviptadil	2933.29	42.750 Ann. O	HSC/22	1998	78	40077-57-4
aviscumine	aviscumine	3002.49	NC2803Bc Ann. T/9	HSC/67	2021	84	223577-45-5	HSC/31 (3002.90)
avitriptan	avitriptan	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	76	151140-96-4	HSC/21 (2935.00)
avizakimab	avizakimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2229685-51-0
avoplacel	avoplacel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	119	no mention	HSC/63 (3002.90)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
avoralstat	avoralstat	2933.39	NC2237B1b Ann. S/8	HSC/57	2016	112	918407-35-9
avorelin	avoréline	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	74	140703-49-7	HSC/21 (2937.99)
avosentan	avosentan	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	93	290815-26-8	HSC/37 (2935.00)
avotaciclib	avotaciclib	2933.59	NC2803Bc Ann. T/7	HSC/67	2021	123	1983983-41-0
avotermin	avotermine	2934.99	NC1649B3b Ann. R/10	HSC/47	2011	77	182212-66-4
axalimogene filolisbac	axalimogén filolisbac	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	112	No mention.	HSC/57 (3002.90)
axatilimab	axatilimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2155851-88-8
axelopran	axélopran	2933.39	NC2004B1b Ann. O/5	HSC/53	2014	109	949904-48-7
axicabtagene ciloleucel	axicabtagène ciloleucel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	117	no mention	HSC/61 (3002.90)
axitinib	axitinib	2933.39	NC1178B1c Ann. O/3	HSC/39	2007	94	319460-85-0
axitirome	axitirome	2924.29	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	156740-57-7
axomadol	axomadol	2922.50	NC0730B2 Ann. M/7	HSC/31	2003	87	187219-95-0
azabon	azabon	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	16	1150-20-5	HSC/11 (2935.00)
azalanstat	azalanstat	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	73	143393-27-5	HSC/18 (2934.90)
azamidugene autotemcel	azamidugène autotemcel	3002.51	NC2930Bc Ann. P/27	HSC/69	2022	125	no mention
azatadine	azatadine	2933.39	38.100 Ann. Q (No. 170)	HSC/11	1993	18	3964-81-6
azathioprine	azathioprine	2933.59	38.100 Ann. Q (No. 171)	HSC/11	1993	12	446-86-6
azelaprag	azélaprag	2935.90	NC2626B1b Ann. O/6	HSC/63	2019	119	2049980-18-7
azeliragon	azéliragon	2933.29	NC2116B1b Ann. R/5	HSC/55	2015	111	603148-36-3
azeloprazole	azéloprazole	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	955095-45-1
azemiglitazone	azémiglitazone	2934.10	NC2803Bc Ann. T/6	HSC/67	2021	122	1133819-87-0
azercabtagene zapreleucel	azercabtagène zapréleucel	3002.51	NC2803Bc Ann. T/7	HSC/67	2021	123	no mention
azetirelin	azétiréline	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	60	95729-65-0	HSC/11 (2937.99)
azilsartan	azilsartan	2934.99	NC1178B1c Ann. O/5	HSC/39	2007	95	147403-03-0
azilsartan medoxomil	azilsartan médoxomil	2934.99	NC1310B1b Ann. N/4	HSC/41	2008	97	863031-21-4
azimilide	azimilide	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	72	149908-53-2	HSC/18 (2934.90)
azintuxizumab	azintuxizumab	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1826819-57-1
azintuxizumab vedotin	azintuxizumab védotine	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1826819-58-2
azoximer bromide	bromure d’azoximère	3911.90	NC1443B1b Ann. P/4	HSC/43	2009	97	892497-01-7
bacmecillinam	bacmécillinam	2941.90	42.100 Ann. O (II)	HSC/21	1998	38	50846-45-2
bafetinib	bafétinib	2933.59	NC1443B1b Ann. P/6	HSC/43	2009	99	859212-16-1
bafisontamab	bafisontamab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2437210-79-0
balaglitazone	balaglitazone	2934.10	NC0590B2 Ann. L/15	HSC/29	2002	84	199113-98-9
balamapimod	balamapimod	2933.49	NC1310B1b Ann. N/10	HSC/41	2008	96	863029-99-6
balapiravir	balapiravir	2934.99	NC1500B1b Ann. K/6	HSC/44	2009	100	690270-29-2
balazipone	balazipone	2926.90	40.600 Ann. D, par. 6	HSC/18	1996	71	137109-71-8
balicatib	balicatib	2933.59	NC1004B1b Ann. L/11	HSC/36	2005	92	354813-19-7
baliforsen	baliforsén	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1698048-23-5
balipodect	balipodect	2933.19	NC2501B1b Ann. M/5	HSC/61	2018	116	1238697-26-1

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
balixafortide	balixafortide	2934.99	NC2237B1b Ann. S/8	HSC/57	2016	112	1051366-32-5
balofloxacin	balofloxacine	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	71	127294-70-6	HSC/18 (2933.40)
baloramotide	baloramotide	3002.41	NC2803Bc Ann. T/2	HSC/67	2021	120	2207581-19-7
balovaptan	balovaptan	2933.39	NC2501B1b Ann. M/5	HSC/61	2018	116	1228088-30-9
baloxavir marboxil	baloxavir marboxil	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1985606-14-1
balstilimab	balstilimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2148321-77-9
baltaleucel	baltaleucel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	116	no mention	HSC/61 (3002.90)
balugrastim	balugrastim	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	527698-09-5	HSC/51 (3002.10)
bamadutide	bamadutide	2937.19	NC2626B1b Ann. O/6	HSC/63	2019	119	1596343-09-7
bamaquimast	bamaquimast	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	76	135779-82-7	HSC/21 (2933.90)
baminercept baminercept		3002.13	NC2116B1b Ann. S/2	HSC/55	2015	98	909110-25-4	HSC/43 (3002.10)
bamirastine	bamirastine	2933.39	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	215529-47-8
bamlanivimab	bamlanivimab	3002.13	NC2803Bc Ann. T/11	HSC/67	2021	4 COVID	2423943-37-5
bamocaftor	bamocaftor	2935.90	NC2803Bc Ann. T/3	HSC/67	2021	121	2204245-48-5
bamosiran	bamosiran	2934.99	NC1874B1b Ann. O/1	HSC/51	2013	106	1337968-84-9
banoxantrone	banoxantrone	2929.90	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	136470-65-0
bapineuzumab	bapineuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	93	648895-38-9	HSC/37 (3002.10)
bapotulimab	bapotulimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2359413-58-2
barasertib	barasertib	2933.59	NC1649B3b Ann. R/13	HSC/47	2011	102	722543-31-9
barbital	barbital	2933.53	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	4	57-44-3
bardoxolone	bardoxolone	2926.90	NC1649B3b Ann. R/12	HSC/47	2011	101	218600-44-3
barecetamab	barécétamab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2275727-74-5
baricitinib	baricitinib	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	107	1187594-09-7	HSC/51 (2935.00)
barixibat	barixibat	2933.39	NC0845B2 Ann. M/2	HSC/33	2004	88	263562-28-3
barusiban	barusiban	2934.99	NC0845B2 Ann. M/2	HSC/33	2004	88	285571-64-4
barzolvolimab	barzolvolimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2438203-51-9
basifungin	basifungine	2941.90	40.600 Ann. D, par. 6	HSC/18	1996	72	127785-64-2
basiliximab	basiliximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	76	179045-86-4	HSC/21 (3002.10)
basimglurant	basimglurant	2933.39	NC2004B1b Ann. O/5	HSC/53	2014	109	802906-73-6
basmisanil	basmisanil	2934.99	NC2116B1b Ann. R/5	HSC/55	2015	111	1159600-41-5
batabulin	batabuline	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	90	195533-53-0	HSC/35 (2935.00)
batefenterol	batéfentérol	2933.79	NC2116B1b Ann. R/4	HSC/55	2015	110	743461-65-6
batimastat	batimastat	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	70	130370-60-4	HSC/18 (2934.90)
batiraxcept	batiraxcept	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2268717-61-7
batoclimab	batoclimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2187430-05-1
bavdegalutamide	bavdégalutamide	2933.59	NC2930Bc Ann. P/27	HSC/69	2022	125	2222112-77-6
bavisant	bavisant	2934.99	NC1649B3b Ann. R/14	HSC/47	2011	103	929622-08-2
bavituximab	bavituximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	95	648904-28-3	HSC/39 (3002.10)
baxdrostat	baxdrostat	2933.79	NC2930Bc Ann. P/27	HSC/69	2022	125	1428652-17-8

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
bazedoxifene	bazédoxifène	2933.99	NC0730B2 Ann. M/6	HSC/31	2003	86	198481-32-2
bazlitoran	bazlitoran	2934.99	NC2373B1b Ann. O/6	HSC/59	2017	114	1378549-07-5
becampanel	bécampanel	2933.99	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	188696-80-2
becaplermin	bécaplermine	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	74	165101-51-9	HSC/21 (2937.99)
becatecarin	becatecarine	2941.90	NC1178B1c Ann. O/2	HSC/39	2007	92	119673-08-4
beclanorsen	béclanorsen	2934.99	NC1604B1b Ann. N/5	HSC/46	2010	101	1072859-54-1
beclavubir	béclavubir	2933.59	NC2116B1b Ann. R/5	HSC/55	2015	111	958002-33-0
becocalcidiol	bécocalcidiol	2906.19	NC1059B2b Ann. O/4	HSC/37	2006	92	524067-21-8
bectumomab	bectumomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	75	158318-63-9	HSC/21 (3002.10)
bedaquiline	bédaquiline	2933.49	NC1649B3b Ann. R/14	HSC/47	2011	103	843663-66-1
bederocin	bédérocine	2934.99	NC1553B1b Ann. O/4	HSC/45	2010	99	757942-43-1
bedinvetmab	bédinvetmab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2171034-69-6
bedoradrine	bédoradrine	2924.29	NC1178B1c Ann. O/5	HSC/39	2007	95	194785-19-8
befetupitant	béfétupitant	2934.99	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	290296-68-3
befiradol	béfiradol	2933.39	NC1443B1b Ann. P/6	HSC/43	2009	99	208110-64-9
befotertinib	béfotertinib	2933.59	NC2803Bc Ann. T/7	HSC/67	2021	123	1835667-63-4
befovacimab	béfovacimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2156634-62-5
begacestat	bégacestat	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	97	769169-27-9	HSC/41 (2935.00)
begelomab	bégélomab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	111	1403744-56-8	HSC/55 (3002.10)
beinaglutide	béinaglutide	2937.19	NC2501B1b Ann. M/6	HSC/61	2018	117	123475-27-4
belantamab	bélantamab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	2061894-48-0
belantamab mafodotin	belantamab mafodotine	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	2050232-20-5
belaperidone	bélapéridone	2933.59	42.100 Ann. O (V)	HSC/21	1998	78	156862-51-0
belatacept	belatacept	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	93	706808-37-9	HSC/37 (3002.10)
belcesiran	belcésiran	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	2375562-54-0
belinostat	bélinostat	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	97	414864-00-9	HSC/41 (2935.00)
belizatinib	bélizatinib	2933.39	NC2237B1b Ann. S/9	HSC/57	2016	113	1357920-84-3
belnacasan	belnacasan	2934.99	NC2004B1b Ann. O/4	HSC/53	2014	108	273404-37-8
beloranib	béloranib	2922.19	NC1553B1b Ann. O/7	HSC/45	2010	100	251111-30-5
belotecan	bélotécan	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	91	256411-32-2	HSC/35 (2939.99)
beloxepin	béloxépine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	75	135928-30-2	HSC/21 (2934.90)
beludavimab	béludavimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2423016-74-2
belumosudil	bélumosudil	2933.59	NC2803Bc Ann. T/7	HSC/67	2021	123	911417-87-3
belvarafenib	belvarafénib	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1446113-23-0
belzupacap sarotalocan	belzupacap sarotalocan	3204.90	NC2803Bc Ann. T/6	HSC/67	2021	122	2390462-37-8
belzutifan	belzutifan	2930.90	NC2803Bc Ann. T/6	HSC/67	2021	122	1672668-24-4
bemarituzumab	bémarituzumab	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1952272-74-0
bemcentinib	bemcentinib	2933.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1037624-75-1
beminafil	béminafil	2934.99	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	566906-50-1

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
bemiparin sodium	bémiparine sodique	3001.90	NC1553B1b Ann. O/5	HSC/45	2010	75	9041-08-1
bemnifosbuvir	bemnifosbuvir	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	1998705-64-8
bemotrizinol	bémotrizinol	2933.69	NC1004B1b Ann. L/11	HSC/36	2005	92	187393-00-6
bempedoic acid	acide bempedoïque	2918.19	NC2116B1b Ann. R/4	HSC/55	2015	110	738606-46-7
bempegaldesleukin	bempégaldesleukine	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	1939126-74-5
benfurodil hemisuccinate	hémisuccinate de benfurodil	2932.20	NC2004B1b Ann. O/6	HSC/53	2014	16	3447-95-8	HSC/11 (2932.29)
benolizime	bénolizime	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	45	61864-30-0	HSC/11 (2933.90)
benperidol	benpéridol	2933.39	38.100 Ann. Q (No. 175)	HSC/11	1993	14	2062-84-2
benralizumab	benralizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	102	1044511-01-4	HSC/46 (3002.10)
bentamapimod	bentamapimod	2934.20	NC1443B1b Ann. P/5	HSC/43	2009	98	848344-36-5
bentemazole	bentémazole	2933.29	38.100 Ann. Q (No. 176)	HSC/11	1993	40	63927-95-7
bentracimab	bentracimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2260568-31-6
benufutamab	bénufutamab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2109730-69-8
benzalkonium chloride	chlorure de benzalkonium	3402.41	NC2803Bc Ann. T/4	HSC/67	2021	1	8001-54-5	HSC/11 (3402.12)
benzethidine	benzéthidine	2933.39	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	9	3691-78-9
benzfetamine	benzfétamine	2921.46	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	55	156-08-1
benzhydrocodone	benzhydrocodone	2939.19	NC2116B1b Ann. R/5	HSC/55	2015	111	1259440-61-3
benzindopyrine	benzindopyrine	2933.39	38.100 Ann. Q (No. 177)	HSC/11	1993	13	16571-59-8
benzodrocortisone	benzodrocortisone	2937.29	NC2501B1b Ann. M/5	HSC/61	2018	116	28956-89-0
benzonatate	benzonatate	3402.42	NC2803Bc Ann. T/4	HSC/67	2021	6	104-31-4	HSC/18 (3402.13)
benzopyrronium bromide	bromure de benzopyrronium	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	12	13696-15-6	HSC/11 (2933.90)
benzpiperylone	benzpipérylone	2933.39	38.100 Ann. Q (No. 55)	HSC/11	1993	13	53-89-4
beperminogene perplasmid	béperminogène perplasmide	2934.99	NC1310B1b Ann. N/7	HSC/41	2008	95	627861-07-8
bepirovirsen	bépirovirsen	2934.99	NC2803Bc Ann. T/7	HSC/67	2021	123	1403787-62-1
bepotastine	bépotastine	2933.39	42.750 Ann. O	HSC/22	1998	78	125602-71-3
bepranemab	bépranémab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2244960-75-4
berdazimer sodium	berdazimère sodique	3910.00	NC2501B1b Ann. M/6	HSC/61	2018	117	1846565-00-1
beremagene geperpavec	bérémagène géperpavec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	123	2241888-62-8	HSC/67 (3002.90)
berlafenone	berlafénone	2922.19	40.260 Ann. L/2 (No. 43)	HSC/17	1996	63	18965-97-4
berlimatoxumab	berlimatoxumab	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1939109-24-6
bermekimab	bermékimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	1401965-15-8
beroctocog alfa	béroctocog alfa	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	95	9001-27-8	HSC/41 (3002.10)
berotralstat	bérotralstat	2933.19	NC2803Bc Ann. T/2	HSC/67	2021	120	1809010-50-1
bersacapavir	bersacapavir	2935.90	NC2803Bc Ann. T/6	HSC/67	2021	122	1638266-40-6
bersanlimab	bersanlimab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	1987854-08-9
bertilimumab	bertilimumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	88	375348-49-5	HSC/33 (3002.10)
berubicin	bérubicine	2941.90	NC1553B1b Ann. O/3	HSC/45	2010	98	677017-23-1
berupipam	bérupipam	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	71	150490-85-0	HSC/18 (2934.90)
bervastatin	bervastatine	2932.99	40.600 Ann. D, par. 6	HSC/18	1996	72	132017-01-7

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
berzosertib	berzosertib	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1232416-25-9
besifloxacin	bésifloxacine	2933.49	NC1443B1b Ann. P/5	HSC/43	2009	98	141388-76-3
besifovir	bésifovir	2933.59	NC1760B1b Ann. N/8	HSC/49	2012	105	441785-25-7
besilesomab	besilesomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	92	537694-98-7	HSC/37 (3002.10)
besipirdine	bésipirdine	2933.39	40.600 Ann. D, par. 6	HSC/18	1996	70	119257-34-0
betacetylmethadol	bétacétylméthadol	2922.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	17199-59-6
betameprodine	bétaméprodine	2933.39	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	1	468-50-8
betamethadol	bétaméthadol	2922.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	17199-55-2
betamicin	bétamicine	2941.90	42.100 Ann. O (II)	HSC/21	1998	38	36889-15-3
betaprodine	bétaprodine	2933.39	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	468-59-7
betasizofiran	bétasizofiran	3913.90	40.600 Ann. D, par. 6	HSC/18	1996	72	39464-87-4
betaxolol	bétaxolol	2922.19	40.260 Ann. L/2 (No. 44)	HSC/17	1996	40	63659-18-7
betiatide	bétiatide	2930.90	38.100 Ann. Q (No. 179)	HSC/11	1993	58	103725-47-9
betibeglogene autotemcel	bétibéglogène autotemcel	3002.51	NC2803Bc Ann. T/3	HSC/67	2021	121	no mention
betibeglogene darolentivec	bétibéglogène darolentivec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	116	1905394-85-5	HSC/61 (3002.90)
betoxycaine	bétoxycaïne	2922.50	40.260 Ann. L/2 (No. 9)	HSC/17	1996	13	3818-62-0
betrixaban	bétrixaban	2933.39	NC1443B1b Ann. P/5	HSC/43	2009	98	330942-05-7
bevacizumab	bevacizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	83	216974-75-3	HSC/27 (3002.10)
bevacizumab beta	bévacizumab bêta	3002.13	NC2373B1b Ann. O/6	HSC/59	2017	114	1438851-35-4
bevasiranib	bévasiranib	2934.99	NC1443B1b Ann. P/6	HSC/43	2009	99	959961-96-7
bevenopran	bévénopran	2934.99	NC1874B1b Ann. O/2	HSC/51	2013	107	676500-67-7
bevifimod	bévifimod	2933.29	NC2626B1b Ann. O/6	HSC/63	2019	119	2223113-32-2
bevirimat	bévirimat	2918.19	NC1310B1b Ann. N/10	HSC/41	2008	96	174022-42-5
bevufenogene nofeparvovec	bévufénogène noféparvovec	3002.49	NC2930Bc Ann. P/25	HSC/69	2022	124	2374772-30-0
bevurogant	bévurogant	2933.59	NC2930Bc Ann. P/27	HSC/69	2022	125	1817773-66-2
bexaglifozin	bexaglifozine	2932.99	NC2237B1b Ann. S/9	HSC/57	2016	113	1118567-05-7
bexarotene	bexarotène	2916.39	NC0090B2 Ann. M/5	HSC/23	1999	80	153559-49-0
bexlosteride	bexlostéride	2933.79	NC0250B2 Ann. P/1 (II)	HSC/25	2000	81	148905-78-6
bexmarilimab	bexmarilimab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2259301-27-2
bezafibrate	bézafibrate	2924.29	38.100 Ann. Q (No. 180)	HSC/11	1993	35	41859-67-0
bezitramide	bézitramide	2933.33	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	15	15301-48-1
bezlotoxumab	bezlotoxumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1246264-45-8	HSC/51 (3002.10)
biapenem	biapénem	2941.90	39.600 Ann. D/1, par. 15	HSC/16	1995	69	120410-24-4
bibapcitide	bibapcitide	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	78	153507-46-1	HSC/22 (2934.90)
bicalutamide	bicalutamide	2930.90	40.600 Ann. D, par. 6	HSC/18	1996	70	90357-06-5
bictegravir	bictégravir	2934.99	NC2237B1b Ann. S/9	HSC/57	2016	113	1611493-60-7
bidridistrogene xeboparvovec	bidridistrogène xéboparvovec	3002.49	NC2930Bc Ann. P/27	HSC/69	2022	125	2365142-14-7
bifarcept	bifarcept	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	86	163796-60-9	HSC/47 (3002.10)
bifeprunox	biféprunox	2934.99	NC0730B2 Ann. M/7	HSC/31	2003	87	350992-10-8

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
bifikafusp alfa	bifikafusp alfa	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	1957239-90-5
bilastine	bilastine	2933.39	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	202189-78-4
bimagrumab	bimagrumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	108	1356922-05-8	HSC/53 (3002.10)
bimatoprost	bimatoprost	2937.50	NC0730B2 Ann. M/4 (III)	HSC/31	2003	85	155206-00-1
bimekizumab	bimékizumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	110	1418205-77-2	HSC/55 (3002.10)
bimiralisib	bimiralisib	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1225037-39-7
bimoclomol	bimoclomol	2933.39	42.100 Ann. O (V)	HSC/21	1998	76	130493-03-7
bimosiamose	bimosiamose	2940.00	NC0590B2 Ann. L/15	HSC/29	2002	84	187269-40-5
binetrakin	binétrakine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	82	207137-56-2	HSC/27 (3002.10)
binfloxacin	binfloxacine	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	60	108437-28-1	HSC/11 (2933.40)
binimetinib	binimétinib	2933.99	NC2004B1b Ann. O/5	HSC/53	2014	109	606143-89-9
binizolast	binizolast	2933.59	38.100 Ann. Q (No. 182)	HSC/11	1993	60	86662-54-6
binodenoson	binodénoson	2934.99	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	144348-08-3
bintrafusp alfa	bintrafusp alfa	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	1918149-01-5
birabresib	birabrésib	2934.99	NC2373B1b Ann. O/7	HSC/59	2017	115	202590-98-5
biricodar	biricodar	2933.39	42.750 Ann. O	HSC/22	1998	78	159997-94-1
birinapant	birinapant	2933.99	NC1874B1b Ann. O/2	HSC/51	2013	107	1260251-31-7
biriperone	biripérone	2933.59	40.260 Ann. L/2 (No. 21)	HSC/17	1996	51	41510-23-0
birtamimab	birtamimab	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	1608108-91-3
bisaramil	bisaramil	2933.39	38.100 Ann. Q (No. 183)	HSC/11	1993	60	89194-77-4
bisegliptin	biségliptine	2933.99	NC1760B1b Ann. N/7	HSC/49	2012	104	862501-61-9
bisnafide	bisnafide	2925.19	40.600 Ann. D, par. 6	HSC/18	1996	73	144849-63-8
bisoctrizole	bisoctrizole	2933.99	NC1004B1b Ann. L/11	HSC/36	2005	92	103597-45-1
bisoprolol	bisoprolol	2922.19	40.260 Ann. L/2 (No. 45)	HSC/17	1996	48	66722-44-9
bivalirudin	bivalirudine	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	72	128270-60-0	HSC/18 (2933.90)
bivatuzumab	bivatuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	83	214559-60-1	HSC/27 (3002.10)
bixalomer	bixalomère	3911.90	NC1760B1b Ann. N/3	HSC/49	2012	101	851373-13-2
bizalimogene ralaplasmid	bizalimogène ralaplasmide	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1977488-08-6
blarcamesine	blarcamésine	2932.19	NC2803Bc Ann. T/2	HSC/67	2021	120	195615-83-9
bleselumab	blésélumab	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	113	1453067-91-8	HSC/57 (3002.10) (S/9)
blinatumomab	blinatumomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	100	853426-35-4	HSC/44 (3002.10)
blisibimod	blisibimod	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1236126-45-6	HSC/51 (3002.10)
blonanserin	blonansérine	2933.59	42.100 Ann. O (V)	HSC/21	1998	76	132810-10-7
blontuvetmab	blontuvetmab	3002.13	NC2373B1b Ann. O/6	HSC/59	2017	114	1608112-78-2
blosozumab	blosozumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	105	1132758-87-2	HSC/49 (3002.10)
boceprevir	bocéprévir	2933.99	NC1310B1b Ann. N/4	HSC/41	2008	97	394730-60-0
bococizumab	bococizumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	110	1407495-02-6	HSC/55 (3002.10)
bofelisimer	bofélisimère	3908.90	NC2930Bc Ann. P/27	HSC/69	2022	125	2485035-32-1

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
bomedemstat	bomédemstat	2933.59	NC2803Bc Ann. T/6	HSC/67	2021	122	1990504-34-1
bomtabegagene bavoparvovec	bomtabégagène bavoparvovec	3002.49	NC2930Bc Ann. P/27	HSC/69	2022	125	2364477-20-1
bornaprolol	bornaprolol	2922.19	40.260 Ann. L/2 (No. 46)	HSC/17	1996	46	66451-06-7
borofalan (10B)	borofalan (10B)	2845.20	NC2803Bc Ann. T/4	HSC/67	2021	118	80994-59-8	HSC/63 (2845.90)
bortezomib	bortezomib	2933.99	NC0845B2 Ann. M/2	HSC/33	2004	88	179324-69-7
bosentan	bosentan	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	70	147536-97-8	HSC/18 (2935.00)
bosutinib	bosutinib	2933.59	NC1178B1c Ann. O/3	HSC/39	2007	94	380843-75-4
botensilimab	botensilimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2408310-37-0
bovhyaluronidase azoximer	bovhyaluronidase azoximère	3507.90	NC2237B1b Ann. S/8	HSC/57	2016	112	1383710-57-3
bradanicline	bradanicline	2934.99	NC2116B1b Ann. R/5	HSC/55	2015	111	639489-84-2
branaplam	branaplam	2933.39	NC2373B1b Ann. O/7	HSC/59	2017	115	1562338-42-4
branebrutinib	branébrutinib	2933.39	NC2803Bc Ann. T/3	HSC/67	2021	121	1912445-55-6
brasofensine	brasofensine	2933.39	42.100 Ann. O (V)	HSC/21	1998	76	171655-91-7
brazergoline	brazergoline	2939.69	NC2004B1b Ann. O/6	HSC/53	2014	37	60019-20-7	HSC/11 (2939.60)
brazikumab	brazikumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1610353-18-8
brecanavir	brécanavir	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	94	313682-08-5	HSC/39 (2935.00)
bremazocine	brémazocine	2933.39	38.100 Ann. Q (No. 185)	HSC/11	1993	43	71990-00-6
bremelanotide	brémélanotide	2933.79	NC1178B1c Ann. O/5	HSC/39	2007	95	189691-06-3
brensocatib	brensocatib	2934.99	NC2803Bc Ann. T/3	HSC/67	2021	121	1802148-05-5
brentuximab vedotin	brentuximab védotine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	103	914088-09-08	HSC/47 (3002.10)
brepocitinib	brépocitinib	2933.59	NC2803Bc Ann. T/3	HSC/67	2021	121	1883299-62-4
brexanolone	brexanolone	2914.40	NC2501B1b Ann. M/6	HSC/61	2018	117	516-54-1
brexpiprazole	brexpiprazole	2934.99	NC1874B1b Ann. O/1	HSC/51	2013	106	913611-97-9
brexucabtagene autoleucel	bréxucabtagène autoleucel	3002.51	NC2930Bc Ann. P/27	HSC/69	2022	125	no mention
briakinumab	briakinumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	101	339308-60-0	HSC/46 (3002.10)
briciclib	briciclib	2930.90	NC2116B1b Ann. R/5	HSC/55	2015	111	865783-99-9
brifentanil	brifentanil	2933.34	NC2803Bc Ann. T/4	HSC/67	2021	63	101345-71-5	HSC/11 (2933.39)
brigatinib	brigatinib	2933.59	NC2237B1b Ann. S/9	HSC/57	2016	113	1197953-54-0
brilacidin	brilacidine	2933.59	NC2004B1b Ann. O/4	HSC/53	2014	108	1224095-98-0
brilanestrant	brilanestrant	2933.99	NC2373B1b Ann. O/7	HSC/59	2017	115	1365888-06-7
brilaroxazine	brilaroxazine	2934.99	NC2626B1b Ann. O/6	HSC/63	2019	119	1239729-06-6
brimapitide	brimapitide	2933.99	NC2373B1b Ann. O/6	HSC/59	2017	114	1445179-97-4
brincidofovir	brincidofovir	2933.59	NC2116B1b Ann. R/4	HSC/55	2015	110	444805-28-1
brinzolamide	brinzolamide	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	76	138890-62-7	HSC/21 (2935.00)
briobacept	briobacept	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	98	869881-54-9	HSC/43 (3002.10)
brivanib alaninate	brivanib alaninate	2933.99	NC1310B1b Ann. N/4	HSC/41	2008	97	649735-63-7
brivaracetam	brivaracetam	2933.79	NC1059B2b Ann. O/5	HSC/37	2006	93	357336-20-0
brivoligide	brivoligide	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1803075-42-4
brobactam	brobactam	2941.90	42.100 Ann. O (II)	HSC/21	1998	53	26631-90-3

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
brodalumab	brodalumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	105	1174395-19-7	HSC/49 (3002.10)
brolamfetamine	brolamfétamine	2922.29	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	55	64638-07-9
brolucizumab	brolucizumab	3002.13	NC2237B1b Ann. T/10	HSC/57	2016	112	1531589-13-5	HSC/57 (3002.10) (S/8)
bromazepam	bromazépam	2933.33	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	22	1812-30-2
bromerguride	bromerguride	2939.69	NC2004B1b Ann. O/6	HSC/53	2014	51	83455-48-5	HSC/11 (2939.69)
brometenamine	brométénamine	2933.69	40.260 Ann. L/2 (No. 22)	HSC/17	1996	12	15585-71-4
bromhexine	bromhexine	2921.59	38.100 Ann. Q (No. 188)	HSC/11	1993	20	3572-43-8
bromindione	bromindione	2914.79	NC2116B1b Ann. S/1	HSC/55	2015	12	1146-98-1	HSC/11 (2914.70)
brontictuzumab	brontictuzumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	111	1447814-75-6	HSC/55 (3002.10)
broperamole	bropéramole	2933.39	38.100 Ann. Q (No. 190)	HSC/11	1993	42	33144-79-5
brostallicin	brostallicine	2933.99	NC0590B2 Ann. L/15	HSC/29	2002	84	203258-60-0
brotizolam	brotizolam	2934.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	40	57801-81-7
bucelipase alfa	bucélipase alfa	3507.90	NC1178B1c Ann. O/5	HSC/39	2007	95	9026-00-0
buciclovir	buciclovir	2933.59	38.100 Ann. Q (No. 191)	HSC/11	1993	52	86304-28-1
budesonide	budésonide	2937.29	38.100 Ann. Q (No. 192)	HSC/11	1993	37	51333-22-3
budigalimab	budigalimab	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	2098225-93-3
budiodarone	budiodarone	2932.99	NC1604B1b Ann. N/5	HSC/46	2010	101	335148-45-3
budotitane	budotitane	2914.40	NC2004B1b Ann. O/6	HSC/53	2014	56	85969-07-9	HSC/11 (2914.49)
bulaquine	bulaquine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	82	223661-25-4	HSC/27 (2934.90)
bulevirtide	bulévirtide	2933.29	NC2626B1b Ann. O/5	HSC/63	2019	118	2012558-47-1
bumepidil	bumépidil	2933.59	38.100 Ann. Q (No. 194)	HSC/11	1993	44	62052-97-5
bunaprolast	bunaprolast	2915.39	38.100 Ann. Q (No. 195)	HSC/11	1993	60	99107-52-5
bunazosin	bunazosine	2933.59	38.100 Ann. Q (No. 196)	HSC/11	1993	50	80755-51-7
bunolol	bunolol	2922.19	40.260 Ann. L/2 (No. 47)	HSC/17	1996	22	27591-01-1
buparlisib	buparlisib	2934.99	NC1874B1b Ann. O/1	HSC/51	2013	106	944396-07-0
bupranolol	bupranolol	2922.19	40.260 Ann. L/2 (No. 48)	HSC/17	1996	27	14556-46-8
buprenorphine	buprénorphine	2939.11	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	29	52485-79-7
buquiterine	buquitérine	2933.59	38.100 Ann. Q (No. 197)	HSC/11	1993	53	76536-74-8
burapitant	burapitant	2934.99	NC1604B1b Ann. N/5	HSC/46	2010	101	537034-22-3
burixafor	burixafor	2933.59	NC1760B1b Ann. N/7	HSC/49	2012	104	1191448-17-5
burlulipase	burlulipase	3507.90	NC1874B1b Ann. O/2	HSC/51	2013	107	1261982-91-5
burosumab	burosumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1610833-03-8
buserelin	buséréline	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	36	57982-77-1	HSC/11 (2937.99)
busulfan	busulfan	2905.39	42.100 Ann. O (I)	HSC/21	1998	6	55-98-1
butalbital	butalbital	2933.53	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	4	77-26-9
butamirate	butamirate	2922.19	40.260 Ann. L/2 (No. 49)	HSC/17	1996	22	18109-80-3
buthalital sodium	buthalital sodique	2933.59	38.100 Ann. Q (No. 199)	HSC/11	1993	8	510-90-7
butixocort	butixocort	2937.29	38.100 Ann. Q (No. 200)	HSC/11	1993	63	120815-74-9

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
butofilolol	butofilolol	2922.19	40.260 Ann. L/2 (No. 50)	HSC/17	1996	40	64552-17-6
butorphanol	butorphanol	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	33	42408-82-2	HSC/13 (2933.40)
butropium bromide	bromure de butropium	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	30	29025-14-7	HSC/11 (2939.90) HSC/53 (2939.99)
butylphthalide	butylphthalide	2932.20	NC2116B1b Ann. R/5	HSC/55	2015	111	6066-49-5
cabazitaxel	cabazitaxel	2932.99	NC1443B1b Ann. P/5	HSC/43	2009	98	183133-96-2
cabiotraxetan	cabiotraxétan	2934.99	NC1604B1b Ann. N/6	HSC/46	2010	102	451478-45-8
cabiralizumab	cabiralizumab	3002.13	NC2373B1b Ann. O/6	HSC/59	2017	114	1613144-80-1
cabotegravir	cabotégravir	2934.99	NC2116B1b Ann. R/5	HSC/55	2015	111	1051375-10-0
cabozantinib	cabozantinib	2933.49	NC1760B1b Ann. N/8	HSC/49	2012	105	849217-68-1
cadalimogene ixalentivec	cadalimogène ixalentivec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	120	2137091-21-3	HSC/67 (3002.90)
cadazolid	cadazolid	2934.99	NC1760B1b Ann. N/7	HSC/49	2012	104	1025097-10-2
cadonilimab	cadonilimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2394841-59-7
cadrofloxacin	cadrofloxacine	2933.59	NC0250B2 Ann. P/1 (II)	HSC/25	2000	81	153808-85-6
caficrestat	caficrestat	2934.20	NC2930Bc Ann. P/25	HSC/69	2022	124	1355612-71-3
cagrilintide	cagrilintide	2937.19	NC2803Bc Ann. T/7	HSC/67	2021	123	1415456-99-3
calaspargase pegol	calaspargase pégol	3507.90	NC1760B1b Ann. N/8	HSC/49	2012	105	941577-06-6
calcium carbimide	carbimide calcique	3102.90	NC2004B1b Ann. O/6	HSC/53	2014	10	156-62-7	HSC/11 (3102.70)
calcobutrol	calcobutrol	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	79	151878-23-8	HSC/25 (2933.90)
caldaret	caldaret	2933.59	NC0590B2 Ann. L/15	HSC/29	2002	85	133804-44-1
caloxetic acid	acide caloxétique	2922.50	NC0250B2 Ann. P/1 (II)	HSC/25	2000	81	135306-78-4
camazepam	camazépam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	30	36104-80-0
camicinal	camicinal	2933.59	NC1874B1b Ann. O/1	HSC/51	2013	106	923565-21-3
camidanlumab	camidanlumab	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	921618-45-3
camidanlumab tesirine	camidanlumab tésirine	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1853239-04-9
camizestrant	camizestrant	2933.39	NC2930Bc Ann. P/27	HSC/69	2022	125	2222844-89-3
camobucol	camobucol	2930.90	NC1178B1c Ann. O/5	HSC/39	2007	95	216167-92-9
camrelizumab	camrélizumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1798286-48-2
camsirubicin	camsirubicine	2941.90	NC2626B1b Ann. O/6	HSC/63	2019	119	236095-26-4
canagliflozin	canagliflozine	2934.99	NC1604B1b Ann. N/6	HSC/46	2010	102	842133-18-0
canakinumab	canakinumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	97	402710-27-4 (light chain) 402710-25-2 (heavy chain)	HSC/41 (3002.10)
candesartan	candésartan	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	71	139481-59-7	HSC/18 (2933.90)
candocuronium iodide	iodure de candocuronium	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	70	54278-85-2	HSC/18 (2933.90)
canerpaturev	canerpaturev	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	117	1662666-66-1	HSC/61 (3002.90)
canertinib	canertinib	2934.99	NC0730B2 Ann. M/7	HSC/31	2003	87	267243-28-7
canfosfamide	canfosfamide	2930.90	NC1059B2b Ann. O/4	HSC/37	2006	92	158382-37-7
cangrelor	cangrélor	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	82	163706-06-7	HSC/27 (2934.90)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
cannabidiol	cannabidiol	2907.29	NC2373B1b Ann. O/7	HSC/59	2017	115	13956-29-1
canoctakin	canoctakine	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	110	1019859-03-0	HSC/55 (3002.10)
canosimibe	canosimibe	2933.79	NC1500B1b Ann. K/6	HSC/44	2009	100	768394-99-6
cantharidin	cantharidine	2932.19	NC2803Bc Ann. T/7	HSC/67	2021	123	56-25-7
cantuzumab ravtansine	cantuzumab ravtansine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	105	868747-45-9	HSC/49 (3002.10)
capadenoson	capadénoson	2934.10	NC1178B1c Ann. O/5	HSC/39	2007	95	544417-40-5
capecitabine	capécitabine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	72	154361-50-9	HSC/18 (2934.90)
capeserod	capésérod	2934.99	NC1123B1b Ann. N/1	HSC/38	2006	94	769901-96-4
capivasertib	capivasertib	2933.59	NC2501B1b Ann. M/6	HSC/61	2018	117	1143532-39-1
caplacizumab	caplacizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	106	915810-67-2	HSC/51 (3002.10)
capmatinib	capmatinib	2933.49	NC2116B1b Ann. R/5	HSC/55	2015	111	1029712-80-8
capravirine	capravirine	2933.39	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	178979-85-6
capromab	capromab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	70	151763-64-3	HSC/18 (3002.10)
capromorelin	capromoréline	2933.99	NC1874B1b Ann. O/3	HSC/51	2013	83	193273-66-4	HSC/27 (2933.90)
capsaicin	capsaïcine	2939.79	NC2237B1b Ann. T/11	HSC/57	2016	113	404-86-4	HSC/57 (2933.99) (S/9)
carabersat	carabersat	2932.99	NC0090B2 Ann. M/5	HSC/23	1999	80	184653-84-7
carafiban	carafiban	2933.29	42.750 Ann. O	HSC/22	1998	78	177563-40-5
carbaldrate	carbaldrate	2842.90	40.260 Ann. L/2 (No. 4)	HSC/17	1996	53	41342-54-5
carbasalate calcium	carbasalate calcique	2924.29	38.100 Ann. Q (No. 202)	HSC/11	1993	27	5749-67-7
carbazocine	carbazocine	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	16	15686-38-1	HSC/11 (2933.40)
carbetimer	carbétimère	3911.90	38.100 Ann. Q (No. 204)	HSC/11	1993	50	82230-03-3
carboplatin	carboplatine	2843.90	38.100 Ann. Q (No. 205)	HSC/11	1993	48	41575-94-4
carfenazine	carfénazine	2934.30	38.100 Ann. Q (No. 206)	HSC/11	1993	12	2622-30-2
carfilzomib	carfilzomib	2934.99	NC1310B1b Ann. N/4	HSC/41	2008	97	868540-17-4
carfloglitazar	carfloglitazar	2933.99	NC2803Bc Ann. T/7	HSC/67	2021	123	2213406-75-6
carglumic acid	acide carglumique	2924.19	NC0590B2 Ann. L/15	HSC/29	2002	84	1188-38-1
caricotamide	caricotamide	2933.39	NC1059B2b Ann. O/5	HSC/37	2006	93	64881-21-6
cariporide	cariporide	2930.90	42.100 Ann. O (III)	HSC/21	1998	74	159138-80-4
cariprazine	cariprazine	2933.59	NC1443B1b Ann. P/5	HSC/43	2009	98	839712-12-8
carisbamate	carisbamate	2924.29	NC1310B1b Ann. N/10	HSC/41	2008	96	194085-75-1
carlumab	carlumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	104	915404-94-3	HSC/49 (3002.10)
carmegliptin	carmégliptine	2933.79	NC1443B1b Ann. P/5	HSC/43	2009	98	813452-18-5
carmofur	carmofur	2933.59	38.100 Ann. Q (No. 207)	HSC/11	1993	45	61422-45-5
carmoterol	carmotérol	2933.79	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	147568-66-9
carotegrast	carotégrast	2933.59	NC1604B1b Ann. N/6	HSC/46	2010	102	401904-75-4
carotuximab	carotuximab	3002.13	NC2373B1b Ann. O/6	HSC/59	2017	114	1268714-50-6
cartasteine	cartastéine	2934.10	40.600 Ann. D, par. 6	HSC/18	1996	72	149079-51-6
carumonam	carumonam	2941.90	38.100 Ann. Q (No. 208)	HSC/11	1993	51	87638-04-8

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
casimersen	casimersen	2934.99	NC2447B1b Ann. N/2	HSC/60	2017	115	1422958-19-7
casirivimab	casirivimab	3002.13	NC2803Bc Ann. T/11	HSC/67	2021	4 COVID	2415933-42-3
casopitant	casopitant	2933.59	NC1178B1c Ann. O/3	HSC/39	2007	94	414910-27-3
caspofungin	caspofungine	2941.90	NC0250B2 Ann. P/1 (I)	HSC/25	2000	80	162808-62-0
catequentinib	catéquentinib	2933.49	NC2803Bc Ann. T/3	HSC/67	2021	121	1058156-90-3
cathine	cathine	2939.43	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	44	492-39-7
cathinone	cathinone	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	44	71031-15-7	HSC/25 (2939.99)
catramilast	catramilast	2933.29	NC1178B1c Ann. O/5	HSC/39	2007	95	183659-72-5
catridecacog	catridécacog	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	99	606138-08-3	HSC/43 (3002.10)
catumaxomab	catumaxomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	93	509077-98-9	HSC/37 (3002.10)
cavosonstat	cavosonstat	2933.49	NC2501B1b Ann. M/5	HSC/61	2018	116	1371587-51-7
cavrotolimod	cavrotolimod	2934.99	NC2930Bc Ann. P/25	HSC/69	2022	124	2378664-12-9
cebranopadol	cébranopadol	2934.99	NC1874B1b Ann. O/2	HSC/51	2013	107	863513-91-1
ceclazepide	céclazépide	2933.39	NC2501B1b Ann. M/5	HSC/61	2018	116	1801749-44-9
cedazuridine	cédazuridine	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1141397-80-9
cedelizumab	cédélizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	77	156586-90-2	HSC/21 (3002.10)
cediranib	cédiranib	2933.59	NC1178B1c Ann. O/5	HSC/39	2007	95	288383-20-0
cedirogant	cédirogant	2933.39	NC2803Bc Ann. T/7	HSC/67	2021	123	2055496-11-0
cefiderocol	céfidérocol	2941.90	NC2373B1b Ann. O/6	HSC/59	2017	114	1225208-94-5
cefilavancin	céfilavancine	2941.90	NC2116B1b Ann. R/5	HSC/55	2015	111	722454-12-8
cefluprenam	céfluprénam	2941.90	40.600 Ann. D, par. 6	HSC/18	1996	71	116853-25-9
cefmatilen	cefmatilène	2941.90	NC0250B2 Ann. P/1 (II)	HSC/25	2000	81	140128-74-1
cefoselis	céfosélis	2941.90	40.600 Ann. D, par. 6	HSC/18	1996	71	122841-10-5
cefovecin	céfovécine	2941.90	NC0730B2 Ann. M/7	HSC/31	2003	87	234096-34-5
cefquinome	cefquinome	2941.90	38.100 Ann. Q (No. 209)	HSC/11	1993	59	84957-30-2
ceftaroline fosamil	ceftaroline fosamil	2941.90	NC1310B1b Ann. N/4	HSC/41	2008	97	229016-73-3
cefteram	ceftéram	2941.90	38.100 Ann. Q (No. 210)	HSC/11	1993	55	82547-58-8
ceftizoxime alapivoxil	ceftizoxime alapivoxil	2941.90	42.100 Ann. O (VI)	HSC/21	1998	77	135821-54-4
ceftobiprole	ceftobiprole	2941.90	NC1004B1b Ann. L/11	HSC/36	2005	92	209467-52-7
ceftobiprole medocaril	ceftobiprole médocaril	2941.90	NC1004B1b Ann. L/11	HSC/36	2005	92	376653-43-9
ceftolozane	ceftolozane	2941.90	NC1760B1b Ann. N/8	HSC/49	2012	105	689293-68-3
cefuzonam	céfuzonam	2941.90	38.100 Ann. Q (No. 211)	HSC/11	1993	55	82219-78-1
celecoxib	célécoxib	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	80	169590-42-5	HSC/23 (2935.00)
celgosivir	celgosivir	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	77	121104-96-9	HSC/21 (2933.90)
celivarone	célivarone	2932.99	NC1123B1b Ann. N/1	HSC/38	2006	94	401925-43-7
cemadotin	cémadotine	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	75	159776-69-9	HSC/21 (2933.90)
cemdisiran	cemdisiran	2934.99	NC2373B1b Ann. O/6	HSC/59	2017	114	1639264-46-2
cemiplimab	cémiplimab	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	1801342-60-8
cendakimab	cendakimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2151032-62-9

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
cenderitide	cendéritide	2937.19	NC1760B1b Ann. N/8	HSC/49	2012	105	507289-11-4
cenegermin	cénégermine	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1772578-74-1
cenerimod	cénérimod	2934.99	NC2237B1b Ann. S/9	HSC/57	2016	113	1262414-04-9
cenersen	cénersen	2934.99	NC1310B1b Ann. N/4	HSC/41	2008	97	872847-66-0
cenicriviroc	cénicriviroc	2933.29	NC1649B3b Ann. R/14	HSC/47	2011	103	497223-25-3
cenisertib	cénisertib	2933.59	NC1760B1b Ann. N/7	HSC/49	2012	104	871357-89-0
cenobamate	cénobamate	2933.99	NC2237B1b Ann. S/9	HSC/57	2016	113	913088-80-9
cenplacel	cenplacel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	115	no mention	HSC/61 (3002.90)
censavudine	censavudine	2934.99	NC2116B1b Ann. R/4	HSC/55	2015	110	634907-30-5
centanafadine	centanafadine	2933.99	NC2237B1b Ann. S/8	HSC/57	2016	112	924012-43-1
centhaquine	centhaquine	2933.59	NC2803Bc Ann. T/3	HSC/67	2021	121	57961-90-7
cenupatide	cénupatide	2925.29	NC2626B1b Ann. O/6	HSC/63	2019	119	1006388-38-0
cepeginterferon alfa-2b	cépeginterféron alfa-2b	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	105	1192706-52-7	HSC/49 (3002.10)
ceralasertib	céralasertib	2934.99	NC2626B1b Ann. O/6	HSC/63	2019	119	1352226-88-0
ceralifimod	céralifimod	2933.99	NC2004B1b Ann. O/5	HSC/53	2014	109	891859-12-4
cerdulatinib	cerdulatinib	2935.90	NC2237B1b Ann. T/12	HSC/57	2016	111	1198300-79-6	HSC/55 (2935.00)
cergutuzumab amunaleukin	cergutuzumab amunaleukine	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	113	1509916-03-3	HSC/57 (3002.10) (S/9)
ceritinib	céritinib	2933.59	NC2004B1b Ann. O/5	HSC/53	2014	109	1032900-25-6
cerivastatin	cérivastatine	2933.39	42.100 Ann. O (III)	HSC/21	1998	74	145599-86-6
cerlapirdine	cerlapirdine	2933.99	NC1874B1b Ann. O/1	HSC/51	2013	106	925448-93-7
cerliponase alfa	cerliponase alfa	3507.90	NC2116B1b Ann. R/5	HSC/55	2015	111	151662-36-1
certolizumab pegol	certolizumab pegol	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	90	428863-50-7	HSC/35 (3002.10)
certoparin sodium	certoparine sodique	3001.90	NC1553B1b Ann. O/5	HSC/45	2010	70	0-00-0
ceruletide	cérulétide	2933.79	40.260 Ann. L/2 (No. 23)	HSC/17	1996	34	17650-98-5
cetermin	cétermine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	74	157238-32-9	HSC/21 (2937.99) HSC/47 (3002.10)
cethromycin	céthromycine	2941.90	NC0845B2 Ann. M/1 (II)	HSC/33	2004	87	205110-48-1
cetilistat	cétilistat	2934.99	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	282526-98-1
cetrelimab	cétrélimab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	2050478-92-5
cetrimide	cétrimide	3808.94	NC2004B1b Ann. O/6	HSC/53	2014	46	505-86-2	HSC/17 (3808.40)
cetuximab	cétuximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	82	205923-56-4	HSC/27 (3002.10)
cetuximab sarotalocan	cétuximab sarotalocan	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2166339-33-7
cevaretigene ritoparvovec	cévarétigène ritoparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	123	2247971-00-0	HSC/67 (3002.90)
cevidoplenib	cévidoplénib	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1703788-21-9
cevimeline	céviméline	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	76	107233-08-9	HSC/21 (2934.90)
cevipabulin	cévipabulin	2933.59	NC1310B1b Ann. N/10	HSC/41	2008	96	849550-05-6
cevoglitazar	cévoglitazar	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	94	839673-52-8	HSC/39 (2935.00)
cevostamab	cévostamab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2249888-53-5

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
chloralodol	chloralodol	2911.00	42.100 Ann. O (I)	HSC/21	1998	12	3563-58-4
chlordiazepoxide	chlordiazépoxide	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	11	58-25-3
chlorotrianisene	chlorotrianisène	2909.30	38.100 Ann. Q (No. 212)	HSC/11	1993	6	569-57-3
choline fenofibrate	fénofibrate de choline	2923.10	NC1310B1b Ann. N/4	HSC/41	2008	97	856676-23-8
choriogonadotropin alfa	choriogonadotropine alfa	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	75	177073-44-8	HSC/21 (2937.10)
choriogonadotropin beta	choriogonadotropine bêta	2937.19	NC2803Bc Ann. T/2	HSC/67	2021	120	2170458-11-2
ciaftalan zinc	ciaftalane zinc	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	74	14320-04-8	HSC/21 (2933.90)
cibinetide	cibinétide	2933.79	NC2373B1b Ann. O/6	HSC/59	2017	114	1208243-50-8
cibisatamab	cibisatamab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	1855925-27-7
ciclesonide	ciclésonide	2937.29	38.100 Ann. Q (No. 213)	HSC/11	1993	74	141845-82-1
cicloprolol	cicloprolol	2922.19	40.260 Ann. L/2 (No. 51)	HSC/17	1996	48	63659-12-1
ciclosporin	ciclosporine	3002.13	NC2570B1b Ann. M/19	HSC/62	2018	46	59865-13-3	HSC/17 (2941.90)
cidofovir	cidofovir	2933.59	40.600 Ann. D, par. 6	HSC/18	1996	72	113852-37-2
ciforadenant	ciforadénant	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1202402-40-1
cilengitide	cilengitide	2933.79	NC0250B2 Ann. P/1 (II)	HSC/25	2000	81	188968-51-6
cilgavimab	cilgavimab	3002.13	NC2803Bc Ann. T/11	HSC/67	2021	4 COVID	2420563-99-9
cilmostim	cilmostim	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	71	148637-05-2	HSC/18 (3002.10)
cilobradine	cilobradine	2933.79	38.100 Ann. Q (No. 214)	HSC/11	1993	66	109859-78-1
cilofexor	cilofexor	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1418274-28-8
cilofungin	cilofungine	2941.90	38.100 Ann. Q (No. 215)	HSC/11	1993	60	79404-91-4
cilomilast	cilomilast	2926.90	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	153259-65-5
ciltacabtagene autoleucel	ciltacabtagène autoleucel	3002.51	NC2803Bc Ann. T/6	HSC/67	2021	122	no mention
ciluprevir	ciluprévir	2934.10	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	300832-84-2
cimaglermin alfa	cimaglermine alfa	2934.99	NC2116B1b Ann. R/4	HSC/55	2015	110	1350717-96-2
cimdelirsen	cimdélirsen	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	2131025-82-4
cimlanod	cimlanod	2935.90	NC2626B1b Ann. O/6	HSC/63	2019	119	1620330-72-4
cimpuciclib	cimpuciclib	2933.59	NC2930Bc Ann. P/25	HSC/69	2022	124	2202767-78-8
cinacalcet	cinacalcet	2921.49	NC0845B2 Ann. M/2	HSC/33	2004	88	226256-56-0
cinaciguat	cinaciguat	2922.50	NC1310B1b Ann. N/4	HSC/41	2008	97	329773-35-5
cinalukast	cinalukast	2934.10	40.600 Ann. D, par. 6	HSC/18	1996	70	128312-51-6
cinamolol	cinamolol	2922.19	40.260 Ann. L/2 (No. 52)	HSC/17	1996	44	39099-98-4
cinaxadamtase alfa	cinaxadamtase alfa	3507.90	NC2930Bc Ann. P/27	HSC/69	2022	125	2406308-29-8
cindunistat	cindunistat	2930.90	NC1874B1b Ann. O/2	HSC/51	2013	107	364067-22-1
cinhyaluronate sodium	cinhyaluronate de sodium	3913.90	NC2237B1b Ann. S/9	HSC/57	2016	113	1372784-20-7
cinpanemab	cinpanémab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2094516-02-4
cinrebafusp alfa	cinrébafusp alfa	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2218515-90-1
cintirorgon	cintirorgon	2935.90	NC2626B1b Ann. O/6	HSC/63	2019	119	1227156-72-0
cintredekin besudotox	cintrédékine bésudotox	3002.49	NC2803Bc Ann. T/9	HSC/67	2021	92	372075-36-0	HSC/39 (3002.90)
cipaglucosidase alfa	cipaglucosidase alfa	3507.90	NC2803Bc Ann. T/7	HSC/67	2021	123	2359727-71-0

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
cipamfylline	cipamfylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	71	132210-43-6	HSC/18 (2939.50)
cipargamin	cipargamine	2933.79	NC2116B1b Ann. R/4	HSC/55	2015	110	1193314-23-6
cipemastat	cipémastat	2933.39	NC0250B2 Ann. P/1 (II)	HSC/25	2000	81	190648-49-8
cipralisant	cipralisant	2933.29	NC0590B2 Ann. L/15	HSC/29	2002	85	213027-19-1
ciraparantag	ciraparantag	2933.59	NC2237B1b Ann. S/9	HSC/57	2016	113	1438492-26-2
cirtuvivint	cirtuvivint	2933.59	NC2803Bc Ann. T/7	HSC/67	2021	123	2143917-62-6
cisatracurium besilate	bésilate de cisatracurium	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	73	96946-42-8	HSC/18 (2933.40)
cismadinone	cismadinone	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	12	54063-31-9	HSC/11 (2937.92)
citarinostat	citarinostat	2933.59	NC2501B1b Ann. M/5	HSC/61	2018	116	1316215-12-9
citatuzumab bogatox	citatuzumab bogatox	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	99	945228-49-9	HSC/45 (3002.10)
cixutumumab	cixutumumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	100	947687-12-9	HSC/44 (3002.10)
cizolirtine	cizolirtine	2933.19	42.100 Ann. O (V)	HSC/21	1998	76	142155-43-9
clamikalant	clamikalant	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	81	158751-64-5	HSC/25 (2935.00)
clascoterone	clascotérone	2937.29	NC2803Bc Ann. T/2	HSC/67	2021	120	19608-29-8
clazakizumab	clazakizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1236278-28-6	HSC/51 (3002.10)
clazosentan	clazosentan	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	90	180384-56-9	HSC/35 (2935.00)
clenoliximab	clénoliximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	77	182912-58-9	HSC/21 (3002.10)
clervonafusp alfa	clervonafusp alfa	3002.13	NC2930Bc Ann. P/30	HSC/69	2022	120	2145123-44-8	HSC/67 (3507.90)
clesacostat	clésacostat	2933.39	NC2930Bc Ann. P/25	HSC/69	2022	124	1370448-25-1
clevidipine	clévidipine	2933.39	42.100 Ann. O (IV)	HSC/21	1998	75	167221-71-8
clevudine	clévudine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	78	163252-36-6	HSC/22 (2934.90)
cligosiban	cligosiban	2933.39	NC2626B1b Ann. O/5	HSC/63	2019	118	900510-03-4
cliropamine	cliropamine	2922.50	38.100 Ann. Q (No. 217)	HSC/11	1993	59	109525-44-2
clivatuzumab tetraxetan	clivatuzumab tétraxétan	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	113	943976-23-6	HSC/57 (3002.10) (S/9)
clobazam	clobazam	2933.72	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	25	22316-47-8
clofarabine	clofarabine	2934.99	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	123318-82-1
clofenoxyde	clofénoxyde	2914.79	NC2116B1b Ann. S/1	HSC/55	2015	14	3030-53-3	HSC/21 (2914.70)
clomifenoxide	clomifènoxide	2929.90	40.260 Ann. L/2 (No. 12)	HSC/17	1996	54	97642-74-5
clonazepam	clonazépam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	22	1622-61-3
clonitazene	clonitazène	2933.99	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	11	3861-76-5
cloprednol	cloprednol	2937.22	42.100 Ann. O (I)	HSC/21	1998	31	5251-34-3
cloranolol	cloranolol	2922.19	40.260 Ann. L/2 (No. 53)	HSC/17	1996	41	39563-28-5
clotiazepam	clotiazépam	2934.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	30	33671-46-4
cloxazolam	cloxazolam	2934.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	29	24166-13-0
cloxestradiol	cloxestradiol	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	12	54063-33-1	HSC/11 (2937.92)
cobicistat	cobicistat	2934.10	NC1649B3b Ann. R/14	HSC/47	2011	103	1004316-88-4
cobimetinib	cobimétinib	2933.39	NC1874B1b Ann. O/2	HSC/51	2013	107	934660-93-2
cobiprostone	cobiprostone	2937.50	NC1443B1b Ann. P/5	HSC/43	2009	98	333963-42-1

t t

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
cobitolimod	cobitolimod	2934.99	NC2237B1b Ann. S/9	HSC/57	2016	113	1226822-98-5
coblopasvir	coblopasvir	2934.99	NC2626B1b Ann. O/6	HSC/63	2019	119	1312608-46-0
cobolimab	cobolimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2022215-65-0
cobomarsen	cobomarsen	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1848257-52-2
codactide	codactide	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	24	22572-04-9	HSC/21 (2937.10)
codoxime	codoxime	2939.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	15	7125-76-0
codrituzumab	codrituzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	109	1365267-33-9	HSC/53 (3002.10)
cofetuzumab	cofétuzumab	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1869928-62-0
cofetuzumab pelidotin	cofétuzumab pélidotine	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1869937-48-3
cofirasersen	cofirasersen	2934.99	NC2930Bc Ann. P/25	HSC/69	2022	124	2247669-96-9
coleneuramide	coléneuramide	2932.99	NC1553B1b Ann. O/7	HSC/45	2010	100	204200-47-5
colesevelam	colésévélam	3911.90	42.100 Ann. O (VI)	HSC/21	1998	77	182815-43-6
colestilan	colestilan	3911.90	40.600 Ann. D, par. 6	HSC/18	1996	74	95522-45-5
colimecycline	colimécycline	2941.30	40.260 Ann. L/2 (No. 5)	HSC/17	1996	33	58298-92-3
coltuximab ravtansine	coltuximab ravtansine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	109	1269764-99-9	HSC/53 (3002.10)
coluracetam	coluracétam	2934.99	NC0730B2 Ann. M/6	HSC/31	2003	86	135463-81-9
conatumumab	conatumumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	99	896731-82-1	HSC/43 (3002.10)
conbercept	conbercept	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	105	1227158-72-6	HSC/49 (3002.10)
concizumab	concizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	108	1312299-39-0	HSC/53 (3002.10)
condoliase	condoliase	3507.90	NC1604B1b Ann. N/6	HSC/46	2010	102	9024-13-9
conendostatin	conendostatine	2934.99	NC2803Bc Ann. T/6	HSC/67	2021	122	2202745-12-6
conestat alfa	conestat alfa	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	98	80295-38-1	HSC/47 (3002.10)
conivaptan	conivaptan	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	82	210101-16-9	HSC/27 (2933.90)
conteltinib	conteltinib	2935.90	NC2626B1b Ann. O/5	HSC/63	2019	118	1384860-29-0
contezolid	contézolid	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1112968-42-9
contusugene ladenovec	contusugène ladénovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	97	600735-73-7	HSC/41 (3002.90)
copanlisib	copanlisib	2934.99	NC2004B1b Ann. O/4	HSC/53	2014	108	1032568-63-0
coprelotamab	coprélotamab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2348469-84-9
corifollitropin alfa	corifollitropine alfa	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	80	195962-23-3	HSC/27 (2934.90)
cortodoxone	cortodoxone	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	15	152-58-9	HSC/11 (2914.49)
cosdosiran	cosdosiran	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1834560-88-1
cosfroviximab	cosfroviximab	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1792982-57-0
cosibelimab	cosibélimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2216751-26-5
cositecan	cositécan	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	100	203923-89-1	HSC/46 (2939.99)
cotadutide	cotadutide	2937.19	NC2626B1b Ann. O/6	HSC/63	2019	119	1686108-82-6
cotoretigene toliparvovec	cotoretigène toliparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	123	2246424-95-1	HSC/67 (3002.90)
cotosudil	cotosudil	2935.90	NC2803Bc Ann. T/7	HSC/67	2021	123	1258833-31-6
crenezumab	crénezumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	105	1095207-05-8	HSC/49 (3002.10)
crenigacestat	crénigacestat	2933.79	NC2501B1b Ann. M/6	HSC/61	2018	117	1421438-81-4

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
crenolanib	crénolanib	2934.99	NC1760B1b Ann. N/8	HSC/49	2012	105	670220-88-9
cridanimod	cridanimod	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	83	38609-97-1	HSC/27 (2933.90)
crilvastatin	crilvastatine	2933.79	38.100 Ann. Q (No. 221)	HSC/11	1993	63	120551-59-9
crinecerfont	crinécerfont	2934.10	NC2803Bc Ann. T/2	HSC/67	2021	120	752253-39-7
crisaborole	crisaborole	2934.99	NC2237B1b Ann. S/8	HSC/57	2016	112	906673-24-3
crisantaspase	crisantaspase	3507.90	NC1874B1b Ann. O/2	HSC/51	2013	107	1349719-22-7
crisdesalazine	crisdésalazine	2922.50	NC2803Bc Ann. T/2	HSC/67	2021	120	927685-43-6
crisnatol	crisnatol	2922.19	38.100 Ann. Q (No. 222)	HSC/11	1993	58	96389-68-3
crizanlizumab	crizanlizumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1690318-25-2
crizotinib	crizotinib	2933.39	NC1649B3b Ann. R/14	HSC/47	2011	103	877399-52-5
crobenetine	crobénétine	2933.39	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	221019-25-6
crolibulin	crolibuline	2932.99	NC1760B1b Ann. N/7	HSC/49	2012	104	1000852-17-4
cromakalim	cromakalim	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	58	94470-67-4	HSC/11 (2934.90)
cromoglicate lisetil	cromoglicate lisétil	2932.99	40.600 Ann. D, par. 6	HSC/18	1996	72	110816-79-0
crotedumab	crotédumab	3002.13	NC2373B1b Ann. O/6	HSC/59	2017	114	1452387-69-7
crotoniazide	crotoniazide	2933.39	38.100 Ann. Q (No. 224)	HSC/11	1993	11	7007-96-7
crovalimab	crovalimab	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	1917321-26-6
cudarolimab	cudarolimab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2244739-29-3
cupabimod	cupabimod	2934.99	NC2373B1b Ann. O/7	HSC/59	2017	115	297774-48-2
cusatuzumab	cusatuzumab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	1864871-20-4
custirsen	custirsen	2934.99	NC1443B1b Ann. P/6	HSC/43	2009	99	903916-27-8
cutamesine	cutamésine	2933.59	NC1500B1b Ann. K/6	HSC/44	2009	100	165377-43-5
cyclobarbital	cyclobarbital	2933.53	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	1	52-31-3
cyclopentolate	cyclopentolate	2922.19	40.260 Ann. L/2 (No. 54)	HSC/17	1996	39	512-15-2
cystine	cystine	2930.90	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	56-89-3
cytisinicline	cytisinicline	2933.79	NC2803Bc Ann. T/2	HSC/67	2021	120	485-35-8
dabelotine	dabélotine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	74	118976-38-8	HSC/21 (2934.90)
dabigatran	dabigatran	2933.39	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	211914-51-1
dabigatran etexilate	dabigatran étexilate	2933.39	NC0730B2 Ann. M/7	HSC/31	2003	87	211915-06-9
dabocemagene autoficel	dabocémagène autoficel	3002.51	NC2930Bc Ann. P/27	HSC/69	2022	125	2365353-63-3
dabrafenib	dabrafénib	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	105	1195765-45-7	HSC/49 (2935.00)
dacetuzumab	dacétuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	98	880486-59-9	HSC/43 (3002.10)
daclatasvir	daclatasvir	2933.29	NC1760B1b Ann. N/8	HSC/49	2012	107	1099119-64-5
daclizumab	daclizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	78	152923-56-3	HSC/18 (3002.10)
daclizumab beta	daclizumab bêta	3002.13	NC2373B1b Ann. O/6	HSC/59	2017	114	152923-56-3
dacomitinib	dacomitinib	2933.59	NC1649B3b Ann. R/14	HSC/47	2011	103	1110813-31-4
dactolisib	dactolisib	2933.49	NC1874B1b Ann. O/2	HSC/51	2013	107	915019-65-7
dafsolimab	dafsolimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2367001-71-4
dafsolimab setaritox	dafsolimab sétaritox	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2361013-28-5

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
daglutril	daglutril	2933.79	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	182821-27-8
dagrocorat	dagrocorat	2933.39	NC2116B1b Ann. R/5	HSC/55	2015	111	1044535-52-5
dalantercept	dalantercept	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	105	1186210-24-1	HSC/49 (3002.10)
dalatazide	dalatazide	3002.49	NC2803Bc Ann. T/9	HSC/67	2021	111	1081110-69-1	HSC/55 (3002.90)
dalbavancin	dalbavancine	2941.90	NC0590B2 Ann. L/15	HSC/29	2002	85	171500-79-1
dalbraminol	dalbraminol	2933.19	38.100 Ann. Q (No. 225)	HSC/11	1993	58	81528-80-5
dalcetrapib	dalcétrapib	2930.90	NC1310B1b Ann. N/10	HSC/41	2008	96	211513-37-0
dalcinonacog alfa	dalcinonacog alfa	3002.12	NC2626B1b Ann. O/5	HSC/63	2019	118	2055206-13-6
dalcotidine	dalcotidine	2933.39	42.100 Ann. O (V)	HSC/21	1998	76	120958-90-9
dalosirvat	dalosirvat	2932.99	NC2803Bc Ann. T/7	HSC/67	2021	123	1360540-81-3
dalotuzumab	dalotuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	102	1005389-60-5	HSC/46 (3002.10)
dalpiciclib	dalpiciclib	2933.79	NC2803Bc Ann. T/7	HSC/67	2021	123	1637781-04-4
dalteparin sodium	daltéparine sodique	3001.90	NC1553B1b Ann. O/5	HSC/45	2010	64	9041-08-1
dalutrafusp alfa	dalutrafusp alfa	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2419918-89-9
damoctocog alfa pegol	damoctocog alfa pégol	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	109	1363853-26-2	HSC/53 (3002.10)
danaparoid sodium	danaparoïde sodique	3913.90	42.100 Ann. O (III)	HSC/21	1998	74	83513-48-8
danavorexton	danavorexton	2935.90	NC2803Bc Ann. T/7	HSC/67	2021	123	2114324-48-8
danegaptide	danégaptide	2933.99	NC1604B1b Ann. N/5	HSC/46	2010	101	943134-39-2
danicamtiv	danicamtiv	2934.99	NC2803Bc Ann. T/2	HSC/67	2021	120	1970972-74-7
danicopan	danicopan	2933.59	NC2626B1b Ann. O/6	HSC/63	2019	119	1903768-17-1
daniplestim	daniplestim	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	76	161753-30-6	HSC/21 (3002.10)
daniquidone	daniquidone	2933.79	38.100 Ann. Q (No. 226)	HSC/11	1993	62	67199-66-0
danirixin	danirixine	2933.39	NC1874B1b Ann. O/2	HSC/51	2013	107	954126-98-8
danoprevir	danoprévir	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	102	916881-67-9	HSC/47 (2935.00)
danuglipron	danuglipron	2934.99	NC2930Bc Ann. P/25	HSC/69	2022	124	2230198-02-2
danusertib	danusertib	2933.59	NC1443B1b Ann. P/6	HSC/43	2009	99	827318-97-8
danvatirsen	danvatirsen	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1402100-56-4
dapabutan	dapabutan	2922.49	40.600 Ann. D, par. 6	HSC/18	1996	70	6582-31-6
dapaconazole	dapaconazole	2933.29	NC2116B1b Ann. R/5	HSC/55	2015	111	1269726-67-1
dapagliflozin	dapagliflozine	2932.99	NC1310B1b Ann. N/4	HSC/41	2008	97	461432-26-8
dapansutrile	dapansutrile	2930.90	NC2373B1b Ann. O/6	HSC/59	2017	114	54863-37-5
dapatifagene navolactibac	dapatifagène navolactibac	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	122	no mention	HSC/67 (3002.90)
dapiclermin	dapiclermine	2933.29	NC1059B2b Ann. O/5	HSC/37	2006	93	444069-80-1
dapiglutide	dapiglutide	2937.19	NC2803Bc Ann. T/7	HSC/67	2021	123	2296814-85-0
dapirolizumab pegol	dapirolizumab pégol	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	110	1416147-64-2	HSC/55 (3002.10)
dapitant	dapitant	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	74	153438-49-4	HSC/21 (2933.90)
dapivirine	dapivirine	2933.59	NC0730B2 Ann. M/6	HSC/31	2003	86	244767-67-7
daplusiran	daplusiran	2934.99	NC2803Bc Ann. T/7	HSC/67	2021	123	2202783-38-6
daporinad	daporinad	2933.39	NC1443B1b Ann. P/5	HSC/43	2009	98	201034-75-5

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
daprodustat	daprodustat	2933.54	NC2237B1b Ann. S/9	HSC/57	2016	113	960539-70-2
darapladib	darapladib	2933.59	NC1178B1c Ann. O/3	HSC/39	2007	94	356057-34-6
daratumumab	daratumumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	101	945721-28-8	HSC/46 (3002.10)
darbepoetin alfa	darbépoétine alfa	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	85	209810-58-2	HSC/31 (3002.10)
darbufelone	darbufélone	2934.10	NC0250B2 Ann. P/1 (I)	HSC/25	2000	80	139226-28-1
darexaban	darexaban	2933.99	NC1604B1b Ann. N/5	HSC/46	2010	104	365462-23-3
darglitazone	darglitazone	2934.10	39.600 Ann. D/1, par. 15	HSC/16	1995	69	141200-24-0
daridorexant	daridorexant	2933.99	NC2626B1b Ann. O/5	HSC/63	2019	120	1505484-82-1	(List 118 nemorexant)
darifenacin	darifénacine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	70	133099-04-4	HSC/18 (2934.90)
darigabat	darigabat	2933.99	NC2803Bc Ann. T/7	HSC/67	2021	123	1614245-70-3
darinaparsin	darinaparsine	2930.90	NC1443B1b Ann. P/5	HSC/43	2009	98	69819-86-9
darolutamide	darolutamide	2933.19	NC2373B1b Ann. O/7	HSC/59	2017	115	1297538-32-9
darotropium bromide	bromure de darotropium	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	99	850607-58-8	HSC/45 (2933.99)
darovasertib	darovasertib	2933.39	NC2803Bc Ann. T/7	HSC/67	2021	123	1874276-76-2
darsidormine	darsidomine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	74	137500-42-6	HSC/18 (2934.90)
darunavir	darunavir	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	88	206361-99-1	HSC/33 (2935.00)
darusentan	darusentan	2933.59	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	171714-84-4
darvadstrocel	darvadstrocel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	117	no mention	HSC/63 (3002.90)
dasabuvir	dasabuvir	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	109	1132935-63-7	HSC/53 (2935.00)
dasantafil	dasantafil	2933.59	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	569351-91-3
dasatinib	dasatinib	2934.10	NC1178B1c Ann. O/3	HSC/39	2007	94	302962-49-8
dasiglucagon	dasiglucagon	2937.19	NC2501B1b Ann. M/5	HSC/61	2018	116	1544300-84-6
dasolampanel	dasolampanel	2933.49	NC1760B1b Ann. N/8	HSC/49	2012	105	503294-13-1
dasotraline	dasotraline	2921.49	NC2116B1b Ann. R/4	HSC/55	2015	110	675126-05-3
datelliptium chloride	chlorure de datelliptium	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	57	105118-14-7	HSC/21 (2939.90) HSC/53 (2933.99)
datopotamab	datopotamab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2267989-53-5
datopotamab deruxtecan	datopotamab déruxtécan	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2238831-60-0
davalintide	davalintide	2937.19	NC1649B3b Ann. R/12	HSC/47	2011	101	863919-85-1
davamotecan pegadexamer	davamotécan pégadexamère	2939.79	NC2501B1b Ann. M/6	HSC/61	2018	117	1883668-61-8
davasaicin	davasaïcine	2924.29	NC1178B1c Ann. O/2	HSC/39	2007	92	147497-64-1
davoceticept	davocéticept	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2307144-64-3
davunetide	davunétide	2933.99	NC1553B1b Ann. O/7	HSC/45	2010	100	211439-12-2
daxalipram	daxalipram	2934.99	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	189940-24-7
daxdilimab	daxdilimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2245966-28-1
dazcapistat	dazcapistat	2934.99	NC2803Bc Ann. T/11	HSC/67	2021	4 COVID	2221010-42-8
dazodalibep	dazodalibep	2934.99	NC2803Bc Ann. T/7	HSC/67	2021	123	2245953-10-8
dazucorilant	dazucorilant	2935.90	NC2930Bc Ann. P/27	HSC/69	2022	125	1496508-34-9
decernotinib	décernotinib	2933.59	NC2004B1b Ann. O/4	HSC/53	2014	110	944842-54-0

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
decitropine	décitropine	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	18	1242-69-9	HSC/11 (2939.90) HSC/53 (2939.99)
declenperone	déclenpérone	2933.39	38.100 Ann. Q (No. 228)	HSC/11	1993	42	63388-37-4
declopramide	déclopramide	2924.29	42.750 Ann. O	HSC/22	1998	78	891-60-1
decoglurant	décoglurant	2933.59	NC2004B1b Ann. O/5	HSC/53	2014	109	911115-16-7
decominol	décominol	2922.19	40.260 Ann. L/2 (No. 55)	HSC/17	1996	45	60812-35-3
dectrekumab	dectrékumab	3002.13	NC2237B1b Ann. T/10	HSC/57	2016	112	1528523-94-5	HSC/57 (3002.10) (S/8)
defactinib	défactinib	2935.90	NC2237B1b Ann. T/12	HSC/57	2016	111	1073154-85-4	HSC/55 (2935.00)
deferasirox	déférasirox	2933.99	NC0730B2 Ann. M/6	HSC/31	2003	86	201530-41-8
deferitazole	déféritazole	2934.10	NC2004B1b Ann. O/4	HSC/53	2014	108	945635-15-4
deferitrin	déféritrine	2934.10	NC1004B1b Ann. L/11	HSC/36	2005	92	239101-33-8
deflazacort	déflazacort	2937.29	38.100 Ann. Q (No. 229)	HSC/11	1993	39	14484-47-0
defosbarasertib	défosbarasertib	2933.59	NC2930Bc Ann. P/25	HSC/69	2022	124	722544-51-6
defoslimod	défoslimod	2932.99	NC0430B2 Ann. Q/1 (III)	HSC/27	2001	79	171092-39-0
degarelix	dégarélix	2937.19	NC0730B2 Ann. M/6	HSC/31	2003	86	214766-78-6
delafloxacin	délafloxacine	2933.49	NC1553B1b Ann. O/7	HSC/45	2010	100	189279-58-1
delamanid	délamanid	2934.99	NC1760B1b Ann. N/7	HSC/49	2012	104	681492-22-8
delandistrogene moxeparvovec	délandistrogène moxéparvovec	3002.49	NC2930Bc Ann. P/25	HSC/69	2022	124	2305040-16-6
delanzomib	délanzomib	2933.39	NC1760B1b Ann. N/8	HSC/49	2012	105	847499-27-8
delavirdine	délavirdine	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	71	136817-59-9	HSC/18 (2935.00)
delcasertib	delcasertib	2934.99	NC1760B1b Ann. N/8	HSC/49	2012	105	949100-39-4
deldeprevir	deldéprévir	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	110	1229626-28-1	HSC/51 (2935.00)
deleobuvir	déléobuvir	2933.59	NC2004B1b Ann. O/4	HSC/53	2014	108	863884-77-9
delequamine	déléquamine	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	73	119905-05-4	HSC/18 (2935.00)
delgocitinib	delgocitinib	2933.59	NC2501B1b Ann. M/6	HSC/61	2018	117	1263774-59-9
deligoparin sodium	déligoparine sodique	3001.90	NC1553B1b Ann. O/5	HSC/45	2010	89	9041-08-1
delimotecan	délimotécan	2939.79	NC2237B1b Ann. T/12	HSC/57	2016	97	187852-63-7	HSC/43 (2939.99)
delmitide	delmitide	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	92	287096-87-1	HSC/47 (3002.10)
delolimogene mupadenorepvec	délolimogène mupadénorépvec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	118	2061938-98-3	HSC/63 (3002.90)
delorazepam	délorazépam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	40	2894-67-9
deloxolone	déloxolone	2918.19	38.100 Ann. Q (No. 230)	HSC/11	1993	51	68635-50-7
delparantag	delparantag	2924.29	NC2004B1b Ann. O/4	HSC/53	2014	108	872454-31-4
delpazolid	delpazolid	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1219707-39-7
deltibant	deltibant	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	75	140661-97-8	HSC/21 (2933.90)
delucemine	délucémine	2921.49	NC0730B2 Ann. M/7	HSC/31	2003	87	186495-49-8
dematirsen	dématirsen	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1802465-55-9
demcizumab	demcizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1243262-17-0	HSC/51 (3002.10)
demegestone	démégestone	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	24	10116-22-0	HSC/11 (2937.92)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
demiditraz	demiditraz	2933.29	NC1443B1b Ann. P/6	HSC/43	2009	99	944263-65-4
demplatin pegraglumer	demplatine pégraglumère	2843.90	NC2501B1b Ann. M/6	HSC/61	2018	117	1009838-50-9
demupitamab	démupitamab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2249926-74-5
denagliptin	dénagliptine	2933.99	NC1123B1b Ann. N/1	HSC/38	2006	94	483369-58-0
denaverine	dénavérine	2922.19	40.260 Ann. L/2 (No. 56)	HSC/17	1996	25	3579-62-2
denbufylline	denbufylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	55	57076-71-8	HSC/11 (2939.50)
denenicokin	dénénicokine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	99	716840-32-3	HSC/43 (3002.10)
denibulin	dénibuline	2933.99	NC1178B1c Ann. O/5	HSC/39	2007	95	284019-34-7
denifanstat	dénifanstat	2933.39	NC2930Bc Ann. P/27	HSC/69	2022	125	1399177-37-7
denileukin diffitox	dénileukine diftitox	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	78	173146-27-5	HSC/25 (3002.10)
denintuzumab mafodotine	dénintuzumab mafodotine	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	111	1399672-02-6	HSC/55 (3002.10)
denosumab	dénosumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	94	615258-40-7	HSC/38 (3002.10)
denotivir	dénotivir	2934.10	40.600 Ann. D, par. 6	HSC/18	1996	70	51287-57-1
denufosol	dénufosol	2934.99	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	211448-85-0
deoxycholic acid	acide désoxycholique	2918.19	NC1874B1B Ann. O/1	HSC/51	2013	106	83-44-3
depatuxizumab	dépatuxizumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1471999-69-5
depatuxizumab mafodotin	dépatuxizumab mafodotine	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1585973-65-4
depelestat	dépélestat	2934.99	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	506433-25-6
depemokimab	dépémokimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2243274-14-6
depreotide	dépréotide	2933.79	NC0250B2 Ann. P/1 (I)	HSC/25	2000	80	161982-62-3
deptropine	deptropine	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	12	604-51-3	HSC/11 (2939.90) HSC/53 (2939.99)
deracoxib	déracoxib	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	80	169590-41-4	HSC/25 (2935.00)
derazantinib	dérazantinib	2933.59	NC2501B1b Ann. M/5	HSC/61	2018	116	1234356-69-4
derenofylline	dérénofylline	2933.59	NC1604B1b Ann. N/6	HSC/46	2010	102	251945-92-3
derpanicate	derpanicate	2933.39	38.100 Ann. Q (No. 233)	HSC/11	1993	58	99518-29-3
derquantel	derquantel	2934.99	NC1443B1b Ann. P/6	HSC/43	2009	99	187865-22-1
dersalazine	dersalazine	2933.39	NC0730B2 Ann. M/6	HSC/31	2003	86	188913-58-8
dersimelagon	dersimélagon	2933.39	NC2626B1b Ann. O/6	HSC/63	2019	119	1835256-48-8
desaspidin	désaspidine	2914.50	42.100 Ann. O (I)	HSC/21	1998	15	114-43-2
desciclovir	desciclovir	2933.59	38.100 Ann. Q (No. 234)	HSC/11	1993	55	84408-37-7
descinolone	descinolone	2937.22	38.100 Ann. Q (No. 235)	HSC/11	1993	17	595-52-8
desfesoterodine	desfésotérodine	2922.50	NC2237B1b Ann. S/8	HSC/57	2016	112	207679-81-0
desidustat	désidustat	2933.79	NC2501B1b Ann. M/6	HSC/61	2018	117	1616690-16-4
desirudin	désirudine	3001.90	40.600 Ann. D, par. 6	HSC/18	1996	70	120993-53-5
deslanoside	deslanoside	2938.90	38.100 Ann. Q (No. 236)	HSC/11	1993	14	17598-65-1
desloratadine	desloratadine	2933.39	NC0090B2 Ann. M/5	HSC/23	1999	80	100643-71-8
desmeninol	desméninol	2930.90	40.600 Ann. D, par. 6	HSC/18	1996	70	583-91-5
desmetramadol	desmétramadol	2922.50	NC2501B1b Ann. M/6	HSC/61	2018	117	80456-81-1

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
desmopressin	desmopressine	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	33	16679-58-6	HSC/11 (2937.99)
desmoteplase	desmoteplase	3507.90	NC0250B2 Ann. P/1 (I)	HSC/25	2000	80	145137-38-8
desomorphine	désomorphine	2939.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	427-00-9
desoximetasone	désoximétasone	2937.22	38.100 Ann. Q (No. 238)	HSC/11	1993	20	382-67-2
detanosal	détanosal	2922.19	40.260 Ann. L/2 (No. 57)	HSC/17	1996	23	23573-66-2
detiviciclovir	détiviciclovir	2933.59	NC0730B2 Ann. M/6	HSC/31	2003	86	220984-26-9
detumomab	détumomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	70	145832-33-3	HSC/18 (3002.10)
deucravacitinib	deucravacitinib	2845.90	NC2803Bc Ann. T/7	HSC/67	2021	123	1609392-27-9
deudextromethorphan	deudextromethorphane	2845.90	NC2373B1b Ann. O/6	HSC/59	2017	114	1079043-55-2
deudomperidone	deudompéridone	2845.90	NC2930Bc Ann. P/25	HSC/69	2022	124	2121525-08-2
deuruxolitinib	deuruxolitinib	2845.90	NC2930Bc Ann. P/25	HSC/69	2022	124	1513883-39-0
deutarserine	deutarsérine	2845.90	NC2930Bc Ann. P/25	HSC/69	2022	124	103292-62-2
deutetrabenazine	deutétrabénazine	2845.90	NC2237B1b Ann. S/8	HSC/57	2016	112	1392826-25-3
deutivacaftor	deutivacaftor	2845.90	NC2626B1b Ann. O/5	HSC/63	2019	118	1413431-07-8
deutolperisone	deutolpérisone	2845.90	NC1059B2b Ann. O/4	HSC/37	2006	92	474641-19-5
devafidugene civaparvovec	devafidugène civaparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	120	2143580-11-2	HSC/67 (3002.90)
devimistat	dévimistat	2930.90	NC2803Bc Ann. T/2	HSC/67	2021	120	95809-78-2
dexamethasone cipecilate	cipécilate de dexaméthasone	2937.22	NC1178B1c Ann. O/3	HSC/39	2007	94	132245-57-9
dexamfetamine	dexamfétamine	2921.46	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	55	51-64-9
dexbudesonide	dexbudésonide	2932.99	NC0250B2 Ann. P/1 (I)	HSC/25	2000	80	51372-29-3
dexecadotril	dexécadotril	2930.90	40.600 Ann. D, par. 6	HSC/18	1996	73	112573-72-5
dexefaroxan	dexéfaroxan	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	76	143249-88-1	HSC/21 (2934.90)
dexelvucitabine	dexelvucitabine	2934.99	NC1178B1c Ann. O/5	HSC/39	2007	95	134379-77-4
dexepicatechin	dexépicatéchine	2932.99	NC2930Bc Ann. P/27	HSC/69	2022	125	35323-91-2
dexisometheptene	dexisométhéptène	2921.19	NC2373B1b Ann. O/7	HSC/59	2017	115	1620401-56-0
dexketoprofen	dexkétoprofène	2918.30	40.600 Ann. D, par. 6	HSC/18	1996	70	22161-81-5
dexlansoprazole	dexlansoprazole	2933.39	NC1059B2b Ann. O/5	HSC/37	2006	93	138530-94-6
dexmecamylamine	dexmécamylamine	2921.30	NC1874B1b Ann. O/1	HSC/51	2013	106	107538-05-6
dexmethylphenidate	dexméthylphénidate	2933.39	NC0845B2 Ann. M/2	HSC/33	2004	88	40431-64-9
dexnebivolol	dexnébivolol	2932.99	NC1443B1b Ann. P/5	HSC/43	2009	98	118457-15-1
dexpemedolac	dexpémédolac	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	71	114030-44-3	HSC/18 (2934.90)
dexpramipexole	dexpramipexole	2934.20	NC1649B3b Ann. R/14	HSC/47	2011	103	104632-28-2
dexpropranolol	dexpropranolol	2922.19	40.260 Ann. L/2 (No. 58)	HSC/17	1996	21	5051-22-9
dexsotalol	dexsotalol	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	74	30236-32-9	HSC/21 (2935.00)
dextiopronin	dextiopronine	2930.90	NC0090B2 Ann. M/1 (II)	HSC/23	1999	79	29335-92-0
dextofisopam	dextofisopam	2933.99	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	82059-50-5
dextromethorphan	dextrométhorphane	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	1	125-71-3	HSC/11 (2933.40)
dextromoramide	dextromoramide	2934.91	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	6	357-56-2
dextropropoxyphene	dextropropoxyphène	2922.14	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	7	469-62-5

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
dextrorphan	dextrorphane	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	1	125-73-5	HSC/11 (2933.40)
dezaguanine	dézaguanine	2933.79	38.100 Ann. Q (No. 241)	HSC/11	1993	51	41729-52-6
dezamizumab	dézamizumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1662664-56-3
dezapelisib	dézapélisib	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1262440-25-4
diampromide	diampromide	2924.29	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	10	552-25-0
dianexin	dianexine	3002.12	NC2373B1b Ann. O/12	HSC/59	2017	109	1352413-49-0	HSC/57 (3002.10)
dianhydrogalactitol	dianhydrogalactitol	2910.90	NC2116B1b Ann. R/5	HSC/55	2015	111	23261-20-3
dianicline	dianicline	2934.99	NC1059B2b Ann. O/5	HSC/37	2006	93	292634-27-6
diaplasinin	diaplasinine	2933.99	NC1123B1b Ann. N/1	HSC/38	2006	94	481631-45-2
diazepam	diazépam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	12	439-14-5
dibotermin alfa	dibotermine alfa	2933.29	NC0938B2b Ann. O/2	HSC/35	2005	89	246539-15-1
dibunate	dibunate	2904.10	38.100 Ann. Q (No. 69)	HSC/11	1993	48	no mention
dichlorisone	dichlorisone	2937.22	38.100 Ann. Q (No. 242)	HSC/11	1993	10	7008-26-6
diciferron	diciferron	2931.90	NC2373B1b Ann. O/12	HSC/59	2017	44	65606-61-3	HSC/11 (2931.00)
dicirenone	dicirénone	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	50	41020-79-5	HSC/11 (2937.99)
diclofenac etalhyaluronate	étalhyaluronate de diclofénac	3913.90	NC2116B1b Ann. R/5	HSC/55	2015	111	1608089-20-8
dicobalt edetate	édétate dicobaltique	2922.49	38.100 Ann. Q (No. 245)	HSC/11	1993	45	36499-65-7
dienestrol	diènestrol	2907.29	38.100 Ann. Q (No. 246)	HSC/11	1993	1	84-17-3
dienogest	diénogest	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	49	65928-58-7	HSC/11 (2907.29)
diethylstilbestrol	diéthylstilbestrol	2907.29	38.100 Ann. Q (No. 248)	HSC/11	1993	4	56-53-1
diethylthiambutene	diéthylthiambutène	2934.99	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	3	86-14-6
dietifen	diétifène	2922.19	40.260 Ann. L/2 (No. 59)	HSC/17	1996	22	3686-78-0
difamilast	difamilast	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	937782-05-3
difelikefalin	difélikéfaline	2933.39	NC2237B1b Ann. S/9	HSC/57	2016	113	1024828-77-0
difemerine	difémérine	2922.19	40.260 Ann. L/2 (No. 60)	HSC/17	1996	17	80387-96-8
difenoximide	difénoximide	2933.39	38.100 Ann. Q (No. 249)	HSC/11	1993	32	47806-92-8
difenoxin	difénoxine	2933.33	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	25	28782-42-5
difeterol	difétérol	2922.19	40.260 Ann. L/2 (No. 61)	HSC/17	1996	36	14587-50-9
diflomotecan	diflomotécan	2934.99	NC2237B1b Ann. S/11	HSC/57	2016	84	220997-97-7	HSC/31 (2939,99)
difluprednate	difluprednate	2937.22	38.100 Ann. Q (No. 250)	HSC/11	1993	21	23674-86-4
dihydrocodeine	dihydrocodéine	2939.11	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	8	125-28-0
dilanubicel	dilanubicel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	119	no mention	HSC/63 (3002.90)
dilmapimod	dilmapimod	2933.79	NC1649B3b Ann. R/13	HSC/47	2011	102	444606-18-2
dilopetine	dilopétine	2934.99	NC1123B1b Ann. N/1	HSC/38	2006	94	247046-52-2
dilpacimab	dilpacimab	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	1791420-09-1
diltiazem	diltiazem	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	30	42399-41-7	HSC/11 (2934.90)
dimabefylline	dimabéfylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	19	1703-48-6	HSC/11 (2939.50)
dimadectin	dimadectine	2941.90	40.600 Ann. D, par. 6	HSC/18	1996	73	156131-91-8
dimelazine	dimélazine	2934.30	38.100 Ann. Q (No. 253)	HSC/11	1993	14	15302-12-2

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
dimenoxadol	diménoxadol	2922.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	7	509-78-4	HSC/17 (2922.19)
dimepheptanol	dimépheptanol	2922.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	545-90-4
dimesone	dimésone	2937.22	38.100 Ann. Q (No. 254)	HSC/11	1993	23	25092-07-3
dimethylthiambutene	diméthylthiambutène	2934.99	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	3	524-84-5
dinaciclib	dinaciclib	2933.59	NC1649B3b Ann. R/13	HSC/47	2011	102	779353-01-4
dinalbuphine sebacate	sébacate de dinalbuphine	2939.19	NC2373B1b Ann. O/6	HSC/59	2017	116	311768-81-7	(List 114 nalbuphine seb
dinutuximab	dinutuximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	109	1363687-32-4	HSC/53 (3002.10)
dinutuximab beta	dinutuximab bêta	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	113	1613303-02-8	HSC/57 (3002.10) (S/9)
dioxaphetyl butyrate	butyrate de dioxaphétyl	2934.99	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	467-86-7
diphenoxylate	diphénoxylate	2933.33	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	10	915-30-0
dipipanone	dipipanone	2933.33	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	467-83-4
diprafenone	diprafénone	2922.19	40.260 Ann. L/2 (No. 63)	HSC/17	1996	48	81447-80-5
dipraglurant	dipraglurant	2933.39	NC1604B1b Ann. N/6	HSC/46	2010	102	872363-17-2
diprogulic acid	acide diprogulique	2932.99	NC2004B1b Ann. O/6	HSC/53	2014	35	18467-77-1	HSC/11 (2932.90)
diridavumab	diridavumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	111	1393659-46-5	HSC/55 (3002.10)
dirithromycin	dirithromycine	2941.50	38.100 Ann. Q (No. 256)	HSC/11	1993	53	62013-04-1
dirloctocogene samoparvovec	dirloctocogène samoparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	121	2163074-23-3	HSC/67 (3002.90)
dirlotapide	dirlotapide	2933.99	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	481658-94-0
dirocaftor	dirocaftor	2933.49	NC2803Bc Ann. T/7	HSC/67	2021	123	2137932-23-9
diroleuton	diroleuton	2916.19	NC2626B1b Ann. O/5	HSC/63	2019	118	1783-84-2
diroximel fumarate	fumarate de diroximel	2925.19	NC2373B1b Ann. O/7	HSC/59	2017	115	1577222-14-0
dirucotide	dirucotide	2933.29	NC1553B1b Ann. O/7	HSC/45	2010	100	152074-97-0
disitamab	disitamab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2185868-98-6
disitamab vedotin	disitamab védotine	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2136633-23-1
disitertide	disitertide	2933.99	NC1443B1b Ann. P/6	HSC/43	2009	99	272105-42-7
disogluside	disogluside	2938.90	38.100 Ann. Q (No. 257)	HSC/11	1993	47	14144-06-0
disomotide	disomotide	3002.41	NC2803Bc Ann. T/4	HSC/67	2021	94	181477-43-0	HSC/40 (3002.20)
disufenton sodium	disufenton sodique	2929.90	NC0845B2 Ann. M/2	HSC/33	2004	88	168021-79-2
disulergine	disulergine	2939.69	42.100 Ann. O (I)	HSC/21	1998	45	59032-40-5
disulfiram	disulfirame	2930.30	38.100 Ann. Q (No. 258)	HSC/11	1993	1	97-77-8
disuprazole	disuprazole	2933.39	38.100 Ann. Q (No. 259)	HSC/11	1993	56	99499-40-8
ditekiren	ditékirène	2933.39	38.100 Ann. Q (No. 260)	HSC/11	1993	84	103336-05-6
ditercalinium chloride	chlorure de ditercalinium	2933.39	38.100 Ann. Q (No. 261)	HSC/11	1993	49	74517-42-3
dithranol	dithranol	2914.50	38.100 Ann. Q (No. 262)	HSC/11	1993	4	480-22-8
divaplon	divaplone	2933.59	38.100 Ann. Q (No. 263)	HSC/11	1993	61	90808-12-1
divozilimab	divozilimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2254061-60-2
dizocilpine	dizocilpine	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	60	77086-21-6	HSC/11 (2933.40)
docaravimab	docaravimab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2247196-23-0

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
docetaxel	docétaxel	2932.99	NC2004B1b Ann. O/6	HSC/53	2014	71	114977-28-5	HSC/11 (2932.90)
dociparstat sodium	dociparstat sodique	3913.90	NC2373B1b Ann. O/6	HSC/59	2017	114	177021-00-0
dofequidar	doféquidar	2933.59	NC0845B2 Ann. M/2	HSC/33	2004	88	129716-58-1
dolcanatide	dolcanatide	2937.19	NC2501B1b Ann. M/3	HSC/61	2018	114	1092457-65-2
dolutegravir	dolutégravir	2934.99	NC1760B1b Ann. N/8	HSC/49	2012	105	1051375-16-6
domagrozumab	domagrozumab	3002.13	NC2373B1b Ann. O/6	HSC/59	2017	114	1629605-31-7
domatinostat	domatinostat	2935.90	NC2626B1b Ann. O/5	HSC/63	2019	118	910462-43-0
domitroban	domitroban	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	73	112966-96-8	HSC/18 (2935.00)
domofenogene zalfaparvovec	domofénogène zalfaparvovec	3002.49	NC2930Bc Ann. P/27	HSC/69	2022	125	2382896-04-8
domoprednate	domoprednate	2937.29	38.100 Ann. Q (No. 266)	HSC/11	1993	47	66877-67-6
domperidone	dompéridone	2933.39	38.100 Ann. Q (No. 267)	HSC/11	1993	36	57808-66-9
domvanalimab	domvanalimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2368219-35-4
donanemab	donanémab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	1931944-80-7
donaperminogene seltoplasmid	donaperminogène seltoplasmide	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1787232-87-4
donepezil	donépézil	2933.39	42.100 Ann. O (IV)	HSC/21	1998	75	120014-06-4
donidalorsen	donidalorsen	2934.99	NC2930Bc Ann. P/25	HSC/69	2022	124	2304692-48-4
donitriptan	donitriptan	2933.59	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	170912-52-4
doqualast	doqualast	2933.59	38.100 Ann. Q (No. 268)	HSC/11	1993	48	64019-03-0
doramapimod	doramapimod	2934.99	NC0845B2 Ann. M/2	HSC/33	2004	88	285983-48-4
doramectin	doramectine	2941.90	38.100 Ann. Q (No. 269)	HSC/11	1993	65	117704-25-3
doranidazole	doranidazole	2933.29	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	149838-23-3
dorastine	dorastine	2933.39	38.100 Ann. Q (No. 270)	HSC/11	1993	23	21228-13-7
doravirine	doravirine	2933.79	NC2004B1b Ann. O/5	HSC/53	2014	109	1338225-97-0
doripenem	doripénem	2941.90	NC0590B2 Ann. L/10	HSC/29	2002	83	148016-81-3
dornase alfa	dornase alfa	3507.90	40.600 Ann. D, par. 6	HSC/18	1996	70	143831-71-4
doruxapapogene ralaplasmid	doruxapapogène ralaplasmide	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	2416305-95-6
dorzagliatin	dorzagliatine	2933.79	NC2501B1b Ann. M/5	HSC/61	2018	116	1191995-00-2
dosergoside	dosergoside	2939.69	NC2004B1b Ann. O/6	HSC/53	2014	54	87178-42-5	HSC/11 (2939.60)
dostarlimab	dostarlimab	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	2022215-59-2
dotinurad	dotinurad	2934.20	NC2501B1b Ann. M/5	HSC/61	2018	116	1285572-51-1
dovanvetmab	dovanvetmab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2171034-71-0
dovitinib	dovitinib	2933.79	NC1310B1b Ann. N/4	HSC/41	2008	97	405169-16-6
doxecitine	doxécitine	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	951-77-9
doxercalciferol	doxercalciférol	2936.29	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	54573-75-0
doxribtimine	doxribtimine	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	50-89-5
draquinolol	draquinolol	2933.79	38.100 Ann. Q (No. 272)	HSC/11	1993	54	67793-71-9
dresbuxelimab	dresbuxélimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2550560-20-6
drinabant	drinabant	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	99	358970-97-5	HSC/43 (2935.00)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
drisapersen	drisapersen	2934.99	NC1874B1b Ann. O/1	HSC/51	2013	106	1251830-50-8
droloxifene	droloxifène	2922.19	40.260 Ann. L/2 (No. 64)	HSC/17	1996	53	82413-20-5
dronedarone	dronédarone	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	75	141626-36-0	HSC/21 (2935.00)
drospirenone	drospirénone	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	63	67392-87-4	HSC/11 (2932.29)
drotebanol	drotébanol	2933.49	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	24	3176-03-2
drotrecogin alfa (activated)	drotrécogine alfa (activé)	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	86	98530-76-8	HSC/31 (3002.10)
droxinavir	droxinavir	2924.21	42.100 Ann. O (III)	HSC/21	1998	74	159910-86-8
drozitumab	drozitumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	103	912628-39-8	HSC/47 (3002.10)
dubermatinib	dubermatinib	2935.90	NC2803Bc Ann. T/2	HSC/67	2021	120	1341200-45-0
dulaglutide	dulaglutide	2937.19	NC1649B3b Ann. R/14	HSC/47	2011	103	923950-08-7
dulanermin	dulanermine	2933.29	NC1443B1b Ann. P/6	HSC/43	2009	99	867153-61-5
duligotumab	duligotumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1314238-96-4	HSC/51 (3002.10)
dupilumab	dupilumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	108	1190264-60-8	HSC/53 (3002.10)
durlobactam	durlobactam	2933.39	NC2626B1b Ann. O/6	HSC/63	2019	119	1467829-71-5
durvalumab	durvalumab	3002.13	NC2237B1b Ann. T/10	HSC/57	2016	112	1428935-60-7	HSC/57 (3002.10) (S/8)
dusigitumab	dusigitumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	108	1204390-13-5	HSC/53 (3002.10)
dusquetide	dusquétide	2933.99	NC2237B1b Ann. S/9	HSC/57	2016	113	931395-42-5
dutacatib	dutacatib	2933.59	NC1123B1b Ann. N/1	HSC/38	2006	94	501000-36-8
dutasteride	dutastéride	2937.29	NC2116B1b Ann. R/7	HSC/55	2015	78	164656-23-9	HSC/22 (2933.79)
duteplase	dutéplase	3507.90	38.100 Ann. Q (No. 275)	HSC/11	1993	62	120608-46-0
dutogliptin	dutogliptine	2933.99	NC1500B1b Ann. K/6	HSC/44	2009	100	852329-66-9
duvelisib	duvélisib	2933.79	NC2116B1b Ann. R/4	HSC/55	2015	110	1201438-56-3
duvoglustat	duvoglustat	2933.39	NC1604B1b Ann. N/6	HSC/46	2010	102	19130-96-2
duvortuxizumab	duvortuxizumab	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1831098-91-9
ebalzotan	ébalzotan	2932.99	40.600 Ann. D, par. 6	HSC/18	1996	72	149494-37-1
ebaresdax	ébaresdax	2934.10	NC2930Bc Ann. P/25	HSC/69	2022	124	1334471-39-4
ebdarokimab	ebdarokimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2393651-11-9
eblasakimab	éblasakimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2445460-16-0
ebopiprant	ébopiprant	2935.90	NC2803Bc Ann. T/6	HSC/67	2021	122	2005486-31-5
ebronucimab	ébronucimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2304800-90-4
ebvaciclib	ebvaciclib	2935.90	NC2930Bc Ann. P/25	HSC/69	2022	124	2185857-97-8
ecalcidene	ecalcidene	2933.39	NC0590B2 Ann. L/15	HSC/29	2002	85	150337-94-3
ecallantide	ecallantide	2934.99	NC1059B2b Ann. O/5	HSC/37	2006	93	460738-38-9
ecamsule	écamsule	2914.79	NC2116B1b Ann. S/1	HSC/55	2015	75	92761-26-7	HSC/21 (2914.70)
ecenofloxacin	écénofloxacine	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	78	162301-05-5	HSC/22 (2933.90)
ecipramidil	écipramidil	2922.19	40.260 Ann. L/2 (No. 65)	HSC/17	1996	40	64552-16-5
ecleralimab	écléralimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2415207-91-7
eclitasertib	éclitasertib	2934.99	NC2803Bc Ann. T/11	HSC/67	2021	4 COVID	2125450-76-0

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
ecogramostim	écogramostim	3504.00	38.100 Ann. Q (No. 276)	HSC/11	1993	62	123120-99-0
ecomustine	écomustine	2932.99	NC2004B1b Ann. O/6	HSC/53	2014	61	98383-18-7	HSC/11 (2932.90)
ecopipam	ecopipam	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	80	112108-01-7	HSC/23 (2933.90)
ecopladib	ecopladib	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	90	381683-92-7	HSC/35 (2935.00)
ecraprost	ecraprost	2937.50	NC2116B1b Ann. R/7	HSC/55	2015	83	136892-64-3	HSC/27 (2918.19)
ecromeximab	écromeximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	87	292819-64-8	HSC/31 (3002.10)
ecubectedin	écubectédine	2939.80	NC2930Bc Ann. P/25	HSC/69	2022	124	2248127-53-7
eculizumab	eculizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	87	219685-50-4	HSC/31 (3002.10)
edaglitazone	edaglitazone	2934.10	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	213411-83-7
edaravone	édaravone	2933.19	42.100 Ann. O (III)	HSC/21	1998	74	89-25-8
edasalonexent	édasalonexent	2924.29	NC2373B1b Ann. O/6	HSC/59	2017	114	1204317-86-1
edaxeterkib	édaxeterkib	2933.59	NC2930Bc Ann. P/25	HSC/69	2022	124	1695534-88-3
edelfosine	édelfosine	2923.90	38.100 Ann. Q (No. 278)	HSC/11	1993	59	70641-51-9
edicotinib	édicotinib	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1142363-52-7
edifolone	édifolone	2932.99	NC2004B1b Ann. O/6	HSC/53	2014	56	90733-40-7	HSC/11 (2932.90)
edivoxetine	édivoxétine	2934.99	NC1760B1b Ann. N/7	HSC/49	2012	104	1194508-25-2
edodekin alfa	édodékine alfa	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	79	187348-17-0	HSC/23 (3002.10)
edonentan	edonentan	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	86	210891-04-6	HSC/31 (2935.00)
edonerpic	édonerpic	2934.99	NC2373B1b Ann. O/6	HSC/59	2017	114	519187-23-6
edotecarin	édotécarine	2934.99	NC0730B2 Ann. M/7	HSC/31	2003	87	174402-32-5
edotreotide	édotréotide	2934.99	NC0590B2 Ann. L/15	HSC/29	2002	84	204318-14-9
edoxaban	édoxaban	2934.99	NC1443B1b Ann. P/6	HSC/43	2009	99	480449-70-5
edralbrutinib	édralbrutinib	2933.99	NC2803Bc Ann. T/7	HSC/67	2021	123	1858206-58-2
edratide	edratide	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	89	433922-67-9	HSC/47 (3002.10)
edrecolomab	édrécolomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	74	156586-89-9	HSC/21 (3002.10)
edronocaine	édronocaïne	2922.19	NC0590B2 Ann. L/15	HSC/29	2002	84	190258-12-9
efalizumab	éfalizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	85	214745-43-4	HSC/29 (3002.10)
efanesoctocog alfa	éfanésoctocog alfa	3002.12	NC2803Bc Ann. T/6	HSC/67	2021	122	2252477-42-0
efaprinermin alfa	éfaprinermine alfa	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2102200-64-4
efaproxiral	éfaproxiral	2924.29	NC0730B2 Ann. M/6	HSC/31	2003	86	131179-95-8
efavaleukin alfa	éfavaleukine alfa	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	2049067-94-7
efavirenz	éfavirenz	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	78	154598-52-4	HSC/22 (2934.90)
efbemalenograstim alfa	efbémalénograstim alfa	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2200269-79-8
efdamrofusp alfa	efdamrofusp alfa	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2375661-82-6
efegatran	éfégatran	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	71	105806-65-3	HSC/18 (2933.90)
efepoetin alfa	éfépoétine alfa	3002.12	NC2501B1b Ann. M/6	HSC/61	2018	117	1905452-78-9
efepristin	éfépristine	2941.90	42.100 Ann. O (IV)	HSC/21	1998	75	57206-54-9
efgartigimod alfa	efgartigimod alfa	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1821402-21-4
efgivanermin alfa	efgivanermine alfa	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	1807864-13-6

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
efinaconazole	éfinaconazole	2933.39	NC1760B1b Ann. N/7	HSC/49	2012	104	164650-44-6
efineptakin alfa	éfineptakine alfa	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	2026634-47-7
efinopegdutide	éfinopégdutide	2937.19	NC2626B1b Ann. O/5	HSC/63	2019	118	2055640-93-0
efipladib	efipladib	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	92	381683-94-9	HSC/37 (2935.00)
efizonerimod alfa	éfizonérimod alfa	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1635395-27-5
eflapegastrim	éflapégastrim	3002.13	NC2373B1b Ann. O/8	HSC/59	2017	111	1384099-30-2	HSC/55 (3002.10)
eflenograstim alfa	éflénograstim alfa	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1905459-83-7
eflepedocokin alfa	eflépédocokine alfa	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2200269-84-5
efletirizine	éflétirizine	2933.59	40.600 Ann. D, par. 6	HSC/18	1996	71	150756-35-7
eflimrufusp alfa	éflimrufusp alfa	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2363779-14-8
eflucimibe	éflucimibe	2930.90	NC0590B2 Ann. L/15	HSC/29	2002	84	202340-45-2
efmarodocokin alfa	efmarodocokine alfa	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2247840-74-8
efmitermant alfa	efmitermant alfa	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	1644543-31-6
efmoroctocog alfa	efmoroctocog alfa	3002.12	NC2237B1b Ann. T/13	HSC/57	2016	111	1270012-79-7	HSC/55 (3002.10)
efpeglenatide	efpèglénatide	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	111	1296200-77-5	HSC/53 (3002.10)
efpegsomatropin	efpegsomatropine	2937.11	NC2237B1b Ann. S/9	HSC/57	2016	113	1314472-89-3
efprezimod alfa	efprézimod alfa	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2574508-57-7
efruxifermin	éfruxifermine	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2375240-92-7
eftansomatropin alfa	eftansomatropine alfa	2937.11	NC2626B1b Ann. O/5	HSC/63	2019	118	1905448-17-0
eftilagimod alfa	eftilagimod alfa	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1800476-36-1
eftozanermin alfa	eftozanermine alfa	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	1820660-69-2
eftrenonacog alfa	eftrénonacog alfa	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	109	1270012-74-2	HSC/53 (3002.10)
efungumab	éfungumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	95	762260-74-2	HSC/39 (3002.10)
efzofitimod	efzofitimod	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2566615-11-8
eganelisib	éganélisib	2933.79	NC2930Bc Ann. P/25	HSC/69	2022	124	1693758-51-8
eganoprost	eganoprost	2937.50	NC0590B2 Ann. L/15	HSC/29	2002	84	63266-93-3
egaptivon pegol	egaptivon pégol	3907.29	NC2803Bc Ann. T/4	HSC/67	2021	104	934868-74-3	HSC/49 (3907.20)
eglumetad	églumétad	2922.49	NC0730B2 Ann. M/7	HSC/31	2003	90	176199-48-7
elacestrant	élacestrant	2922.29	NC2373B1b Ann. O/7	HSC/59	2017	115	722533-56-4
elacridar	élacridar	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	76	143664-11-3	HSC/21 (2933.40)
elacytarabine	élacytarabine	2934.99	NC1178B1c Ann. O/5	HSC/39	2007	95	188181-42-2
eladocagene exuparvovec	éladocagène exuparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	119	2098615-91-7	HSC/63 (3002.90)
elafibranor	élafibranor	2930.90	NC2237B1b Ann. S/8	HSC/57	2016	112	824932-88-9
elagolix	élagolix	2937.90	NC1443B1b Ann. P/6	HSC/43	2009	99	834153-87-6
elamipretide	élamiprétide	2925.29	NC2237B1b Ann. S/9	HSC/57	2016	113	736992-21-5
elapegademase	élapégadémase	3507.90	NC2373B1b Ann. O/7	HSC/59	2017	115	1709806-75-6
elarofiban	elarofiban	2933.39	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	198958-88-2
elasomeran	élasoméran	3002.41	NC2930Bc Ann. P/27	HSC/69	2022	25-COVI	2430046-03-8
elbasvir	elbasvir	2934.99	NC2116B1b Ann. R/4	HSC/55	2015	110	1370468-36-2

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
elbimilast	elbimilast	2933.39	NC1760B1b Ann. N/7	HSC/49	2012	107	418794-42-0
eldacimibe	eldacimibe	2922.50	42.100 Ann. O (V)	HSC/21	1998	76	141993-70-6
eldecalcitol	eldécalcitol	2936.29	NC1443B1b Ann. P/3	HSC/43	2009	97	104121-92-8
eldelumab	eldélumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	109	946414-98-8	HSC/53 (3002.10)
eleclazine	éléclazine	2934.99	NC2237B1b Ann. S/8	HSC/57	2016	112	1443211-72-0
eledoisin	élédoïsine	2933.79	40.260 Ann. L/2 (No. 25)	HSC/17	1996	28	69-25-0
elenbecestat	élenbécestat	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1388651-30-6
elesclomol	élesclomol	2930.90	NC1443B1b Ann. P/6	HSC/43	2009	99	488832-69-5
eletriptan	élétriptan	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	74	143322-58-1	HSC/21 (2933.90)
elexacaftor	élexacaftor	2935.90	NC2803Bc Ann. T/3	HSC/67	2021	121	2216712-66-0
elezanumab	élézanumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1791416-49-3
elgemtumab	elgemtumab	3002.13	NC2237B1b Ann. T/10	HSC/57	2016	112	1512559-37-3	HSC/57 (3002.10) (S/8)
eliapixant	éliapixant	2934.10	NC2803Bc Ann. T/6	HSC/67	2021	122	1948229-21-7
eliglustat	éliglustat	2934.99	NC1649B3b Ann. R/14	HSC/47	2011	103	491833-29-5
elimusertib	élimusertib	2934.99	NC2803Bc Ann. T/7	HSC/67	2021	123	1876467-74-1
elinafide	élinafide	2925.19	42.100 Ann. O (IV)	HSC/21	1998	75	162706-37-8
elinogrel	élinogrel	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	101	936500-94-6	HSC/46 (2935.00)
elinzanetant	élinzanétant	2934.99	NC2803Bc Ann. T/6	HSC/67	2021	122	929046-33-3
elipovimab	élipovimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2101210-43-7
elisartan	élisartan	2933.29	40.600 Ann. D, par. 6	HSC/18	1996	72	158682-68-9
elisidepsin	élisidepsine	2934.99	NC1649B3b Ann. R/12	HSC/47	2011	101	681272-30-0
elismetrep	élismétrep	2935.90	NC2626B1b Ann. O/5	HSC/63	2019	118	1400699-64-0
elivaldogene autotemcel	élivaldogène autotemcel	3002.51	NC2803Bc Ann. T/3	HSC/67	2021	121	no mention
elivaldogene tavalentivec	élivaldogène tavalentivec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	115	1905397-73-0	HSC/59 (3002.90)
elliptinium acetate	acétate d’elliptinium	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	43	58337-35-2	HSC/11 (2939.90) HSC/53 (2939.99)
elobixibat	élobixibat	2934.99	NC1760B1b Ann. N/7	HSC/49	2012	104	439087-18-0
elocalcitol	élocalcitol	2906.19	NC1178B1c Ann. O/5	HSC/39	2007	95	199798-84-0
elomotecan	élomotécan	2934.99	NC2237B1b Ann. S/11	HSC/57	2016	92	220998-10-7	HSC/37 (2939.99)
elopiprazole	élopiprazole	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	70	115464-77-2	HSC/18 (2934.90)
elopultide	élopultide	2933.29	NC2626B1b Ann. O/6	HSC/63	2019	119	1018791-84-8
elosulfase alfa	élosulfase alfa	3507.90	NC2004B1b Ann. O/4	HSC/53	2014	108	9025-60-9
elotuzumab	elotuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	100	915296-00-3	HSC/44 (3002.10)
elpamotide	elpamotide	3002.41	NC2803Bc Ann. T/4	HSC/67	2021	103	673478-49-4	HSC/47 (3002.20)
elpetrigine	elpétrigine	2933.99	NC1604B1b Ann. N/5	HSC/46	2010	101	212778-82-0
elraglusib	elraglusib	2934.99	NC2930Bc Ann. P/25	HSC/69	2022	124	1034895-42-5
elranatamab	elranatamab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2408850-14-4
elsamitrucin	elsamitrucine	2941.90	38.100 Ann. Q (No. 281)	HSC/11	1993	62	97068-30-9

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
elsibucol	elsibucol	2930.90	NC1178B1c Ann. O/5	HSC/39	2007	95	216167-95-2
elsiglutide	elsiglutide	2937.19	NC1760B1b Ann. N/7	HSC/49	2012	104	914009-84-0
elsubrutinib	elsubrutinib	2933.39	NC2803Bc Ann. T/3	HSC/67	2021	121	1643570-24-4
elsulfavirine	elsulfavirine	2935.90	NC2501B1b Ann. M/6	HSC/61	2018	117	868046-19-9
eltanexor	eltanexor	2933.59	NC2501B1b Ann. M/5	HSC/61	2018	116	1642300-52-4
eltrapuldencel	eltrapuldencel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	115	no mention	HSC/61 (3002.90)
eltrombopag	eltrombopag	2933.19	NC1178B1c Ann. O/3	HSC/39	2007	94	496775-61-2
elubrixin	élubrixine	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	107	688763-64-6	HSC/51 (2935.00)
eluforsen	éluforsen	2934.99	NC2626B1b Ann. O/6	HSC/63	2019	119	2101868-82-8
elunonavir	élunonavir	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	2242428-57-3
eluvixtamab	éluvixtamab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	1679391-73-1
eluxadoline	eluxadoline	2933.29	NC2004B1b Ann. O/5	HSC/53	2014	109	864821-90-9
elvitegravir	elvitégravir	2933.49	NC1310B1b Ann. N/4	HSC/41	2008	97	697761-98-1
elzasonan	elzasonan	2934.99	NC0730B2 Ann. M/7	HSC/31	2003	87	361343-19-3
emactuzumab	emactuzumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	111	1448221-67-7	HSC/55 (3002.10)
emapalumab	émapalumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1709815-23-5
emapticap pegol	émapticap pégol	3907.29	NC2803Bc Ann. T/4	HSC/67	2021	108	1390630-22-4	HSC/53 (3907.20)
emapunil	émapunil	2933.59	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	226954-04-7
emavusertib	émavusertib	2934.99	NC2930Bc Ann. P/25	HSC/69	2022	124	1801344-14-8
embeconazole	embéconazole	2934.99	NC1059B2b Ann. O/4	HSC/37	2006	92	329744-44-7
embusartan	embusartan	2933.79	42.750 Ann. O	HSC/22	1998	78	156001-18-2
emeramide	éméramide	2930.90	NC2237B1b Ann. S/8	HSC/57	2016	112	351994-94-0
emerfetamab	émerfétamab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2250261-27-7
emfilermin	emfilermine	2933.29	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	159075-60-2
emibetuzumab	émibetuzumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	111	1365287-97-3	HSC/55 (3002.10)
emicerfont	emicerfont	2933.29	NC1649B3b Ann. R/13	HSC/47	2011	102	786701-13-1
emicizumab	émicizumab	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	113	1610943-06-0	HSC/57 (3002.10) (S/9)
emideltide	émideltide	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	70	62568-57-4	HSC/18 (2933.90)
emiplacel	émiplacel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	117	no mention	HSC/63 (3002.90)
emivirine	émivirine	2933.59	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	149950-60-7
emixustat	émixustat	2922.50	NC2004B1b Ann. O/4	HSC/53	2014	108	1141777-14-1
emlenoflast	emlénoflast	2935.90	NC2930Bc Ann. P/27	HSC/69	2022	125	1995067-59-8
emoctakin	émoctakine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	74	142298-00-8	HSC/21 (3002.10)
emodepside	emodepside	2934.99	NC0590B2 Ann. L/15	HSC/29	2002	84	155030-63-0
empagliflozin	empagliflozin	2932.19	NC1760B1b Ann. N/7	HSC/49	2012	104	864070-44-0
empegfilgrastim	empegfilgrastim	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1192706-53-8	HSC/51 (3002.10)
empesertib	empésertib	2933.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1443763-60-7
emraclidine	emraclidine	2933.39	NC2930Bc Ann. P/27	HSC/69	2022	125	2170722-84-4

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
emricasan	emricasan	2924.29	NC1443B1b Ann. P/5	HSC/43	2009	98	254750-02-2
emtricitabine	emtricitabine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	80	143491-57-0	HSC/23 (2934.90)
emvododstat	emvododstat	2933.99	NC2930Bc Ann. P/25	HSC/69	2022	124	1256565-36-2
enadenoticirev	énadénoticirev	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	111	1402042-02-7	HSC/55 (3002.90)
enapotamab	énapotamab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	1912423-61-0
enapotamab vedotin	énapotamab védotine	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	1912424-97-5
enarodustat	énarodustat	2933.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1262132-81-9
enasidenib	énasidénib	2933.69	NC2237B1b Ann. S/9	HSC/57	2016	113	1446502-11-9
enavatuzumab	énavatuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	104	62149-33-0	HSC/49 (3002.10)
enavogliflozin	énavogliflozine	2932.99	NC2803Bc Ann. T/3	HSC/67	2021	121	1415472-28-4
encaleret	encaléret	2922.19	NC1874B1b Ann. O/4	HSC/51	2013	105	787583-71-5
encelimab	encelimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2173096-82-5
encenicline	encénicline	2934.99	NC2116B1b Ann. R/5	HSC/55	2015	111	550999-75-2
encequidar	encéquidar	2934.99	NC2626B1b Ann. O/6	HSC/63	2019	119	849675-66-7
encoberminogene rezmadenovec	encoberminogène rezmadénovec	3002.49	NC2930Bc Ann. P/25	HSC/69	2022	124	2376853-01-7
encorafenib	encorafénib	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	109	1269440-17-6	HSC/53 (2935.00)
endixaprine	endixaprine	2933.39	38.100 Ann. Q (No. 282)	HSC/11	1993	60	93181-85-2
enecadin	énécadine	2933.59	NC0730B2 Ann. M/7	HSC/31	2003	87	259525-01-4
enerisant	énérisant	2934.99	NC2237B1b Ann. S/9	HSC/57	2016	113	1152747-82-4
enestebol	énestébol	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	22	2320-86-7	HSC/11 (2937.99)
enexasogaol	énexasogaol	2914.50	NC2626B1b Ann. O/5	HSC/63	2019	118	23513-13-5
enflicoxib	enflicoxib	2935.90	NC2803Bc Ann. T/6	HSC/67	2021	122	251442-94-1
enfortumab vedotin	enfortumab vedotin	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	109	1346452-25-2	HSC/53 (3002.10)
enfuvirtide	enfuvirtide	2933.29	NC0730B2 Ann. M/4 (III)	HSC/31	2003	85	159519-65-0
enibarcimab	énibarcimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2305638-98-4
eniluracil	eniluracil	2933.59	42.100 Ann. O (VI)	HSC/21	1998	77	59989-18-3
eniporide	éniporide	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	79	176644-21-6	HSC/23 (2933.90)
enisamium iodide	iodure d’énisamium	2933.39	NC1604B1b Ann. N/5	HSC/46	2010	101	201349-37-3
enlimomab	enlimomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	70	142864-19-5	HSC/18 (3002.10)
enlimomab pegol	enlimomab pégol	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	77	169802-84-0	HSC/21 (3002.10)
enmetazobactam	enmétazobactam	2934.99	NC2803Bc Ann. T/3	HSC/67	2021	121	1001404-83-6
enoblituzumab	énoblituzumab	3002.13	NC2373B1b Ann. O/6	HSC/59	2017	114	1353485-38-7
enobosarm	enobosarm	2926.90	NC1874B1b Ann. O/2	HSC/51	2013	107	841205-47-8
enocitabine	énocitabine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	46	55726-47-1	HSC/11 (2934.90)
enokizumab	énokizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	104	909875-08-7	HSC/49 (3002.10)
enomimeran	énomiméran	2934.99	NC2803Bc Ann. T/7	HSC/67	2021	123	2348560-99-4
enoticumab	énoticumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1192578-27-0	HSC/51 (3002.10)
enoxacin	énoxacine	2933.59	38.100 Ann. Q (No. 285)	HSC/11	1993	49	74011-58-8
enoxaparin sodium	énoxaparine sodique	3001.90	NC1553B1b Ann. O/5	HSC/45	2010	65	9041-08-1

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
enoximone	énoximone	2933.29	38.100 Ann. Q (No. 287)	HSC/11	1993	52	77671-31-9
enpatoran	enpatoran	2933.49	NC2803Bc Ann. T/11	HSC/67	2021	4 COVID	2101938-42-3
enprofylline	enprofylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	44	41078-02-8	HSC/11 (2939.50)
enrasentan	enrasentan	2932.99	NC0090B2 Ann. M/5	HSC/23	1999	80	167256-08-8
ensartinib	ensartinib	2933.59	NC2373B1b Ann. O/7	HSC/59	2017	115	1370651-20-9
ensereptide	enséreptide	2934.99	NC1874B1b Ann. O/2	HSC/51	2013	107	254433-51-7
ensifentrine	ensifentrine	2933.59	NC2626B1b Ann. O/6	HSC/63	2019	119	1884461-72-6
ensituximab	ensituximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	103	1092658-06-4	HSC/47 (3002.10)
ensomafusp alfa	ensomafusp alfa	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2417199-08-5
ensovibep	ensovibep	2933.29	NC2930Bc Ann. P/25	HSC/69	2022	124	2451126-06-8
ensulizole	ensulizole	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	83	27503-81-7	HSC/27 (2933.90)
entacingene turiparvovec	entacingène turiparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	123	2247971-01-1	HSC/67 (3002.90)
entasobulin	entasobuline	2933.49	NC2116B1b Ann. R/4	HSC/55	2015	110	501921-61-5
entecavir	entécavir	2933.59	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	142217-69-4
entinostat	entinostat	2933.39	NC1443B1b Ann. P/6	HSC/43	2009	99	209783-80-2
entolimod	entolimod	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	108	951628-22-1	HSC/53 (3002.10)
entospletinib	entosplétinib	2934.99	NC2116B1b Ann. R/4	HSC/55	2015	110	1229208-44-9
entrectinib	entrectinib	2934.99	NC2237B1b Ann. S/9	HSC/57	2016	113	1108743-60-7
enuvaptan	énuvaptan	2933.39	NC2930Bc Ann. P/25	HSC/69	2022	124	2145062-48-0
enuzovimab	énuzovimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2531098-91-4
envafolimab	envafolimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2102192-68-5
enzacamene	enzacamène	2914.39	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	36861-47-9
enzalutamide	enzalutamide	2933.29	NC1874B1b Ann. O/2	HSC/51	2013	107	915087-33-1
enzaplatovir	enzaplatovir	2934.99	NC2373B1b Ann. O/7	HSC/59	2017	115	1323077-89-9
enzastaurin	enzastaurine	2933.39	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	170364-57-5
epacadostat	épacadostat	2934.99	NC2373B1b Ann. O/6	HSC/59	2017	114	1204669-58-8
epafipase	epafipase	3507.90	NC0730B2 Ann. M/4 (III)	HSC/31	2003	85	208576-22-1
epaminurad	épaminurad	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1198153-15-9
epcoritamab	épcoritamab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2134641-34-0
epeleuton	épéleuton	2918.19	NC2626B1b Ann. O/5	HSC/63	2019	118	1667760-39-5
epelsiban	épelsiban	2934.99	NC1760B1b Ann. N/8	HSC/49	2012	105	872599-83-2
eperezolid	épérézolide	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	76	165800-04-4	HSC/21 (2934.90)
epertinib	épertinib	2934.99	NC2373B1b Ann. O/7	HSC/59	2017	115	908305-13-5
epervudine	épervudine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	61	60136-25-6	HSC/11 (2934.90)
epetirimod	épétirimod	2933.99	NC1310B1b Ann. N/4	HSC/41	2008	97	227318-71-0
epetraborole	épétraborole	2934.99	NC2237B1b Ann. S/8	HSC/57	2016	112	1093643-37-8
epicriptine	épicriptine	2939.69	NC2004B1b Ann. O/6	HSC/53	2014	58	88660-47-3	HSC/11 (2939.60)
epiestriol	épiestriol	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	12	547-81-9	HSC/11 (2937.92)
epimestrol	épimestrol	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	22	7004-98-0	HSC/11 (2937.92)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
epipropidine	épipropidine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	12	5696-17-3	HSC/11 (2934.90)
epirubicin	épirubicine	2941.90	38.100 Ann. Q (No. 294)	HSC/11	1993	48	56420-45-2
epitizide	épitizide	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	91	1764-85-8	HSC/11 (2935.00)
epitumomab	epitumomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	82	263547-71-3	HSC/27 (3002.10)
eplerenone	éplérénone	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	77	107724-20-9	HSC/21 (2932.29)
eplivanserin	éplivansérine	2928.00	NC0090B2 Ann. M/5	HSC/23	1999	80	130579-75-8
eplontersen	éplontersen	2934.99	NC2803Bc Ann. T/7	HSC/67	2021	123	1637600-16-8
epoetin alfa	époétine alfa	3002.12	NC2373B1b Ann. O/8	HSC/59	2017	66	113427-24-0	HSC/41 (3002.10)
epoetin beta	époétine bêta	3002.12	NC2373B1b Ann. O/8	HSC/59	2017	62	122312-54-3	HSC/41 (3002.10)
epoetin delta	epoétine delta	3002.12	NC2373B1b Ann. O/8	HSC/59	2017	85	261356-80-3	HSC/31 (3002.10)
epoetin epsilon	époétine epsilon	3002.12	NC2373B1b Ann. O/8	HSC/59	2017	72	154725-65-2	HSC/23 (3002.10)
epoetin gamma	époétine gamma	3002.12	NC2373B1b Ann. O/8	HSC/59	2017	67	130455-76-4	HSC/41 (3002.10)
epoetin kappa	époétine kappa	3002.12	NC2373B1b Ann. O/8	HSC/59	2017	97	879555-13-2	HSC/41 (3002.10)
epoetin omega	époétine oméga	3002.12	NC2373B1b Ann. O/8	HSC/59	2017	73	148363-16-0	HSC/18 (3002.10)
epoetin theta	époétine thêta	3002.12	NC2373B1b Ann. O/8	HSC/59	2017	95	762263-14-9	HSC/39 (3002.10)
epoetin zeta	epoétine zéta	3002.12	NC2373B1b Ann. O/8	HSC/59	2017	92	604802-70-2	HSC/39 (3002.10)
epratuzumab	épratuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	82	205923-57-5	HSC/27 (3002.10)
eprenetapopt	éprénétapopt	2933.39	NC2803Bc Ann. T/7	HSC/67	2021	123	5291-32-7
eprinomectin	éprinomectine	2941.90	40.600 Ann. D, par. 6	HSC/18	1996	73	123997-26-2
eprociclovir	éprociclovir	2933.59	NC2237B1b Ann. S/8	HSC/57	2016	112	145512-85-2
eprodisate	éprodisate	2904.10	NC1178B1c Ann. O/3	HSC/39	2007	94	21668-77-9
eprosartan	éprosartan	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	71	133040-01-4	HSC/18 (2934.90)
eprotirome	éprotirome	2924.29	NC1443B1b Ann. P/6	HSC/43	2009	99	355129-15-6
epsiprantel	epsiprantel	2933.59	38.100 Ann. Q (No. 296)	HSC/11	1993	57	98123-83-2
eptacog alfa (activated)	eptacog alfa (activé)	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	72	102786-61-8	HSC/18 (3002.10)
eptacog alfa pegol (activated)	eptacog alfa pégol (activé)	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	101	944130-77-2	HSC/47 (3002.10)
eptacog beta (activated)	eptacog bêta (activé)	3002.12	NC2237B1b Ann. T/10	HSC/57	2016	112	1228539-24-9	HSC/57 (3002.10) (S/8)
eptapirone	eptapirone	2933.69	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	179756-85-5
eptaplatin	eptaplatine	2843.90	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	146665-77-2
eptifibatide	eptifibatide	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	78	148031-34-9	HSC/22 (2934.90)
eptinezumab	eptinezumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1644539-04-7
eptotermin alfa	eptotermine alfa	2933.29	NC0938B2b Ann. O/2	HSC/35	2005	89	129805-33-0
eragidomide	éragidomide	2933.79	NC2930Bc Ann. P/27	HSC/69	2022	125	1860875-51-9
eramkafusp alfa	éramkafusp alfa	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2388499-82-7
eravacycline	éravacycline	2941.30	NC2004B1b Ann. O/4	HSC/53	2014	108	1207283-85-9
erdafitinib	erdafitinib	2933.19	NC2237B1b Ann. S/9	HSC/57	2016	113	1346242-81-6
erenumab	érénumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1582205-90-0
eretidigene velentivec	érétidigène vélentivec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	115	1800541-90-5	HSC/59 (3002.90)
erfonrilimab	erfonrilimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2367013-69-0

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
ergometrine	ergométrine	2939.61	E.N. Chap. 29 – List I-III (Precur	HSC/21	1998	4	60-79-7
ergotamine	ergotamine	2939.62	E.N. Chap. 29 – List I-III (Precur	HSC/21	1998	4	113-15-5
eribaxaban	éribaxaban	2933.79	NC1443B1b Ann. P/5	HSC/43	2009	98	536748-46-6
eribulin	éribuline	2932.19	NC1310B1b Ann. N/4	HSC/41	2008	97	253128-41-5
ericolol	éricolol	2922.19	40.260 Ann. L/2 (No. 66)	HSC/17	1996	50	85320-67-8
eritoran	eritoran	2932.99	NC1178B1c Ann. O/2	HSC/39	2007	92	185955-34-4
eritrityl tetranitrate	tétranitrate d’éritrityle	2920.90	38.100 Ann. Q (No. 298)	HSC/11	1993	13	7297-25-8
erlizumab	erlizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	84	211323-03-4	HSC/29 (3002.10)
erlotinib	erlotinib	2933.59	NC0590B2 Ann. L/15	HSC/29	2002	85	183321-74-6
ersemadromcel	ersémadromcel	3002.51	NC2930Bc Ann. P/27	HSC/69	2022	125	no mention
ersentilide	ersentilide	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	72	125279-79-0	HSC/18 (2935.00)
ertapenem	ertapénem	2941.90	NC0590B2 Ann. L/15	HSC/29	2002	84	153832-46-3
erteberel	ertébérel	2932.99	NC1760B1b Ann. N/7	HSC/49	2012	104	533884-09-2
ertiprotafib	ertiprotafib	2934.99	NC0730B2 Ann. M/7	HSC/31	2003	87	251303-04-5
ertugliflozin	ertugliflozine	2932.99	NC1874B1b Ann. O/2	HSC/51	2013	107	1210344-57-2
ertumaxomab	ertumaxomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	93	509077-99-0	HSC/37 (3002.10)
ervogastat	ervogastat	2934.99	NC2930Bc Ann. P/25	HSC/69	2022	124	2186700-33-2
esafoxolaner	ésafoxolaner	2934.99	NC2803Bc Ann. T/2	HSC/67	2021	120	1096103-99-9
esamisulpride	ésamisulpride	2933.99	NC2803Bc Ann. T/6	HSC/67	2021	122	71675-92-8
esatenolol	ésaténolol	2924.29	42.100 Ann. O (V)	HSC/21	1998	76	93379-54-5
esaxerenone	ésaxérénone	2933.99	NC2373B1b Ann. O/6	HSC/59	2017	114	1632006-28-0
escibenzoline	escibenzoline	2933.29	NC2930Bc Ann. P/27	HSC/69	2022	125	103419-18-7
escitalopram	escitalopram	2932.99	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	128196-01-0
esketamine	eskétamine	2922.39	NC2004B1b Ann. O/6	HSC/53	2014	81	33643-46-8	HSC/25 (2922.30)
eslicarbazepine	eslicarbazépine	2933.99	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	104746-04-5
esmirtazapine	esmirtazapine	2933.59	NC1059B2b Ann. O/5	HSC/37	2006	93	61337-87-9
esmolol	esmolol	2922.19	40.260 Ann. L/2 (No. 67)	HSC/17	1996	50	103598-03-4
esomeprazole	ésoméprazole	2933.39	NC0090B2 Ann. M/1 (II)	HSC/23	1999	79	119141-88-7
esonarimod	ésonarimod	2930.90	NC0090B2 Ann. M/1 (II)	HSC/23	1999	79	101973-77-7
esorubicin	ésorubicine	2941.90	38.100 Ann. Q (No. 299)	HSC/11	1993	47	63521-85-7
esoxybutynin	ésoxybutynine	2922.19	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	119618-22-3
esreboxetine	esréboxétine	2934.99	NC1443B1b Ann. P/6	HSC/43	2009	99	98819-76-2
estazolam	estazolam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	31	29975-16-4
estetrol	estétrol	2937.23	NC2501B1b Ann. M/5	HSC/61	2018	116	15183-37-6
esuberaprost	ésubéraprost	2932.99	NC2237Bib Ann. S/10	HSC/57	2016	111	94132-88-4
eszopiclone	eszopiclone	2933.79	NC0845B2 Ann. M/1 (II)	HSC/33	2004	87	138729-47-2
etafedrine	étafédrine	2939.49	NC2803Bc Ann. T/4	HSC/67	2021	14	7681-79-0	HSC/53 (2939.49) HSC/63 (2939.79)
etafenone	étafénone	2922.19	40.260 Ann. L/2 (No. 68)	HSC/17	1996	19	90-54-0

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
etalocib	étalocib	2918.99	NC2373B1b Ann. O/12	HSC/59	2017	92	161172-51-6	HSC/37 (2918.90)
etamicastat	étamicastat	2934.99	NC1604B1b Ann. N/5	HSC/46	2010	101	760173-05-5
etanercept	étanercept	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	81	185243-69-0	HSC/25 (3002.10)
etaracizumab	étaracizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	99	892553-42-3	HSC/43 (3002.10)
etavopivat	étavopivat	2935.90	NC2930Bc Ann. P/25	HSC/69	2022	124	2245053-57-8
etelcalcetide	ételcalcétide	2928.00	NC2116B1b Ann. R/4	HSC/55	2015	110	1093130-72-3
eteplirsen	étéplirsen	2934.99	NC1649B3b Ann. R/14	HSC/47	2011	103	1173755-55-9
etesevimab	étésévimab	3002.13	NC2803Bc Ann. T/11	HSC/67	2021	4 COVID	2423948-94-9
etevritamab	étévritamab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2329692-74-0
ethchlorvynol	éthchlorvynol	2905.51	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	38	113-18-8
ethinamate	éthinamate	2924.24	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	6	126-52-3
ethyl loflazepate	loflazépate d’éthyle	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	43	29177-84-2
ethylcellulose	éthylcellulose	3912.39	NC0090B2 Ann. M/5	HSC/23	1999	80	9004-57-3
ethylestrenol	éthylestrénol	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	13	965-90-2	HSC/21 (2937.99)
ethylmethylthiambutene	éthylméthylthiambutène	2934.99	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	3	441-61-2
ethynerone	éthynérone	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	17	3124-93-4	HSC/11 (2937.92)
ethypicone	éthypicone	2933.79	38.100 Ann. Q (No. 302)	HSC/11	1993	6	467-90-3
eticyclidine	éticyclidine	2921.49	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	44	2201-15-2
etidaligide	étidaligide	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1974402-87-3
etigilimab	étigilimab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	2044984-83-8
etiguanfacine	étiguanfacine	2925.29	NC2116B1b Ann. R/4	HSC/55	2015	110	1346686-31-4
etilamfetamine	étilamfétamine	2921.46	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	40	457-87-4
etilevodopa	étilévodopa	2922.50	NC0090B2 Ann. M/5	HSC/23	1999	80	37178-37-3
etiprednol dicloacetate	dicloacétate d’étiprednol	2937.22	NC0845B2 Ann. M/2	HSC/33	2004	88	199331-40-3
etirinotecan pegol	étirinotecan pégol	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	107	848779-32-8	HSC/51 (2933.99)
etisomicin	étisomicine	2941.90	42.100 Ann. O (II)	HSC/21	1998	47	70639-48-4
etisulergine	étisulergine	2939.69	42.100 Ann. O (I)	HSC/21	1998	47	64795-23-9
etofenamate	étofénamate	2922.49	40.260 Ann. L/2 (No. 69)	HSC/17	1996	29	30544-47-9
etofylline	étofylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	14	519-37-9	HSC/11 (2939.50)
etofylline clofibrate	clofibrate d’étofylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	38	54504-70-0	HSC/11 (2939.50)
etokimab	étokimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2022981-44-6
etonitazene	étonitazène	2933.99	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	11	911-65-9
etoposide	étoposide	2938.90	38.100 Ann. Q (No. 305)	HSC/11	1993	34	33419-42-0
etoposide toniribate	toniribate d’étoposide	2938.90	NC2626B1b Ann. O/3	HSC/63	2019	116	433304-61-1
etoricoxib	étoricoxib	2933.39	NC0590B2 Ann. L/15	HSC/29	2002	84	202409-33-4
etorphine	étorphine	2939.11	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	17	14521-96-1
etoxeridine	étoxéridine	2933.39	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	6	469-82-9
etoxybamide	étoxybamide	2924.19	NC1760B1b Ann. N/8	HSC/49	2012	105	66857-17-8
etrabamine	étrabamine	2934.20	38.100 Ann. Q (No. 306)	HSC/11	1993	59	70590-58-8

t t t

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
etranacogene dezaparvovec	étranacogène dezaparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	120	2156583-26-3	HSC/67 (3002.90)
etrasimod	étrasimod	2933.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1206123-37-6
etravirine	etravirine	2933.59	NC0845B2 Ann. M/2	HSC/33	2004	88	269055-15-4
etriciguat	etriciguat	2933.59	NC0845B2 Ann. M/2	HSC/33	2004	88	402595-29-3
etripamil	étripamil	2926.90	NC2237B1b Ann. S/9	HSC/57	2016	113	1593673-23-4
etrolizumab	étrolizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	104	1044758-60-2	HSC/49 (3002.10)
etrumadenant	étrumadénant	2933.59	NC2930Bc Ann. P/25	HSC/69	2022	124	2239273-34-6
etuvetidigene autotemcel	étuvétidigène autotemcel	3002.51	NC2930Bc Ann. P/27	HSC/69	2022	125	no mention
eufauserase	eufausérase	3507.90	NC0590B2 Ann. L/15	HSC/29	2002	84	no mention
evacetrapib	évacétrapib	2933.99	NC1760B1b Ann. N/8	HSC/49	2012	105	1186486-62-3
evagenretcel	évagenretcel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	116	no mention	HSC/63 (3002.90)
evandamine	évandamine	2934.20	38.100 Ann. Q (No. 307)	HSC/11	1993	56	100035-75-4
evatanepag	évatanépag	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	101	223488-57-1	HSC/46 (2935.00)
evenamide	événamide	2924.29	NC2237B1b Ann. S/9	HSC/57	2016	113	1092977-61-1
evernimicin	evernimicine	2941.90	NC0590B2 Ann. L/10	HSC/29	2002	82	109545-84-8
everolimus	évérolimus	2934.99	NC1874B1b Ann. O/5	HSC/51	2013	82	159351-69-6
evexomostat	évexomostat	3906.90	NC2930Bc Ann. P/27	HSC/69	2022	125	2416263-67-5
evifacotrep	évifacotrep	2933.59	NC2930Bc Ann. P/27	HSC/69	2022	125	2413739-88-3
evinacumab	évinacumab	3002.13	NC2237B1b Ann. T/10	HSC/57	2016	112	1446419-85-7	HSC/57 (3002.10) (S/8)
evixapodlin	évixapodline	2933.79	NC2930Bc Ann. P/27	HSC/69	2022	125	2374856-75-2
evobrutinib	évobrutinib	2933.59	NC2373B1b Ann. O/7	HSC/59	2017	115	1415823-73-2
evocalcet	évocalcet	2933.99	NC2237B1b Ann. S/9	HSC/57	2016	113	870964-67-3
evodenoson	évodénoson	2934.99	NC2004B1b Ann. O/4	HSC/53	2014	108	844873-47-8
evofosfamide	évofosfamide	2933.29	NC2116B1b Ann. R/5	HSC/55	2015	111	918633-87-1
evogliptin	évogliptin	2933.59	NC1874B1b Ann. O/2	HSC/51	2013	107	1222102-29-5
evolocumab	évolocumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	108	1256937-27-5	HSC/53 (3002.10)
evoncabtagene pazurgedleucel	évoncabtagène pazurgedleucel	3002.51	NC2930Bc Ann. P/27	HSC/69	2022	125	no mention
exagamglogene autotemcel	exagamglogène autotemcel	3002.51	NC2930Bc Ann. P/25	HSC/69	2022	124	no mention
exaluren	exalurène	2932.19	NC2803Bc Ann. T/6	HSC/67	2021	122	1375073-93-0
exametazime	examétazime	2928.00	38.100 Ann. Q (No. 308)	HSC/11	1993	57	105613-48-7
examorelin	examoréline	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	72	140703-51-1	HSC/53 (2937.19) HSC/18 (2937.99)
exaprolol	exaprolol	2922.19	40.260 Ann. L/2 (No. 70)	HSC/17	1996	32	55837-19-9
exatecan	exatécan	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	81	171335-80-1	HSC/27 (2939.90) HSC/53 (2939.99)
exatecan alideximer	exatécan alideximer	2939.79	NC2237B1b Ann. T/12	HSC/57	2016	89	no mention	HSC/37 (2939.99)
exbivirumab	exbivirumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	91	569658-80-6	HSC/35 (3002.10)
exebacase	exébacase	3507.90	NC2501B1b Ann. M/6	HSC/61	2018	117	1404122-92-4

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
exenatide	exenatide	2937.19	NC1760B1b Ann. N/3	HSC/49	2012	89	141758-74-9
exeporfinium chloride	chlorure d’exéporfinium	2933.99	NC1760B1b Ann. N/8	HSC/49	2012	105	718638-68-7
exicorilant	exicorilant	2935.90	NC2626B1b Ann. O/6	HSC/63	2019	119	1781244-77-6
exidavnemab	exidavnémab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2438229-02-6
exisulind	exisulind	2930.90	NC0090B2 Ann. M/5	HSC/23	1999	80	59973-80-7
ezabenlimab	ézabenlimab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2249882-54-8
ezaladcigene resoparvovec	ézaladcigène résoparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	121	2226647-27-2	HSC/67 (3002.90)
ezatiostat	ézatiostat	2930.90	NC1443B1b Ann. P/5	HSC/43	2009	98	168682-53-9
ezeprogind	ézéprogind	2933.59	NC2803Bc Ann. T/6	HSC/67	2021	122	615539-20-3
ezetimibe	ézétimibe	2933.79	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	163222-33-1
ezlopitant	ezlopitant	2933.39	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	147116-64-1
ezurpimtrostat	ézurpimtrostat	2933.49	NC2930Bc Ann. P/27	HSC/69	2022	125	1914148-72-3
ezutromid	ézutromid	2934.99	NC2237B1b Ann. S/9	HSC/57	2016	113	945531-77-1
fabesetron	fabésétron	2933.79	42.100 Ann. O (III)	HSC/21	1998	74	129300-27-2
facinicline	facinicline	2933.39	NC1760B1b Ann. N/8	HSC/49	2012	105	677306-35-3
fadaltran	fadaltran	2934.99	NC2803Bc Ann. T/2	HSC/67	2021	120	1799809-36-1
fadolmidine	fadolmidine	2933.29	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	86	189353-31-9
fadraciclib	fadraciclib	2933.59	NC2803Bc Ann. T/3	HSC/67	2021	121	1070790-89-4
faldaprevir	faldaprévir	2934.10	NC1874B1b Ann. O/1	HSC/51	2013	106	801283-95-4
falnidamol	falnidamol	2933.59	NC0250B2 Ann. P/1 (II)	HSC/25	2000	81	196612-93-8
famciclovir	famciclovir	2933.59	38.100 Ann. Q (No. 309)	HSC/11	1993	61	104227-87-4
famiraprinium chloride	chlorure de famiraprinium	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	58	108894-41-3	HSC/11 (2933.90)
famitinib	famitinib	2933.79	NC2930Bc Ann. P/27	HSC/69	2022	125	1044040-56-3
fampridine	fampridine	2933.39	40.600 Ann. D, par. 6	HSC/18	1996	72	504-24-5
fampronil	fampronil	2933.29	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	134183-95-2
fanapanel	fanapanel	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	80	161605-73-8	HSC/23 (2934.90)
fandofloxacin	fandofloxacine	2933.59	42.750 Ann. O	HSC/22	1998	78	164150-99-6
fandosentan	fandosentan	2934.99	NC0730B2 Ann. M/7	HSC/31	2003	87	221241-63-0
fanotaprim	fanotaprim	2933.59	NC2803Bc Ann. T/7	HSC/67	2021	123	2120282-75-7
faralimomab	faralimomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	76	167816-91-3	HSC/21 (3002.10)
farampator	farampator	2934.99	NC1059B2b Ann. O/4	HSC/37	2006	92	211735-76-1
farglitazar	farglitazar	2934.99	NC0590B2 Ann. L/15	HSC/29	2002	84	196808-45-4
faricimab	faricimab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	1607793-29-2
farletuzumab	farletuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	100	896723-44-7	HSC/44 (3002.10)
farletuzumab ecteribulin	farlétuzumab ectéribuline	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2407465-18-1
farudodstat	farudodstat	2933.39	NC2930Bc Ann. P/27	HSC/69	2022	125	1035688-66-4
fasidotril	fasidotril	2932.99	42.100 Ann. O (III)	HSC/21	1998	74	135038-57-2
fasiglifam	fasiglifam	2932.99	NC1874B1b Ann. O/2	HSC/51	2013	107	1000413-72-8
fasinumab	fasinumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1190239-42-9	HSC/51 (3002.10)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
fasitibant chloride	chlorure de fasitibant	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	103	1157852-02-2	HSC/47 (2935.00)
fasobegron	fasobégron	2922.50	NC1443B1b Ann. P/5	HSC/43	2009	98	643094-49-9
fasoracetam	fasoracétam	2933.79	42.750 Ann. O	HSC/22	1998	78	110958-19-5
favipiravir	favipiravir	2933.99	NC1443B1b Ann. P/5	HSC/43	2009	98	259793-96-9
faxeladol	faxéladol	2922.29	NC1310B1b Ann. N/4	HSC/41	2008	97	433265-65-7
fazarabine	fazarabine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	56	65886-71-7	HSC/11 (2934.90)
fazulemeran	fazuléméran	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	2417174-26-4
febuxostat	febuxostat	2934.10	NC0590B2 Ann. L/15	HSC/29	2002	85	144060-53-7
fedotozine	fédotozine	2922.19	40.260 Ann. L/2 (No. 71)	HSC/17	1996	62	123618-00-8
fedovapagon	fédovapagon	2933.99	NC1649B3b Ann. R/14	HSC/47	2011	103	347887-36-9
fedratinib	fédratinib	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	108	936091-26-8	HSC/53 (2935.00)
feladilimab	féladilimab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2252518-85-5
felbinac	felbinac	2916.39	38.100 Ann. Q (No. 312)	HSC/11	1993	54	5728-52-9
felcisetrag	felcisétrag	2933.39	NC2803Bc Ann. T/3	HSC/67	2021	121	916075-84-8
felezonexor	félézonexor	2933.39	NC2803Bc Ann. T/3	HSC/67	2021	121	1076235-04-5
feloprentan	féloprentan	2933.59	NC0590B2 Ann. L/15	HSC/29	2002	85	204267-33-4
felvizumab	felvizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	77	167747-20-8	HSC/21 (3002.10)
felzartamab	felzartamab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2197112-39-1
fenalcomine	fénalcomine	2922.19	40.260 Ann. L/2 (No. 72)	HSC/17	1996	29	34616-39-2
fencamfamin	fencamfamine	2921.46	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	12	1209-98-9
fenebrutinib	fénébrutinib	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1434048-34-6
fenetylline	fénétylline	2939.51	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	16	3736-08-1
fenfluthrin	fenfluthrine	2916.20	38.100 Ann. Q (No. 314)	HSC/11	1993	54	75867-00-4
fenleuton	fenleuton	2928.00	40.600 Ann. D, par. 6	HSC/18	1996	72	141579-54-6
fenproporex	fenproporex	2926.30	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	17	15686-61-0
fentanyl	fentanyl	2933.33	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	14	437-38-7
fentonium bromide	bromure de fentonium	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	29	5868-06-4	HSC/11 (2939.90) HSC/53 (2939.99)
fermagate	fermagate	2842.90	NC1443B1b Ann. P/5	HSC/43	2009	98	119175-48-3
ferric (59Fe) citrate injection	soluté injec.de citrate ferrique (59Fe)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	24	54063-42-2	HSC/11 (2844.40)
ferric bepectate	bépectate ferrique	3505.10	NC2803Bc Ann. T/3	HSC/67	2021	121	2087952-70-1
ferric carboxymaltose	carboxymaltose ferrique	2940.00	NC1553B1b Ann. O/2	HSC/45	2010	97	9007-72-1
ferric derisomaltose	dérisomaltose ferrique	2940.00	NC2116B1b Ann. R/4	HSC/55	2015	110	1345510-43-1
ferric maltol	maltol ferrique	2932.99	NC2116B1b Ann. R/5	HSC/55	2015	111	33725-54-1
ferroquine	ferroquine	2933.49	NC1178B1c Ann. O/5	HSC/39	2007	95	185055-67-8
ferrotrenine	ferrotrénine	2925.29	NC2004B1b Ann. O/6	HSC/53	2014	15	15339-50-1	HSC/21 (2925.20)
fesomersen	fésomersen	2934.99	NC2930Bc Ann. P/25	HSC/69	2022	124	2380135-03-3
fesoterodine	fésotérodine	2922.50	NC0730B2 Ann. M/4	HSC/31	2003	84	286930-03-8

t t

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
fevipiprant	févipiprant	2933.99	NC2004B1b Ann. O/5	HSC/53	2014	109	872365-14-5
fexapotide	fexapotide	2930.90	NC2373B1b Ann. O/6	HSC/59	2017	114	492447-54-8
fexofenadine	fexofénadine	2933.39	42.100 Ann. O (III)	HSC/21	1998	74	83799-24-0
fexuprazan	fexuprazan	2935.90	NC2626B1b Ann. O/5	HSC/63	2019	120	1902954-60-2	(List 118 abeprazan)
fezakinumab	fézakinumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	101	1007106-86-6	HSC/46 (3002.10)
fezolinetant	fézolinétant	2934.99	NC2373B1b Ann. O/7	HSC/59	2017	115	1629229-37-3
fiacitabine	fiacitabine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	59	69123-90-6	HSC/11 (2934.90)
fianlimab	fianlimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2126132-98-5
fiboflapon	fiboflapon	2933.39	NC1760B1b Ann. N/8	HSC/49	2012	105	936350-00-4
ficlatuzumab	ficlatuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	105	1174900-84-5	HSC/49 (3002.10)
fidanacogene elaparvovec	fidanacogène élaparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	118	1954659-47-2	HSC/63 (3002.90)
fidarestat	fidarestat	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	78	136087-85-9	HSC/22 (2934.90)
fidasimtamab	fidasimtamab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2377419-89-9
fidaxomicin	fidaxomicine	2941.90	NC1553B1b Ann. O/7	HSC/45	2010	100	873857-62-6
fidexaban	fidexaban	2933.39	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	183305-24-0
fiduxosin	fiduxosine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	82	208993-54-8	HSC/27 (2934.90)
figitumumab	figitumumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	100	943453-46-1	HSC/44 (3002.10)
figopitant	figopitant	2933.59	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	502422-74-4
filaminast	filaminast	2928.00	42.100 Ann. O (IV)	HSC/21	1998	75	141184-34-1
filanesib	filanésib	2934.99	NC2004B1b Ann. O/5	HSC/53	2014	109	885060-09-3
filapixant	filapixant	2934.10	NC2803Bc Ann. T/6	HSC/67	2021	122	1948232-63-0
filgotinib	filgotinib	2934.99	NC2004B1b Ann. O/4	HSC/53	2014	108	1206161-97-8
filibuvir	filibuvir	2934.99	NC1604B1b Ann. N/5	HSC/46	2010	101	877130-28-4
filociclovir	filociclovir	2933.59	NC2116B1b Ann. R/5	HSC/55	2015	111	632325-71-4
filorexant	filorexant	2933.59	NC2004B1b Ann. O/4	HSC/53	2014	108	1088991-73-4
fimaporfin	fimaporfine	2933.99	NC2116B1b Ann. R/4	HSC/55	2015	110	1443547-43-0
fimasartan	fimasartan	2933.59	NC1178B1c Ann. O/3	HSC/39	2007	94	247257-48-3
fimepinostat	fimépinostat	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1339928-25-4
finafloxacin	finafloxacine	2934.99	NC0590B2 Ann. L/15	HSC/29	2002	85	209342-40-5
finerenone	finérénone	2933.99	NC2004B1b Ann. O/4	HSC/53	2014	108	1050477-31-0
fingolimod	fingolimod	2922.19	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	162359-55-9
finotonlimab	finotonlimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2350298-85-8
finrozole	finrozole	2933.99	NC2373B1b Ann. O/12	HSC/59	2017	81	160146-17-8	HSC/25 (2933.90)
finrozole	finrozole	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	81	160146-17-8
fipamezole	fipamézole	2933.29	NC0845B2 Ann. M/2	HSC/33	2004	88	150586-58-6
firategrast	firatégrast	2924.29	NC1310B1b Ann. N/10	HSC/41	2008	96	402567-16-2
firazorexton	firazorexton	2935.90	NC2803Bc Ann. T/7	HSC/67	2021	123	2274802-95-6
firibastat	firibastat	2930.90	NC2501B1b Ann. M/6	HSC/61	2018	117	648927-86-0
firivumab	firivumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	111	1443004-15-6	HSC/55 (3002.10)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
firolimogene autotemcel	firolimogène autotemcel	3002.51	NC2930Bc Ann. P/27	HSC/69	2022	125	no mention
firsocostat	firsocostat	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1434635-54-7
firtecan peglumer	firtécan péglumère	2939.79	NC2373B1b Ann. O/12	HSC/59	2017	108	1204768-03-5	HSC/53 (2933.99) HSC/57 (2939.99)
firtecan pegol	firtécan pégol	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	107	946062-05-1	HSC/51 (2939.99)
firuglipel	firuglipel	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1371591-51-3
firzacorvir	firzacorvir	2934.10	NC2930Bc Ann. P/25	HSC/69	2022	124	2243747-96-6
firzotemcel	firzotemcel	3002.51	NC2803Bc Ann. T/3	HSC/67	2021	121	no mention
fisogatinib	fisogatinib	2934.99	NC2803Bc Ann. T/2	HSC/67	2021	120	1707289-21-1
fispemifene	fispémifène	2909.49	NC0938B2b Ann. O/2	HSC/35	2005	89	341524-89-8
fitusiran	fitusiran	2934.99	NC2237B1b Ann. S/9	HSC/57	2016	113	1499251-18-1
flanvotumab	flanvotumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	106	1188277-05-5	HSC/51 (3002.10)
flestolol	flestolol	2924.21	38.100 Ann. Q (No. 317)	HSC/11	1993	53	87721-62-8
fletikumab	flétikumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	110	1357158-22-5	HSC/55 (3002.10)
flibanserin	flibansérine	2933.59	42.100 Ann. O (IV)	HSC/21	1998	75	167933-07-5
flindokalner	flindokalner	2933.79	NC0730B2 Ann. M/6	HSC/31	2003	86	187523-35-9
flomoxef	flomoxef	2941.90	38.100 Ann. Q (No. 318)	HSC/11	1993	55	99665-00-6
flopristin	flopristine	2941.90	NC1553B1b Ann. O/3	HSC/45	2010	98	318498-76-9
florbenazine (18F)	florbénazine (18F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	104	956903-29-0	HSC/49 (2844.40)
florbetaben (18F)	florbétabène (18F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	102	902143-01-5	HSC/46 (2844.40)
florbetapir (18F)	florbétapir (18F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	103	956103-76-7	HSC/47 (2844.40)
florfenicol	florfénicol	2941.40	40.260 Ann. L/2 (No. 1)	HSC/17	1996	54	76639-94-6
florilglutamic acid (18F)	acide florilglutamique (18F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	106	1196963-74-2	HSC/51 (2844.40)
flortanidazole (18F)	flortanidazole (¹⁸F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	108	70878-86-2	HSC/53 (2844.40)
flortaucipir (18F)	flortaucipir (18F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	114	1522051-90-6	HSC/59 (2844.40)
flotegatide (18F)	flotégatide (¹⁸F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	108	1010702-75-6	HSC/53 (2844.40)
flotetuzumab	flotétuzumab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	1664355-28-5
flotufolastat (¹⁸F)	flotufolastat (¹⁸F)	2844.43	NC2803Bc Ann. T/7	HSC/67	2021	123	2305060-41-5
flovagatran	flovagatran	2933.99	NC1310B1b Ann. N/4	HSC/41	2008	97	871576-03-3
flubentylosin	flubentylosine	2941.90	NC2803Bc Ann. T/7	HSC/67	2021	123	1809266-03-2
flubrobenguane (18F)	flubrobenguane (18F)	2844.43	NC2803Bc Ann. T/3	HSC/67	2021	121	1037359-47-9
fluciclatide (18F)	fluciclatide (18F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	103	879894-01-6	HSC/47 (2844.40)
fluciclovine (18F)	fluciclovine (18F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	103	222727-39-1	HSC/47 (2844.40)
fludalanine	fludalanine	2845.90	38.100 Ann. Q (No. 319)	HSC/11	1993	38	35523-45-6
fludeoxyglucose (18F)	fludésoxyglucose (18F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	61	105851-17-0	HSC/11 (2844.40)
fludiazepam	fludiazépam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	36	3900-31-0
flugestone	flugestone	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	16	337-03-1	HSC/11 (2937.92)
fluindarol	fluindarol	2914.79	NC2116B1b Ann. S/1	HSC/55	2015	16	6723-40-6	HSC/21 (2914.70)
fluindione	fluindione	2914.79	NC2116B1b Ann. S/1	HSC/55	2015	40	957-56-2	HSC/11 (2914.70)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
flumazenil	flumazénil	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	55	78755-81-4	HSC/11 (2933.90)
flumbatinib	flumbatinib	2933.59	NC2930Bc Ann. P/27	HSC/69	2022	125	895519-90-1
flumoxonide	flumoxonide	2937.22	40.260 Ann. L/2 (No. 29)	HSC/17	1996	38	60135-22-0
flunitrazepam	flunitrazépam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	24	1622-62-4
fluocortin	fluocortine	2937.22	42.100 Ann. O (I)	HSC/21	1998	31	33124-50-4
fluorfenidine (¹⁸F)	fluorfénidine (¹⁸F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	108	917894-12-3	HSC/53 (2844.40)
fluralaner	fluralaner	2934.99	NC1874B1b Ann. O/2	HSC/51	2013	107	864731-61-3
flurazepam	flurazépam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	20	17617-23-1
flurdihydroergotamine	flurdihydroergotamine	2939.69	NC2373B1b Ann. O/7	HSC/59	2017	115	1416417-27-0
flurpiridaz (18F)	flurpiridaz (18F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	103	863887-89-2	HSC/47 (2844.40)
flusoxolol	flusoxolol	2922.19	40.260 Ann. L/2 (No. 73)	HSC/17	1996	50	84057-96-5
fluspirilene	fluspirilène	2933.39	40.260 Ann. L/2 (No. 26)	HSC/17	1996	15	1841-19-6
flutafuranol (¹⁸F)	flutafuranol (¹⁸F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	112	1211333-21-9	HSC/57 (2844.40)
flutemetamol (18F)	flutémétamol (18F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	101	765922-62-1	HSC/46 (2844.40)
fluticasone furoate	furoate de fluticasone	2937.22	NC1178B1c Ann. O/5	HSC/39	2007	95	397864-44-7
flutriciclamide (18F)	flutriciclamide (¹⁸F)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	108	1274863-98-7	HSC/53 (2844.40)
fluvastatin	fluvastatine	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	62	93957-54-1	HSC/11 (2933.90)
fobrépodacine	fobrépodacine	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	1384984-31-9
fodipir	fodipir	2933.39	40.600 Ann. D, par. 6	HSC/18	1996	72	118248-91-2
foliglurax	foliglurax	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1883329-51-8
folitixorin	folitixorine	2933.59	NC1443B1b Ann. P/5	HSC/43	2009	98	3432-99-3
follitropin alfa	follitropine alfa	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	71	9002-68-0	HSC/18 (2937.10)
follitropin beta	follitropine bêta	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	75	150490-84-9	HSC/21 (2937.10)
follitropin delta	fillitropine delta	2937.19	NC2237B1b Ann. S/8	HSC/57	2016	112	146479-72-3
follitropin epsilon	follitropine epsilon	2937.19	NC2373B1b Ann. O/7	HSC/59	2017	115	1359819-75-2
follitropin gamma	follitropine gamma	2937.19	NC1874B1b Ann. O/1	HSC/51	2013	106	1219693-73-8
fomidacillin	fomidacilline	2941.10	38.100 Ann. Q (No. 325)	HSC/11	1993	55	98048-07-8
fomivirsen	fomivirsen	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	75	144245-52-3	HSC/21 (2934.90)
fonadelpar	fonadelpar	2934.10	NC2373B1b Ann. O/6	HSC/59	2017	114	515138-06-4
fondaparinux sodium	fondaparinux sodique	2932.99	NC0590B2 Ann. L/10	HSC/29	2002	83	114870-03-0
fontolizumab	fontolizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	87	326859-36-3	HSC/31 (3002.10)
fonturacetam	fonturacétam	2933.79	NC1604B1b Ann. N/5	HSC/46	2010	101	77472-70-9
foralumab	foralumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	103	946415-64-1	HSC/47 (3002.10)
forasartan	forasartan	2933.39	42.100 Ann. O (III)	HSC/21	1998	74	145216-43-9
foravirumab	foravirumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	99	944548-38-3	HSC/43 (3002.10)
fordadistrogene movaparvovec	fordadistrogène movaparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	123	2248111-37-5	HSC/67 (3002.90)
foretinib	forétinib	2934.99	NC1604B1b Ann. N/6	HSC/46	2010	102	849217-64-7
forigerimod	forigérimod	2933.29	NC1760B1b Ann. N/7	HSC/49	2012	104	497156-60-2
formebolone	formébolone	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	31	2454-11-7	HSC/11 (2937.99)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
forodesine	forodesine	2933.59	NC1059B2b Ann. O/4	HSC/37	2006	92	209799-67-7
foropafant	foropafant	2934.10	42.100 Ann. O (IV)	HSC/21	1998	75	136468-36-5
fosalvudine tidoxil	fosalvudine tidoxil	2934.99	NC1178B1c Ann. O/5	HSC/39	2007	95	763903-67-9
fosamprenavir	fosamprénavir	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	83	226700-79-4	HSC/27 (2935.00)
fosaprepitant	fosaprépitant	2934.99	NC1123B1b Ann. N/1	HSC/38	2006	94	172673-20-0
fosbretabulin	fosbrétabuline	2919.90	NC1500B1b Ann. K/6	HSC/44	2009	100	222030-63-9
foscarbidopa	foscarbidopa	2928.00	NC2803Bc Ann. T/2	HSC/67	2021	120	1907685-81-7
foscenvivint	foscenvivint	2933.79	NC2930Bc Ann. P/25	HSC/69	2022	124	1422253-38-0
fosciclopirox	fosciclopirox	2933.79	NC2803Bc Ann. T/6	HSC/67	2021	122	1380539-06-9
fosdagrocorat	fosdagrocorat	2933.39	NC2116B1b Ann. R/5	HSC/55	2015	111	1044535-58-1
fosdenopterin	fosdénoptérine	2934.99	NC2803Bc Ann. T/3	HSC/67	2021	121	150829-29-1
fosdevirine	fosdévirine	2933.99	NC1649B3b Ann. R/14	HSC/47	2011	103	1018450-26-4
fosfluconazole	fosfluconazole	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	83	194798-83-9	HSC/27 (2933.90)
fosfluridine tidoxil	fosfluridine tidoxil	2934.99	NC1059B2b Ann. O/5	HSC/37	2006	93	174638-15-4
fosfructose	fosfructose	2940.00	NC0250B2 Ann. P/1 (II)	HSC/25	2000	81	488-69-7
fosgemcitabine palabenamide	fosgemcitabine palabénamide	2934.99	NC2626B1b Ann. O/6	HSC/63	2019	119	1562406-27-2
fosgonimeton	fosgoniméton	2924.29	NC2930Bc Ann. P/27	HSC/69	2022	125	2093305-05-4
fosifidancitinib	fosifidancitinib	2934.99	NC2803Bc Ann. T/6	HSC/67	2021	122	1237168-58-9
fosifloxuridine nafalbenamide	fosifloxuridine nafalbénamide	2934.99	NC2626B1b Ann. O/6	HSC/63	2019	119	1332837-31-6
foslevodopa	foslévodopa	2922.50	NC2803Bc Ann. T/2	HSC/67	2021	120	97321-87-4
foslinanib	foslinanib	2933.49	NC2626B1b Ann. O/6	HSC/63	2019	119	1256037-60-1
fosmanogepix	fosmanogépix	2934.99	NC2626B1b Ann. O/6	HSC/63	2019	119	2091769-17-2
fosmetpantotenate	fosmetpantoténate	2929.90	NC2501B1b Ann. M/5	HSC/61	2018	116	1858268-66-2
fosnetupitant	fosnétupitant	2933.59	NC2237B1b Ann. S/9	HSC/57	2016	113	1703748-89-3
fosopamine	fosopamine	2922.29	40.260 Ann. L/2 (No. 74)	HSC/17	1996	69	103878-96-2
fospropofol	fospropofol	2919.90	NC1123B1b Ann. N/1	HSC/38	2006	94	258516-89-1
fosquidone	fosquidone	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	64	114517-02-1	HSC/11 (2933.90)
fosravuconazole	fosravuconazole	2934.10	NC2116B1b Ann. R/4	HSC/55	2015	110	351227-64-0
fostamatinib	fostamatinib	2934.99	NC1500B1b Ann. K/6	HSC/44	2009	100	901119-35-5
fostemsavir	fostemsavir	2933.59	NC2373B1b Ann. O/7	HSC/59	2017	115	864953-29-7
fostriecin	fostriécine	2932.20	NC2004B1b Ann. O/6	HSC/53	2014	55	87810-56-8	HSC/11 (2932.29)
fostroxacitabine bralpamide	fostroxacitabine bralpamide	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	2129993-56-0
fosveset	fosvéset	2922.50	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	193901-91-6
fozivudine tidoxil	fozivudine tidoxil	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	73	141790-23-0	HSC/18 (2934.90)
fradafiban	fradafiban	2933.79	40.600 Ann. D, par. 6	HSC/18	1996	72	148396-36-5
frakefamide	frakéfamide	2924.29	NC0250B2 Ann. P/1 (II)	HSC/25	2000	81	188196-22-7
fremanezumab	frémanezumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1655501-53-3
frenlosirsen	frenlosirsen	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	2304711-81-5
fresolimumab	frésolimumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	101	948564-73-6	HSC/46 (3002.10)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
frovatriptan	frovatriptan	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	78	158747-02-5	HSC/22 (2933.90)
frovocimab	frovocimab	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	1643672-70-1
frunevetmab	frunévetmab	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1708936-80-4
fruquintinib	fruquintinib	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1194506-26-7
fudosteine	fudostéine	2930.90	42.100 Ann. O (VI)	HSC/21	1998	77	13189-98-5
fulacimstat	fulacimstat	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1488354-15-9
fuladectin	fuladectine	3003.90	40.600 Ann. D, par. 6	HSC/18	1996	71	Component A4 : 150702-32-2 / Component A3 : 150702-33-3
fulranumab	fulranumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	104	902141-80-4	HSC/49 (3002.10)
fulvestrant	fulvestrant	2937.23	NC2116B1b Ann. R/7	HSC/55	2015	78	129453-61-8	HSC/22 (2930.90)
funapide	funapide	2934.99	NC2116B1b Ann. R/5	HSC/55	2015	111	1259933-16-8
furaprevir	furaprévir	2935.90	NC2237B1b Ann. T/12	HSC/57	2016	111	1435923-88-8	HSC/55 (2935.00)
furethidine	furéthidine	2934.99	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	9	2385-81-1
furomine	furomine	2932.19	42.100 Ann. O (III)	HSC/21	1998	74	142996-66-5
futibatinib	futibatinib	2933.59	NC2626B1b Ann. O/6	HSC/63	2019	119	1448169-71-8
futuximab	futuximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1310460-85-5	HSC/51 (3002.10)
fuzapladib	fuzapladib	2935.90	NC2803Bc Ann. T/2	HSC/67	2021	120	141283-87-6
fuzuloparib	fuzuloparib	2933.59	NC2930Bc Ann. P/27	HSC/69	2022	125	1358715-18-0
gabapentin enacarbil	gabapentine énacarbil	2924.29	NC1178B1c Ann. O/3	HSC/39	2007	94	478296-72-9
gacyclidine	gacyclidine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	76	68134-81-6	HSC/21 (2934.90)
gadocoletic acid	acide gadocolétique	2846.90	NC0590B2 Ann. L/15	HSC/29	2002	85	280776-87-6
gadodenterate	gadodentérate	2846.90	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	544697-52-1
gadodiamide	gadodiamide	2846.90	38.100 Ann. Q (No. 329)	HSC/11	1993	70	131410-48-5
gadofosveset	gadofosvéset	2846.90	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	193901-90-5
gadomelitol	gadomélitol	2846.90	NC0590B2 Ann. L/15	HSC/29	2002	85	227622-74-4
gadopenamide	gadopénamide	2846.90	38.100 Ann. Q (No. 330)	HSC/11	1993	60	117827-80-2
gadopentetic acid	acide gadopentétique	2846.90	38.100 Ann. Q (No. 331)	HSC/11	1993	50	80529-93-7
gadopiclenol	gadopiclénol	2846.90	NC2626B1b Ann. O/5	HSC/63	2019	118	933983-75-6
gadoquatrane	gadoquatrane	2846.90	NC2930Bc Ann. P/27	HSC/69	2022	125	2048221-65-2
gadoteric acid	acide gadotérique	2846.90	38.100 Ann. Q (No. 332)	HSC/11	1993	59	72573-82-1
gadoversetamide	gadoversétamide	2846.90	40.600 Ann. D, par. 6	HSC/18	1996	71	131069-91-5
gadoxetic acid	acide gadoxétique	2846.90	40.600 Ann. D, par. 6	HSC/18	1996	71	135326-11-3
galantamine	galantamine	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	79	357-70-0	HSC/11 (2939.90) HSC/53 (2939.99)
galarubicin	galarubicine	2941.90	NC0090B2 Ann. M/5	HSC/23	1999	80	140637-86-1
galcanezumab	galcanézumab	3002.13	NC2373B1b Ann. O/6	HSC/59	2017	114	1578199-75-3
galdansetron	galdansétron	2933.29	40.600 Ann. D, par. 6	HSC/18	1996	72	116684-92-5

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
galegenimab	galégénimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2403683-24-7
galeterone	galétérone	2937.29	NC1760B1b Ann. N/8	HSC/49	2012	105	851983-85-2
galicaftor	galicaftor	2932.99	NC2626B1b Ann. O/6	HSC/63	2019	119	1918143-53-9
galidesivir	galidésivir	2933.59	NC2373B1b Ann. O/6	HSC/59	2017	114	249503-25-1
gallium (⁶⁸Ga) gozetotide	gallium (⁶⁸Ga) gozétotide	2844.43	NC2803Bc Ann. T/7	HSC/67	2021	123	1906894-20-9
galsulfase	galsulfase	3507.90	NC1004B1b Ann. L/11	HSC/36	2005	92	552858-79-4
galunisertib	galunisertib	2933.49	NC2004B1b Ann. O/5	HSC/53	2014	109	700874-72-2
gamithromycin	gamithromycine	2941.90	NC1178B1c Ann. O/5	HSC/39	2007	95	145435-72-9
ganaplacide	ganaplacide	2933.59	NC2626B1b Ann. O/5	HSC/63	2019	118	1261113-96-5
ganaxolone	ganaxolone	2914.40	42.100 Ann. O (V)	HSC/21	1998	76	38398-32-2
ganciclovir	ganciclovir	2933.59	38.100 Ann. Q (No. 334)	HSC/11	1993	56	82410-32-0
gancotamab	gancotamab	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	1509928-00-0
gandotinib	gandotinib	2934.99	NC2004B1b Ann. O/4	HSC/53	2014	108	1229236-86-5
ganetespib	ganétespib	2933.99	NC1760B1b Ann. N/8	HSC/49	2012	105	888216-25-9
ganglefene	ganglefène	2922.19	40.260 Ann. L/2 (No. 75)	HSC/17	1996	12	299-61-6
ganitumab	ganitumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	103	905703-97-1	HSC/47 (3002.10)
ganstigmine	ganstigmine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	81	457075-21-7	HSC/25 (2934.90)
gantacurium chloride	chlorure de gantacurium	2933.49	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	213998-46-0
gantenerumab	ganténérumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	108	1043556-46-2	HSC/41 (3002.10)
gantofiban	gantofiban	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	80	183547-57-1	HSC/23 (2934.90)
ganulameran	ganulaméran	3002.41	NC2803Bc Ann. T/11	HSC/67	2021	4 COVID	2433844-55-2
garadacimab	garadacimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2162134-62-3
garenoxacin	garénoxacine	2933.49	NC0730B2 Ann. M/7	HSC/31	2003	87	194804-75-6
garetosmab	garétosmab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2097125-54-5
garivulimab	garivulimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2342597-81-1
garnocestim	garnocestim	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	85	246861-96-1	HSC/31 (3002.10)
gartisertib	gartisertib	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	1613191-99-3
garvagliptin	garvagliptine	2935.90	NC2501B1b Ann. M/6	HSC/61	2018	117	1601479-87-1
garveleucel	garvéleucel	3002.51	NC2803Bc Ann. T/7	HSC/67	2021	123	no mention
gataparsen	gataparsen	2934.99	NC1649B3b Ann. R/14	HSC/47	2011	103	1065019-70-6
gatifloxacin	gatifloxacine	2933.59	42.100 Ann. O (III)	HSC/21	1998	74	160738-57-8
gatipotuzumab	gatipotuzumab	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1264737-26-9
gatralimab	gatralimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	1826020-80-7
gavestinel	gavestinel	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	77	153436-22-7	HSC/21 (2933.90)
gavilimomab	gavilimomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	84	244096-20-6	HSC/29 (3002.10)
gavocabtagene autoleucel	gavocabtagène autoleucel	3002.51	NC2803Bc Ann. T/7	HSC/67	2021	123	no mention
gaxilose	gaxilose	2940.00	NC1760B1b Ann. N/7	HSC/49	2012	104	14087-31-1
geclosporin	géclosporine	2933.79	40.600 Ann. D, par. 6	HSC/18	1996	70	74436-00-3
gedatolisib	gedatolisib	2934.99	NC2116B1b Ann. R/5	HSC/55	2015	111	1197160-78-3

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
gedivumab	gédivumab	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1807954-17-1
gefapixant	géfapixant	2935.90	NC2626B1b Ann. O/5	HSC/63	2019	118	1015787-98-0
gefitinib	gefitinib	2934.99	NC0590B2 Ann. L/15	HSC/29	2002	85	184475-35-2
gemcabene	gemcabène	2918.99	NC2373B1b Ann. O/12	HSC/59	2017	88	183293-82-5	HSC/33 (2918.90)
gemcitabine	gemcitabine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	62	95058-81-4	HSC/11 (2934.90)
gemcitabine elaidate	élaïdate de gemcitabine	2934.99	NC1874B1b Ann. O/1	HSC/51	2013	106	210829-30-4
gemifloxacin	gémifloxacine	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	81	204519-64-2	HSC/25 (2933.90)
gemigliptin	gémigliptine	2933.79	NC1649B3b Ann. R/14	HSC/47	2011	103	911637-19-9
gemilukast	gémilukast	2933.99	NC2116B1b Ann. R/4	HSC/55	2015	110	1232861-58-3
gemnelatinib	gemnélatinib	2933.79	NC2930Bc Ann. P/27	HSC/69	2022	125	2225123-30-6
gemopatrilat	gémopatrilate	2933.79	NC0590B2 Ann. L/15	HSC/29	2002	84	160135-92-2
gemtuzumab	gemtuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	83	220578-59-6	HSC/27 (3002.10)
gemtuzumab ozogamicin	gemtuzumab ozogamicine	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	220578-59-6
genistein	génistéine	2932.99	NC2803Bc Ann. T/6	HSC/67	2021	122	446-72-0
gepotidacin	gépotidacine	2934.99	NC2237B1b Ann. S/8	HSC/57	2016	112	1075236-89-3
geptanolimab	geptanolimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2348469-43-0
gevokizumab	gévokizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	104	1129435-60-4	HSC/49 (3002.10)
giloralimab	giloralimab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2226292-20-0
gilteritinib	giltéritinib	2934.99	NC2237B1b Ann. S/8	HSC/57	2016	112	1254053-43-4
gilvetmab	gilvetmab	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1808081-43-7
gimatecan	gimatécan	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	86	292618-32-7	HSC/31 (2939.99)
gimeracil	giméracil	2933.39	NC0090B2 Ann. M/5	HSC/23	1999	80	103766-25-2
giminabant	giminabant	2933.59	NC1874B1b Ann. O/2	HSC/51	2013	107	890033-57-5
gimsilumab	gimsilumab	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1648796-29-5
gindameran	gindaméran	2934.99	NC2803Bc Ann. T/7	HSC/67	2021	123	2348560-89-2
ginisortamab	ginisortamab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2390147-17-6
giractide	giractide	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	29	24870-04-0	HSC/21 (2937.10)
giredestrant	girédestrant	2933.99	NC2803Bc Ann. T/6	HSC/67	2021	122	1953133-47-5
girentuximab	girentuximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	101	916138-87-9	HSC/46 (3002.10)
giripladib	giripladib	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	96	865200-20-0	HSC/41 (2935.00)
giroctocogene fitelparvovec	giroctocogène fitelparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	121	2166101-71-7	HSC/67 (3002.90)
gisadenafil	gisadénafil	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	101	334826-98-1	HSC/46 (2935.00)
givinostat	givinostat	2928.00	NC1649B3b Ann. R/12	HSC/47	2011	101	497833-27-9
givosiran	givosiran	2934.99	NC2373B1b Ann. O/6	HSC/59	2017	114	1639325-43-1
glasdegib	glasdégib	2933.39	NC2116B1b Ann. R/5	HSC/55	2015	111	1095173-27-5
glaspimod	glaspimod	2933.79	42.100 Ann. O (III)	HSC/21	1998	74	134143-28-5
glaziovine	glaziovine	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	34	17127-48-9	HSC/21 (2939.90) HSC/53 (2939.99)
glecaprevir	glécaprévir	2935.90	NC2373B1b Ann. O/6	HSC/59	2017	114	1365970-03-1

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
glembatumumab	glembatumumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	102	1020264-78-1	HSC/46 (3002.10)
glembatumumab vedotin	glembatumumab védotine	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	113	1182215-65-1	HSC/57 (3002.10) (S/9)
glenvastatin	glenvastatine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	70	122254-45-9	HSC/18 (2934.90)
glenzocimab	glenzocimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2101829-58-5
glepaglutide	glépaglutide	2937.19	NC2501B1b Ann. M/5	HSC/61	2018	116	914009-86-2
gleptoferron	gleptoferron	3913.90	38.100 Ann. Q (No. 336)	HSC/11	1993	36	57680-55-4
glesatinib	glésatinib	2934.99	NC2373B1b Ann. O/6	HSC/59	2017	114	936694-12-1
glofitamab	glofitamab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2229047-91-8
gloximonam	gloximonam	2941.90	38.100 Ann. Q (No. 337)	HSC/11	1993	54	90850-05-8
glucalox	glucalox	3003.90	42.100 Ann. O (II)	HSC/21	1998	13	12182-48-8
glucarpidase	glucarpidase	3507.90	NC1004B1b Ann. L/11	HSC/36	2005	92	9074-87-7
glufosfamide	glufosfamide	2940.00	42.100 Ann. O (VI)	HSC/21	1998	77	132682-98-5
glusoferron	glusoferron	3911.90	38.100 Ann. Q (No. 338)	HSC/11	1993	37	56959-18-3
glutethimide	glutéthimide	2925.12	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	6	77-21-4
glycerol phenylbutyrate	phénylbutyrate de glycérol	2916.39	NC1874B1b Ann. O/1	HSC/51	2013	106	611168-24-2
goflikicept	goflikicept	3002.13	NC2803Bc Ann. T/11	HSC/67	2021	4 COVID	2416984-26-2
golexanolone	golexanolone	2928.00	NC2626B1b Ann. O/6	HSC/63	2019	119	2089238-18-4
golidocitinib	golidocitinib	2933.59	NC2930Bc Ann. P/27	HSC/69	2022	125	2091134-68-6
golimumab	golimumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	91	476181-74-5	HSC/35 (3002.10)
golnerminogene pradenovec	golnerminogène pradénovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	101	957472-14-9	HSC/47 (3002.90)
golodirsen	golodirsen	2934.99	NC2447B1b Ann. N/2	HSC/60	2017	115	1422959-91-8
golotimod	golotimod	2933.99	NC1310B1b Ann. N/4	HSC/41	2008	97	229305-39-9
golvatinib	golvatinib	2933.59	NC1874B1b Ann. O/2	HSC/51	2013	107	928037-13-2
gontivimab	gontivimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	1257358-38-5
goralatide	goralatide	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	72	120081-14-3	HSC/18 (2933.90)
goserelin	goséréline	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	55	65807-02-5	HSC/11 (2937.99)
gosogliptin	gosogliptin	2933.59	NC1649B3b Ann. R/12	HSC/47	2011	101	869490-23-3
gosuranemab	gosuranémab	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	1788032-39-2
govorestat	govorestat	2934.20	NC2930Bc Ann. P/25	HSC/69	2022	124	2170729-29-8
goxalapladib	goxalapladib	2933.39	NC1178B1c Ann. O/3	HSC/39	2007	94	412950-27-7
granotapide	granotapide	2924.29	NC1760B1b Ann. N/7	HSC/49	2012	104	594842-13-4
grapiprant	grapiprant	2935.90	NC2237B1b Ann. T/12	HSC/57	2016	110	415903-37-6	HSC/55 (2935.00)
graunimotide	graunimotide	3002.41	NC2803Bc Ann. T/4	HSC/67	2021	113	851666-89-2	HSC/57 (3002.13) HSC/59 (3002.20)
grazoprevir	grazoprévir	2935.90	NC2237B1b Ann. T/12	HSC/57	2016	110	1350514-68-9	HSC/55 (2935.00)
gremubamab	grémubamab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	1800381-36-5
gresonitamab	grésonitamab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2413817-97-5
grisnilimab	grisnilimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2367001-70-3

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
grisnilimab setaritox	grisnilimab sétaritox	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2361013-29-6
guadecitabine	guadécitabine	2934.99	NC2237B1b Ann. S/9	HSC/57	2016	113	929901-49-5
guafecainol	guafécaïnol	2922.19	40.260 Ann. L/2 (No. 76)	HSC/17	1996	38	36199-78-7
guaiactamine	guaïactamine	2922.19	40.260 Ann. L/2 (No. 77)	HSC/17	1996	16	15687-23-7
guaraprolose	guaraprolose	1302.32	NC1649B3b Ann. R/13	HSC/47	2011	102	39421-75-5
gumokimab	gumokimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2428381-52-4
gunagratinib	gunagratinib	2933.19	NC2930Bc Ann. P/27	HSC/69	2022	125	2211082-53-8
guretolimod	gurétolimod	2933.59	NC2930Bc Ann. P/25	HSC/69	2022	124	1488364-57-3
gusacitinib	gusacitinib	2933.59	NC2803Bc Ann. T/2	HSC/67	2021	120	1425381-60-7
guselkumab	guselkumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	109	1350289-85-8	HSC/53 (3002.10)
halazepam	halazépam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	29	23092-17-3
halopredone	haloprédone	2937.22	38.100 Ann. Q (No. 341)	HSC/11	1993	36	57781-15-4
haloxazolam	haloxazolam	2934.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	38	59128-97-1
hemoglobin betafumaril (bovine)	hémoglobine bêtafumaril (bovine)	3002.12	NC2373B1b Ann. O/7	HSC/59	2017	115	1797415-38-3
hemoglobin crosfumaril	hémoglobine crosfumaril	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	76	142261-03-8	HSC/21 (3002.10)
hemoglobin crosfumaril (bovine)	hémoglobine crosfumaril (bovine)	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	108	1360741-07-6	HSC/53 (3002.10)
hemoglobin glutamer	hémoglobine glutamère	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	80	no mention	HSC/25 (3002.10)
hemoglobin raffimer	raffimère d’hémoglobine	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	89	197462-97-8	HSC/37 (3002.10)
hepcidin	hepcidine	2937.19	NC2803Bc Ann. T/7	HSC/67	2021	123	1356390-47-0
hexasodium fytate	fytate d’hexasodium	2919.90	NC2930Bc Ann. P/27	HSC/69	2022	125	34367-89-0
hexobendine	hexobendine	2922.19	40.260 Ann. L/2 (No. 78)	HSC/17	1996	15	54-03-5
histrelin	histréline	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	53	76712-82-8	HSC/11 (2937.99)
homidium bromide	bromure d’homidium	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	36	1239-45-8	HSC/11 (2933.90)
hydrocodone	hydrocodone	2939.11	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	1	125-29-1
hydroflumethiazide	hydrofluméthiazide	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	10	135-09-1	HSC/11 (2935.00)
hydromethylthionine	hydrométhylthionine	2934.30	NC2626B1b Ann. O/6	HSC/63	2019	119	613-11-6
hydromorphinol	hydromorphinol	2939.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	11	2183-56-4
hydromorphone	hydromorphone	2939.11	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	1	466-99-9
hydroxycarbamide	hydroxycarbamide	2928.00	38.100 Ann. Q (No. 342)	HSC/11	1993	16	127-07-1
hydroxypethidine	hydroxypéthidine	2933.39	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	468-56-4
hyetellose	hyétellose	3912.39	NC0090B2 Ann. M/5	HSC/23	1999	80	9004-62-0
hymetellose	hymétellose	3912.39	NC0090B2 Ann. M/5	HSC/23	1999	80	9032-42-2
hyprolose	hyprolose	3912.39	NC0090B2 Ann. M/5	HSC/23	1999	80	9004-64-2
hypromellose	hypromellose	3912.39	38.100 Ann. Q (No. 343)	HSC/11	1993	80	9004-65-3
iadademstat	iadademstat	2921.59	NC2626B1b Ann. O/6	HSC/63	2019	119	1431304-21-0
ianalumab	ianalumab	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1929549-92-7
ibacitabine	ibacitabine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	57	611-53-0	HSC/11 (2934.90)

t t

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
ibafloxacin	ibafloxacine	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	60	91618-36-9	HSC/11 (2933.90)
ibalizumab	ibalizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	97	680188-33-4	HSC/41 (3002.10)
ibandronic acid	acide ibandronique	2931.49	NC2803Bc Ann. T/4	HSC/67	2021	71	114084-78-5	HSC/18 (2931.00) HSC/59 (2931.39)
ibazocine	ibazocine	2933.39	40.260 Ann. L/2 (No. 16)	HSC/17	1996	36	57653-28-8
iberdomide	iberdomide	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1323403-33-3
ibezapolstat	ibézapolstat	2934.99	NC2803Bc Ann. T/7	HSC/67	2021	123	1275582-97-2
ibipinabant	ibipinabant	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	99	464213-10-3	HSC/43 (2935.00)
iboctadekin	iboctadékine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	92	479198-61-3	HSC/39 (3002.10)
ibodutant	ibodutant	2934.99	NC1443B1b Ann. P/5	HSC/43	2009	98	522664-63-7
ibrexafungerp	ibrexafungerp	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1207753-03-4
ibrigampar	ibrigampar	2935.90	NC2930Bc Ann. P/25	HSC/69	2022	124	315224-26-1
ibritumomab tiuxetan	ibritumomab tiuxétan	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	81	206181-63-7	HSC/25 (3002.10)
ibrolipim	ibrolipim	2931.59	NC2803Bc Ann. T/4	HSC/67	2021	88	133208-93-2	HSC/33 (2931.00) HSC/56 (2931.39)
ibrutinib	ibrutinib	2933.59	NC1874B1b Ann. O/2	HSC/51	2013	107	936563-96-1
ibudilast	ibudilast	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	58	50847-11-5	HSC/11 (2933.90)
ibutamoren	ibutamoren	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	78	159634-47-6	HSC/22 (2935.00)
icapamespib	icapamespib	2934.99	NC2803Bc Ann. T/7	HSC/67	2021	123	1000999-96-1
icaridin	icaridine	2933.39	NC0730B2 Ann. M/6	HSC/31	2003	86	119515-38-7
icatolimab	icatolimab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2236068-83-8
icenticaftor	icenticaftor	2933.39	NC2803Bc Ann. T/6	HSC/67	2021	122	1334546-77-8
icerguastat	icerguastat	2928.00	NC2803Bc Ann. T/6	HSC/67	2021	122	951441-04-6
iclaprim	iclaprim	2934.99	NC0845B2 Ann. M/2	HSC/33	2004	88	192314-93-5
iclepertin	iclépertine	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	1421936-85-7
icometasone enbutate	icométasone enbutate	2937.22	40.600 Ann. D, par. 6	HSC/18	1996	70	103466-73-5
icomucret	icomucret	2918.19	NC1059B2b Ann. O/4	HSC/37	2006	92	54845-95-3
icopezil	icopézil	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	75	145508-78-7	HSC/21 (2934.90)
icosabutate	icosabutate	2918.99	NC2116B1b Ann. R/4	HSC/55	2015	110	1253909-57-7
icospiramide	icospiramide	2933.39	40.260 Ann. L/2 (No. 27)	HSC/17	1996	68	79449-99-3
icrucumab	icrucumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	104	1024603-92-6	HSC/49 (3002.10)
idactamab	idactamab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2245205-37-0
idalopirdine	idalopirdine	2933.99	NC2116B1b Ann. R/4	HSC/55	2015	110	467459-31-0
idarubicin	idarubicine	2941.90	38.100 Ann. Q (No. 347)	HSC/11	1993	47	58957-92-9
idarucizumab	idarucizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	109	1362509-93-0	HSC/53 (3002.10)
idasanutlin	idasanutline	2933.99	NC2116B1b Ann. R/5	HSC/55	2015	111	1229705-06-9
idecabtagene vicleucel	idécabtagène vicleucel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	119	no mention	HSC/63 (3002.90)
idelalisib	idélalisib	2933.59	NC1874B1b Ann. O/2	HSC/51	2013	107	870281-82-6
idestopoetin alfa	idestopoétine alfa	3002.12	NC2930Bc Ann. P/27	HSC/69	2022	125	2370888-96-1

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
idetrexed	idétrexed	2933.59	NC2803Bc Ann. T/6	HSC/67	2021	122	501332-69-0
idrabiotaparinux sodium	idrabiotaparinux sodique	2934.99	NC1310B1b Ann. N/4	HSC/41	2008	97	405159-59-3
idramantone	idramantone	2914.40	40.600 Ann. D, par. 6	HSC/18	1996	71	20098-14-0
idraparinux sodium	idraparinux sodique	2932.99	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	149920-56-9
idremcinal	idremcinal	2941.50	NC0250B2 Ann. P/1 (II)	HSC/25	2000	81	110480-13-2
idrevloride	idrévloride	2933.99	NC2930Bc Ann. P/27	HSC/69	2022	125	1416973-63-1
idronoxil	idronoxil	2932.99	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	81267-65-4
idropranolol	idropranolol	2922.19	40.260 Ann. L/2 (No. 79)	HSC/17	1996	31	27581-02-8
idroxioleic acid	acide idroxioléique	2918.19	NC2930Bc Ann. P/25	HSC/69	2022	124	56472-29-8
idursulfase	idursulfase	3507.90	NC0730B2 Ann. M/7	HSC/31	2003	90	50936-59-9
idursulfase beta	idursulfase bêta	3507.90	NC1874B1b Ann. O/1	HSC/51	2013	106	1271734-34-9
ieramilimab	iéramilimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2137049-37-5
ifabotuzumab	ifabotuzumab	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	115	1234137-51-9	(List 114 fibatuzumab)
iferanserin	iféransérine	2933.39	NC0938B2b Ann. O/2	HSC/35	2005	89	58754-46-4
ifetroban	ifétroban	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	71	143443-90-7	HSC/18 (2934.90)
ifezuntirgene inilparvovec	ifezuntirgène inilparvovec	3002.49	NC2930Bc Ann. P/27	HSC/69	2022	125	2407582-19-6
ifidancitinib	ifidancitinib	2934.99	NC2803Bc Ann. T/6	HSC/67	2021	122	1236667-40-5
iganidipine	iganidipine	2933.59	40.600 Ann. D, par. 6	HSC/18	1996	70	119687-33-1
igovomab	igovomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	74	171656-50-1	HSC/21 (3002.10)
iguratimod	iguratimod	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	86	123663-49-0	HSC/31 (2935.00)
ilacirnon	ilacirnon	2935.90	NC2803Bc Ann. T/7	HSC/67	2021	123	1100318-47-5
iladatuzumab	iladatuzumab	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1906205-76-2
iladatuzumab vedotin	iladatuzumab védotine	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1906205-77-3
ilaprazole	ilaprazole	2933.39	NC0730B2 Ann. M/6	HSC/31	2003	86	172152-36-2
ilepatril	ilépatril	2933.79	NC1178B1c Ann. O/5	HSC/39	2007	95	473289-62-2
ilepcimide	ilepcimide	2939.79	NC2803Bc Ann. T/10	HSC/67	2021	70	82857-82-7	HSC/18 (2934.90) HSC/53 (2934.99)
ilginatinib	ilginatinib	2933.39	NC2626B1b Ann. O/6	HSC/63	2019	119	1239358-86-1
ilixadencel	ilixadencel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	116	no mention	HSC/61 (3002.90)
ilmetropium iodide	iodure d’ilmétropium	2939.79	NC2373B1b Ann. O/7	HSC/59	2017	115	129109-88-2
ilodecakin	ilodécakine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	81	149824-15-7	HSC/25 (3002.10)
ilofotase alfa	ilofotase alfa	3507.90	NC2930Bc Ann. P/25	HSC/69	2022	124	2387636-92-0
ilomastat	ilomastat	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	73	142880-36-2	HSC/18 (2933.90)
ilonidap	ilonidap	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	70	135202-79-8	HSC/18 (2934.90)
iloprost	iloprost	2918.19	38.100 Ann. Q (No. 351)	HSC/11	1993	48	73873-87-7
ilorasertib	ilorasertib	2934.99	NC2004B1b Ann. O/4	HSC/53	2014	108	1227939-82-3
iltamiocel	iltamiocel	3002.51	NC2930Bc Ann. P/25	HSC/69	2022	124	no mention
ilunocitinib	ilunocitinib	2935.90	NC2930Bc Ann. P/27	HSC/69	2022	125	1187594-14-4
imagabalin	imagabaline	2922.49	NC1604B1b Ann. N/5	HSC/46	2010	101	610300-07-7

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
imalumab	imalumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	111	1430205-07-4	HSC/55 (3002.10)
imaprelimab	imaprélimab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	2014343-04-3
imaradenant	imaradénant	2933.69	NC2803Bc Ann. T/6	HSC/67	2021	122	1321514-06-0
imarikiren	imarikirène	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	1202265-63-1
imatinib	imatinib	2933.59	NC0590B2 Ann. L/15	HSC/29	2002	84	152459-95-5
imazodan	imazodan	2933.29	38.100 Ann. Q (No. 352)	HSC/11	1993	55	84243-58-3
imdevimab	imdévimab	3002.13	NC2803Bc Ann. T/11	HSC/67	2021	4 COVID	2415933-40-1
imeglimin	iméglimine	2933.69	NC1443B1b Ann. P/5	HSC/43	2009	98	775351-65-0
imepitoin	imépitoïne	2934.99	NC1310B1b Ann. N/10	HSC/41	2008	96	188116-07-6
imetelstat	imételstat	2934.99	NC1604B1b Ann. N/5	HSC/46	2010	101	868169-64-6
imgatuzumab	imgatuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	959963-46-3	HSC/51 (3002.10)
imidafenacin	imidafénacine	2933.29	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	170105-16-5
imidaprilat	imidaprilate	2933.29	40.600 Ann. D, par. 6	HSC/18	1996	71	89371-44-8
imifoplatin	imifoplatine	2843.90	NC2803Bc Ann. T/3	HSC/67	2021	121	1339960-28-9
imiglitazar	imiglitazar	2934.99	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	250601-04-8
imiglucerase	imiglucérase	3507.90	40.600 Ann. D, par. 6	HSC/18	1996	72	154248-97-2
imirestat	imirestat	2933.21	38.100 Ann. Q (No. 353)	HSC/11	1993	59	89391-50-4
imisopasem manganese	imisopasem manganèse	2933.39	NC1310B1b Ann. N/3	HSC/41	2008	95	218791-21-0
imitrodast	imitrodast	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	70	114686-12-3	HSC/18 (2934.90)
imlatoclax	imlatoclax	2935.90	NC2373B1b Ann. O/7	HSC/59	2017	115	1257050-45-5
imlifidase	imlifidase	3507.90	NC2501B1b Ann. M/6	HSC/61	2018	117	1947415-68-0
imnopitant	imnopitant	2933.59	NC2803Bc Ann. T/3	HSC/67	2021	121	290297-57-3
implitapide	implitapide	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	82	177469-96-4	HSC/27 (2933.90)
imsidolimab	imsidolimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2102543-86-0
inakalant	inakalant	2934.99	NC1178B1c Ann. O/5	HSC/39	2007	95	335619-18-6
inarigivir soproxil	inarigivir soproxil	2934.99	NC2501B1b Ann. M/5	HSC/61	2018	116	942123-43-5
inavolisib	inavolisib	2934.99	NC2803Bc Ann. T/6	HSC/67	2021	122	2060571-02-8
inaxaplin	inaxapline	2933.79	NC2930Bc Ann. P/27	HSC/69	2022	125	2446816-88-0
inbakicept	inbakicept	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2135939-52-3
incadronic acid	acide incadronique	2931.49	NC2803Bc Ann. T/4	HSC/67	2021	70	124351-85-5	HSC/18 (2931.00) HSC/59 (2931.39)
inclacumab	inclacumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	106	1256258-86-2	HSC/51 (3002.10)
inclisiran	inclisiran	2934.99	NC2373B1b Ann. O/6	HSC/59	2017	115	1639324-58-5	(List 114)
incyclinide	incyclinide	2924.29	NC1178B1c Ann. O/3	HSC/39	2007	94	15866-90-7
indacaterol	indacaterol	2933.79	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	312753-06-3
indalpine	indalpine	2933.39	38.100 Ann. Q (No. 354)	HSC/11	1993	41	63758-79-2
indanidine	indanidine	2933.29	38.100 Ann. Q (No. 355)	HSC/11	1993	50	85392-79-6
indantadol	indantadol	2924.29	NC1178B1c Ann. O/3	HSC/39	2007	94	202844-10-8
indatuximab ravtansine	indatuximab ravtansine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	105	1238517-16-2	HSC/49 (3002.10)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
indeglitazar	indéglitazar	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	100	835619-41-5	HSC/44 (2935.00)
indenolol	indénolol	2922.19	40.260 Ann. L/2 (No. 80)	HSC/17	1996	37	60607-68-3
indibulin	indibuline	2933.39	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	204205-90-3
indimilast	indimilast	2934.10	NC2237B1b Ann. S/8	HSC/57	2016	112	1038825-85-2
indinavir	indinavir	2933.59	42.100 Ann. O (III)	HSC/21	1998	74	150378-17-9
indiplon	indiplon	2934.99	NC0730B2 Ann. M/7	HSC/31	2003	87	325715-02-4
indisetron	indisétron	2933.59	42.100 Ann. O (V)	HSC/21	1998	76	141549-75-9
indisulam	indisulam	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	86	165668-41-7	HSC/31 (2935.00)
indolidan	indolidan	2933.79	38.100 Ann. Q (No. 356)	HSC/11	1993	57	100643-96-7
indoprofen	indoprofène	2933.79	38.100 Ann. Q (No. 357)	HSC/11	1993	32	31842-01-0
indoramin	indoramine	2933.39	38.100 Ann. Q (No. 358)	HSC/11	1993	25	26844-12-2
indoximod	indoximod	2933.99	NC2116B1b Ann. R/5	HSC/55	2015	111	110117-83-4
indusatumab	indusatumab	3002.13	NC2237B1b Ann. T/10	HSC/57	2016	112	1497400-26-6	HSC/57 (3002.10) (S/8)
indusatumab vedotin	indusatumab védotine	3002.13	NC2237B1b Ann. T/10	HSC/57	2013	112	1514889-12-3	HSC/57 (3002.10) (S/8)
inebilizumab	inébilizumab	3002.13	NC2237B1b Ann. T/11	HSC/57	2013	113	1299440-37-1	HSC/57 (3002.10) (S/9)
inecalcitol	inécalcitol	2906.19	NC0938B2b Ann. O/1	HSC/35	2005	87	163217-09-2
inetagugene geperpavec	inétagugène géperpavec	3002.49	NC2930Bc Ann. P/25	HSC/69	2022	124	2374924-65-7
infigratinib	infigratinib	2933.59	NC2237B1b Ann. S/8	HSC/57	2016	112	872511-34-7
infliximab	infliximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	77	170277-31-3	HSC/21 (3002.10)
ingenol disoxate	disoxate d’ingénol	2934.99	NC2237B1b Ann. S/9	HSC/57	2016	113	1383547-60-1
ingenol mebutate	mébutate d’ingénol	2916.19	NC1553B1b Ann. O/7	HSC/45	2010	100	75567-37-2
ingliforib	ingliforib	2933.99	NC0590B2 Ann. L/15	HSC/29	2002	85	186392-65-4
iniparib	iniparib	2924.29	NC1649B3b Ann. R/14	HSC/47	2011	103	160003-66-7
inlezifigene civaparvovec	inlezifigène civaparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	120	2143578-31-6	HSC/67 (3002.90)
inobrodib	inobrodib	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	2222941-37-7
inocoterone	inocotérone	2937.90	NC2004B1b Ann. O/6	HSC/53	2014	54	83646-97-3	HSC/11 (2937.99)
inodiftagene vixteplasmid	inodiftagène vixteplasmide	2934.99	NC2803Bc Ann. T/2	HSC/67	2021	120	2166100-08-7
inogatran	inogatran	2933.39	40.600 Ann. D, par. 6	HSC/18	1996	72	155415-08-0
inolimomab	inolimomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	71	152981-31-2	HSC/18 (3002.10)
inolitazone	inolitazone	2934.10	NC1443B1b Ann. P/6	HSC/43	2009	99	223132-37-4
inositol	inositol	2906.13	NC2501B1b Ann. M/5	HSC/61	2018	116	87-89-8
inotersen	inotersen	2934.99	NC2373B1b Ann. O/7	HSC/59	2017	115	1492984-65-2
inotuzumab ozogamicin	inotuzumab ozogamicine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	92	635715-01-4	HSC/37 (3002.10)
insulin argine	insuline argine	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	58	68859-20-1	HSC/11 (2937.99)
insulin aspart	insuline asparte	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	76	116094-23-6	HSC/21 (2937.99)
insulin degludec	insuline dégludec	2937.19	NC1649B3b Ann. R/12	HSC/47	2011	101	844439-96-9

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
insulin detemir	insuline detemir	2937.19	NC2116B1b Ann. R/7	HSC/55	2015	80	169148-63-4	HSC/25 (2934.90) HSC/53 (2934.99)
insulin glargine	insuline glargine	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	76	160337-95-1	HSC/21 (2937.99)
insulin glulisine	insuline glulisine	2937.19	NC0730B2 Ann. M/4	HSC/31	2003	84	207748-29-6
insulin icodec	insuline icodec	2937.19	NC2803Bc Ann. T/7	HSC/67	2021	123	1188379-43-2
insulin lispro	insuline lispro	2937.19	NC2116B1b Ann. R/7	HSC/55	2015	72	133107-64-9	HSC/21 (2934.90) HSC/53 (2934.99)
insulin peglispro	insulin péglispro	2937.19	NC1874B1b Ann. O/2	HSC/51	2013	107	1200440-65-8
insulin sudelidec	insuline sudélidec	2937.19	NC2930Bc Ann. P/27	HSC/69	2022	125	2415174-82-0
insulin tregopil	insuline trégopil	2937.19	NC1649B3b Ann. R/14	HSC/47	2011	103	874442-57-6
insuline efsitora alfa	insuline efsitora alfa	2937.19	NC2803Bc Ann. T/6	HSC/67	2021	122	2131038-11-2
intedanib	intédanib	2933.79	NC1649B3b Ann. R/13	HSC/47	2011	102	656247-17-5
intepirdine	intépirdine	2933.59	NC2373B1b Ann. O/6	HSC/59	2017	114	607742-69-8
interferon alfacon-1	interféron alfacon-1	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	77	118390-30-0	HSC/21 (3002.10)
intetumumab	intétumumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	101	725735-28-4	HSC/46 (3002.10)
intiquinatine	intiquinatine	2933.49	NC1310B1b Ann. N/4	HSC/41	2008	99	445041-75-8
inupadenant	inupadénant	2934.99	NC2803Bc Ann. T/7	HSC/67	2021	123	2246607-08-7
invimestrocel	invimestrocel	3002.51	NC2803Bc Ann. T/7	HSC/67	2021	123	no mention
iocanlidic acid	acide iocanlidique (123I)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	77	74855-17-7	HSC/21 (2844.40)
iodine (¹²⁴I) evuzamitide	iodine (¹²⁴I) évuzamitide	2844.43	NC2930Bc Ann. P/27	HSC/69	2022	125	2420475-06-3
iodine (124I) girentuximab	girentuximab iodé (124I)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	101	1011710-99-8	HSC/46 (2844.40)
iodine (¹³¹I) apamistamab	iodine (¹³¹I) apamistamab	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	119	2097132-02-8	HSC/63 (2844.40)
iodine (¹³¹I) derlotuximab biotin	iodine (¹³¹I) derlotuximab biotine	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	113	340013-96-9	HSC/57 (2844.40)
iodofiltic acid (123I)	acide iodofiltique (123 I)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	95	123748-56-1	HSC/39 (2844.40)
iodophthalein sodium	iodophtaléine sodique	2918.99	NC2373B1b Ann. O/12	HSC/59	2017	1	2217-44-9	HSC/11 (2918.90)
ioflubenzamide (131I)	ioflubenzamide (131I)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	103	1214283-52-9	HSC/47 (2844.40)
ioflupane (123I)	ioflupane (123I)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	75	155798-07-5	HSC/24 (2844.40)
iofolastat (123I)	iofolastat (123I)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	105	949575-24-0	HSC/49 (2844.40)
ioforminol	ioforminol	2924.29	NC1649B3b Ann. R/14	HSC/47	2011	103	1095110-48-7
iolopride (123I)	iolopride (123I)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	73	113716-48-6	HSC/18 (2844.40)
iometopane (123I)	iométopane (123I)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	76	136794-86-0	HSC/21 (2844.40)
iosimenol	iosiménol	2924.29	NC0845B2 Ann. M/2	HSC/33	2004	88	181872-90-2
ipafricept	ipafricept	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	109	1391727-24-4	HSC/53 (3002.10)
ipamorelin	ipamoréline	2937.19	NC1649B3b Ann. R/10	HSC/47	2011	78	170851-70-4
iparomlimab	iparomlimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2417649-33-1
ipatasertib	ipatasertib	2933.59	NC2004B1b Ann. O/4	HSC/53	2014	108	1001264-89-6
ipazilide	ipazilide	2933.19	38.100 Ann. Q (No. 362)	HSC/11	1993	62	115436-73-2
ipenoxazone	ipénoxazone	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	71	104454-71-9	HSC/18 (2934.90)
ipidacrine	ipidacrine	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	73	62732-44-9	HSC/18 (2933.90)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
ipilimumab	ipilimumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	94	477202-00-9	HSC/38 (3002.10)
ipivivint	ipivivint	2933.39	NC2803Bc Ann. T/7	HSC/67	2021	123	1481617-15-5
ipragliflozin	ipragliflozine	2934.99	NC1649B3b Ann. R/14	HSC/47	2011	103	761423-87-4
ipragratine	ipragratine	2933.39	38.100 Ann. Q (No. 363)	HSC/11	1993	35	22150-28-3
ipratropium bromide	bromure d’ipratropium	2939.79	NC2237B1b Ann. T/12	HSC/57	2016	31	22254-24-6	HSC/11 (2939.90) HSC/53 (2939.99)
ipravacaine	ipravacaïne	2933.39	NC0590B2 Ann. L/15	HSC/29	2002	85	166181-63-1
iproxamine	iproxamine	2922.19	40.260 Ann. L/2 (No. 81)	HSC/17	1996	34	52403-19-7
ipsapirone	ipsapirone	2934.20	38.760 Ann. D, par. 34	HSC/13	1994	54	95847-70-4
iptacopan	iptacopan	2933.39	NC2803Bc Ann. T/6	HSC/67	2021	122	1644670-37-0
iralukast	iralukast	2932.99	40.600 Ann. D, par. 6	HSC/18	1996	70	151581-24-7
irampanel	irampanel	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	82	206260-33-5	HSC/27 (2934.90)
iratumumab	iratumumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	94	640735-09-7	HSC/38 (3002.10)
irbesartan	irbésartan	2933.29	40.600 Ann. D, par. 6	HSC/18	1996	71	138402-11-6
irbinitinib	irbinitinib	2934.99	NC2116B1b Ann. R/5	HSC/55	2015	111	937263-43-9
irdabisant	irdabisant	2933.99	NC1760B1b Ann. N/8	HSC/49	2012	105	1005402-19-6
irinotecan	irinotécan	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	64	97682-44-5	HSC/16 (2939.90) HSC/53 (2939.99)
irofulven	irofulvène	2914.40	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	158440-71-2
iroplact	iroplact	3002.12	NC2116B1b Ann. S/2	HSC/55	2015	74	154248-96-1	HSC/21 (3002.10)
irosustat	irosustat	2932.20	NC1760B1b Ann. N/7	HSC/49	2012	104	288628-05-7
iroxanadine	iroxanadine	2934.99	NC0730B2 Ann. M/7	HSC/31	2003	87	276690-58-5
irsenontrine	irsénontrine	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	1429509-82-9
irtemazole	irtémazole	2933.29	38.100 Ann. Q (No. 366)	HSC/11	1993	60	115574-30-6
isalmadol	isalmadol	2922.50	NC1059B2b Ann. O/4	HSC/37	2006	92	269079-62-1
isamoltan	isamoltan	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	58	116861-00-8	HSC/11 (2933.90)
isaralgagene civaparvovec	isaralgagène civaparvovec	3002.49	NC2930Bc Ann. P/25	HSC/69	2022	124	2378601-29-5
isatoribine	isatoribine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	83	122970-40-5	HSC/27 (2934.90)
isatuximab	isatuximab	3002.13	NC2237B1b Ann. T/10	HSC/57	2016	112	1461640-62-9	HSC/57 (3002.10) (S/8)
isavuconazole	isavuconazole	2934.10	NC1310B1b Ann. N/10	HSC/41	2008	96	241479-67-4
isavuconazonium chloride	chlorure d’isavuconazonium	2934.10	NC1310B1b Ann. N/10	HSC/41	2008	96	338990-84-4
isbufylline	isbufylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	62	90162-60-0	HSC/11 (2939.50)
iscalimab	iscalimab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	2031153-61-2
isecarosmab	isécarosmab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2254082-79-4
iseganan	iséganan	2934.99	NC0590B2 Ann. L/15	HSC/29	2002	85	257277-05-7
isepamicin	isépamicine	2941.90	38.100 Ann. Q (No. 369)	HSC/11	1993	54	58152-03-7
islatravir	islatravir	2934.99	NC2803Bc Ann. T/2	HSC/67	2021	120	865363-93-5
ismomultin alfa	ismomultine alfa	2934.99	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	457913-93-8

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
isoetarine	isoétarine	2922.50	38.100 Ann. Q (No. 370)	HSC/11	1993	13	530-08-5
isoflupredone	isofluprédone	2937.22	38.100 Ann. Q (No. 371)	HSC/11	1993	36	338-95-4
isometamidium chloride	chlorure d’isométamidium	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	18	34301-55-8	HSC/11 (2933.90)
isomethadone	isométhadone	2922.39	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	1	466-40-0
isophane insulin	isophane insuline	3003.31	38.100 Ann. Q (No. 373)	HSC/11	1993	4	8052-74-2
isoprednidene	isoprednidène	2937.29	42.100 Ann. O (I)	HSC/21	1998	24	17332-61-5
isoprenaline	isoprénaline	2922.50	38.100 Ann. Q (No. 374)	HSC/11	1993	1	7683-59-2
isosorbide	isosorbide	2932.99	NC2004B1b Ann. O/6	HSC/53	2014	61	652-67-5	HSC/11 (2932.90)
isosulpride	isosulpride	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	36	42792-26-7	HSC/11 (2935.00)
ispinesib	ispinesib	2933.59	NC1059B2b Ann. O/4	HSC/37	2006	92	336113-53-2
ispronicline	ispronicline	2933.39	NC1059B2b Ann. O/5	HSC/37	2006	93	252870-53-4
israpafant	israpafant	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	76	117279-73-9	HSC/21 (2934.90)
istaroxime	istaroxime	2928.00	NC1059B2b Ann. O/5	HSC/37	2006	93	203737-93-3
istiratumab	istiratumab	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1509928-04-4
isunakinra	isunakinra	3002.13	NC2237B1b Ann.T/11	HSC/57	2016	113	1357527-05-9	HSC/57 (3002.10) (S/9)
isuzinaxib	isuzinaxib	2933.39	NC2930Bc Ann. P/25	HSC/69	2022	124	1270084-92-8
itacitinib	itacitinib	2933.59	NC2373B1b Ann. O/7	HSC/59	2017	115	1334298-90-6
itacnosertib	itacnosertib	2933.59	NC2803Bc Ann. T/6	HSC/67	2021	122	1628870-27-8
itameline	itaméline	2933.39	40.600 Ann. D, par. 6	HSC/18	1996	71	121750-57-0
itanapraced	itanapraced	2916.39	NC2501B1b Ann. M/5	HSC/61	2018	116	749269-83-8
itepekimab	itépékimab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	2226742-52-3
itezocabtagene autoleucel	itézocabtagène autoleucel	3002.51	NC2930Bc Ann. P/27	HSC/69	2022	125	no mention
itolizumab	itolizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	103	1116433-11-4	HSC/47 (3002.10)
itriglumide	itriglumide	2933.39	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	201605-51-8
itrocainide	itrocaïnide	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	54	90828-99-2	HSC/11 (2933.40)
iturelix	iturélix	2933.39	NC0090B2 Ann. M/1 (II)	HSC/23	1999	79	112568-12-4
ivabradine	ivabradine	2933.79	42.100 Ann. O (IV)	HSC/21	1998	75	155974-00-8
ivacaftor	ivacaftor	2933.49	NC1760B1b Ann. N/7	HSC/49	2012	104	873054-44-5
ivaltinostat	ivaltinostat	2928.00	NC2803Bc Ann. T/3	HSC/67	2021	121	936221-33-9
ivermectin	ivermectine	2932.20	NC2004B1b Ann. O/6	HSC/53	2014	43	70288-86-7	HSC/41 (2932.29)
ivicentamab	ivicentamab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2364496-42-2
ivonescimab	ivonescimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2428381-53-5
ivoqualine	ivoqualine	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	52	72714-75-1	HSC/11 (2933.40)
ivosidenib	ivosidénib	2933.79	NC2373B1b Ann. O/6	HSC/59	2017	114	1448347-49-6
ivospemin	ivospémine	2922.19	NC2930Bc Ann. P/27	HSC/69	2022	125	748119-79-1
ivuxolimab	ivuxolimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2128729-41-7
ixabepilone	ixabépilone	2941.90	NC1059B2b Ann. O/3	HSC/37	2006	89	219989-84-1
ixazomib	ixazomib	2931.90	NC2373B1b Ann. O/12	HSC/59	2017	104	1072833-77-2	HSC/49 (2931.00)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
ixekizumab	ixékizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	105	1143503-69-8	HSC/49 (3002.10)
izaflortaucipir (18F)	izaflortaucipir (18F)	2844.43	NC2803Bc Ann. T/6	HSC/67	2021	122	2173353-61-0
izencitinib	izencitinib	2933.39	NC2803Bc Ann. T/3	HSC/67	2021	121	2051918-33-1
izokibep	izokibep	2933.99	NC2803Bc Ann. T/6	HSC/67	2021	122	2226130-02-3
izonsteride	izonstéride	2934.20	NC0250B2 Ann. P/1 (II)	HSC/25	2000	81	176975-26-1
izuralimab	izuralimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2329669-80-7
josamycin	josamycine	2941.90	38.100 Ann. Q (No. 380)	HSC/11	1993	23	16846-24-5
kalafungin	kalafungine	2941.90	38.100 Ann. Q (No. 381)	HSC/11	1993	20	11048-15-0
kallidinogenase	kallidinogénase	3507.90	38.100 Ann. Q (No. 382)	HSC/11	1993	22	9001-01-8
kanamycin	kanamycine	2941.90	38.100 Ann. Q (No. 383)	HSC/11	1993	10	59-01-8
keliximab	kéliximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	76	174722-30-6	HSC/21 (3002.10)
keracyanin	kéracyanine	2938.90	38.100 Ann. Q (No. 384)	HSC/11	1993	31	18719-76-1
ketanserin	kétansérine	2933.59	38.100 Ann. Q (No. 385)	HSC/11	1993	46	74050-98-9
ketazocine	kétazocine	2933.39	38.100 Ann. Q (No. 386)	HSC/11	1993	34	36292-69-0
ketazolam	kétazolam	2934.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	26	27223-35-4
ketobemidone	cétobémidone	2933.33	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	1	469-79-4
ketocaine	kétocaïne	2922.19	40.260 Ann. L/2 (No. 82)	HSC/17	1996	15	1092-46-2
ketocainol	kétocaïnol	2922.19	40.260 Ann. L/2 (No. 83)	HSC/17	1996	32	7488-92-8
ketorfanol	kétorfanol	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	49	79798-39-3	HSC/11 (2933.40)
ketotrexate	kétotrexate	2933.59	38.100 Ann. Q (No. 388)	HSC/11	1993	50	52196-22-2
khelloside	khelloside	2938.90	38.100 Ann. Q (No. 389)	HSC/11	1993	8	17226-75-4
kitasamycin	kitasamycine	2941.90	38.100 Ann. Q (No. 390)	HSC/11	1993	13	1392-21-8
labetuzumab	labetuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	85	219649-07-7	HSC/29 (3002.10)
labetuzumab govitecan	labétuzumab govitécan	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	113	1469876-18-3	HSC/57 (3002.10) (S/9)
labradimil	labradimil	2937.19	NC0730B2 Ann. M/4	HSC/31	2003	83	159768-75-9
labuvirtide	labuvirtide	2933.29	NC2930Bc Ann. P/25	HSC/69	2022	124	2395796-76-4
lacnotuzumab	lacnotuzumab	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1831128-32-5
lacosamide	lacosamide	2924.29	NC0590B2 Ann. L/15	HSC/29	2002	90	175481-36-4
lactalfate	lactalfate	2940.00	38.100 Ann. Q (No. 391)	HSC/11	1993	53	96427-12-2
lacutamab	lacutamab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2187368-16-5	List 121 change
ladarixin	ladarixine	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	105	849776-05-2	HSC/49 (2935.00)
lademirsen	lademirsen	2934.99	NC2803Bc Ann. T/2	HSC/67	2021	120	1404019-95-9
ladiratuzumab	ladiratuzumab	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1629760-28-6
ladiratuzumab vedotin	ladiratuzumab védotine	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1629760-29-7
ladirubicin	ladirubicine	2941.90	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	171047-47-5
laduviglusib	laduviglusib	2933.59	NC2803Bc Ann. T/7	HSC/67	2021	123	252917-06-9
laflunimus	laflunimus	2926.90	40.600 Ann. D, par. 6	HSC/18	1996	70	147076-36-6
lafutidine	lafutidine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	70	118288-08-7	HSC/18 (2934.90)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
lagatide	lagatide	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	75	157476-77-2	HSC/21 (2933.90)
lagociclovir	lagociclovir	2934.99	NC1649B3b Ann. R/12	HSC/47	2011	101	92562-88-4
laidlomycin	laidlomycine	2941.90	38.100 Ann. Q (No. 392)	HSC/11	1993	61	56283-74-0
lalikinogene sifuplasmid	lalikinogène sifuplasmide	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	2418030-84-7
lamifiban	lamifiban	2933.39	40.600 Ann. D, par. 6	HSC/18	1996	72	144412-49-7
lampalizumab	lampalizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1278466-20-8	HSC/51 (3002.10)
lamtidine	lamtidine	2933.39	38.100 Ann. Q (No. 393)	HSC/11	1993	48	73278-54-3
lanabecestat	lanabécestat	2933.39	NC2501B1b Ann. M/5	HSC/61	2018	116	1383982-64-6
lanacogene vosiparvovec	lanacogène vosiparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	117	1939139-26-0	HSC/61 (3002.90)
lanadelumab	lanadélumab	3002.13	NC2373B1b Ann. O/6	HSC/59	2017	114	1426055-14-2
lancovutide	lancovutide	2934.99	NC1443B1b Ann. P/6	HSC/43	2009	99	1391-36-2
landiolol	landiolol	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	75	133242-30-5	HSC/21 (2934.90)
landipirdine	landipirdine	2930.90	NC2501B1b Ann. M/5	HSC/61	2018	116	1000308-25-7
landogrozumab	landogrozumab	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	113	1391726-30-9	HSC/57 (3002.10) (S/9)
lanepitant	lanépitant	2933.39	42.100 Ann. O (VI)	HSC/21	1998	77	170566-84-4
lanicemine	lanicémine	2933.39	NC0430B2 Ann. Q/1 (I)	HSC/27	2001	82	153322-05-5
lanifibranor	lanifibranor	2935.90	NC2501B1b Ann. M/5	HSC/61	2018	116	927961-18-0
lanimostim	lanimostim	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	91	117276-75-2	HSC/47 (3002.10)
laninamivir	laninamivir	2932.99	NC1500B1b Ann. K/6	HSC/44	2009	100	203120-17-6
laniquidar	laniquidar	2933.49	NC0590B2 Ann. L/15	HSC/29	2002	85	197509-46-9
lanopepden	lanopepdène	2934.99	NC2237B1b Ann. S/8	HSC/57	2016	112	1152107-25-9
lanoteplase	lanotéplase	3507.90	NC0090B2 Ann. M/1 (III)	HSC/23	1999	76	171870-23-8
lanperisone	lanpérisone	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	72	116287-14-0	HSC/18 (2933.90)
lanproston	lanprostone	2932.99	40.600 Ann. D, par. 6	HSC/18	1996	72	105674-77-9
lanraplenib	lanraplénib	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1800046-95-0
lapaquistat	lapaquistat	2934.99	NC1178B1c Ann. O/5	HSC/39	2007	95	189059-71-0
lapisteride	lapistéride	2933.79	NC0730B2 Ann. M/4 (III)	HSC/31	2003	85	142139-60-4
laprafylline	laprafylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	60	90749-32-9	HSC/11 (2939.50)
lapretolimod	laprétolimod	2932.99	NC2803Bc Ann. T/2	HSC/67	2021	120	960324-04-3
laprituximab	laprituximab	3002.13	NC2373B1b Ann. O/6	HSC/59	2017	114	1622327-38-1
laprituximab emtansine	laprituximab emtansine	3002.13	NC2373B1b Ann. O/6	HSC/59	2017	114	1622327-37-0
laquinimod	laquinimod	2933.79	NC0590B2 Ann. L/15	HSC/29	2002	85	248281-84-7
larazotide	larazotide	2933.99	NC1553B1b Ann. O/4	HSC/45	2010	99	258818-34-7
larcaviximab	larcaviximab	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1792982-56-9
laromustine	laromustine	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	98	173424-77-6	HSC/43 (2935.00)
laronidase	laronidase	3507.90	NC0590B2 Ann. L/15	HSC/29	2002	85	210589-09-6
laropiprant	laropiprant	2933.99	NC1310B1b Ann. N/4	HSC/41	2008	97	571170-77-9
larotaxel	larotaxel	2932.99	NC1178B1c Ann. O/3	HSC/39	2007	94	156294-36-9

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
larotrectinib	larotrectinib	2933.59	NC2373B1b Ann. O/7	HSC/59	2017	115	1223403-58-4
lasalocid	lasalocide	2941.90	38.100 Ann. Q (No. 395)	HSC/11	1993	30	25999-31-9
lascufloxacin	lascufloxacine	2933.49	NC2237B1b Ann. S/8	HSC/57	2016	112	848416-07-9
lasinavir	lasinavir	2924.29	42.100 Ann. O (V)	HSC/21	1998	76	175385-62-3
lasmiditan	lasmiditan	2933.39	NC1604B1b Ann. N/6	HSC/46	2010	102	439239-90-4
lasofoxifene	lasofoxifène	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	81	180916-16-9	HSC/25 (2933.90)
latamoxef	latamoxef	2941.90	38.100 Ann. Q (No. 396)	HSC/11	1993	46	64952-97-2
latanoprostene bunod	latanoprostène bunod	2937.50	NC1874B1b Ann. O/2	HSC/51	2013	107	860005-21-6
latidectin	latidectine	2941.90	NC0845B2 Ann. M/2	HSC/33	2004	88	371918-51-3
latozinemab	latozinémab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2376132-27-1
latrepirdine	latrépirdine	2933.39	NC1604B1b Ann. N/6	HSC/46	2010	102	3613-73-8
latromotide	latromotide	3002.41	NC2803Bc Ann. T/4	HSC/67	2021	107	1049674-65-8	HSC/51 (3002.20)
laurcetium bromide	bromure de laurcétium	2923.90	40.600 Ann. D, par. 6	HSC/18	1996	70	1794-75-8
lauroguadine	lauroguadine	2925.29	NC2004B1b Ann. O/6	HSC/53	2014	29	135-43-3	HSC/11 (2925.20)
lauromacrogol 400	lauromacrogol 400	3402.42	NC2803Bc Ann. T/4	HSC/67	2021	90	9002-92-0	HSC/11 (3402.13)
lavamilast	lavamilast	2934.99	NC2237B1b Ann. S/8	HSC/57	2016	112	1218778-89-2
lavoltidine	lavoltidine	2933.39	38.100 Ann. Q (No. 399)	HSC/11	1993	61	76956-02-0
lazertinib	lazertinib	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1903008-80-9
lazucirnon	lazucirnon	2933.79	NC2803Bc Ann. T/7	HSC/67	2021	123	1251528-23-0
lazuvapagon	lazuvapagon	2933.19	NC2803Bc Ann. T/6	HSC/67	2021	122	2379889-71-9
lebrikizumab	lébrikizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	101	953400-68-5	HSC/46 (3002.10)
lecanemab	lécanémab	3002.13	NC2803Bc Ann. T/6	HSC/67	2021	122	1260393-98-3
lecimibide	lécimibide	2933.29	40.600 Ann. D, par. 6	HSC/18	1996	70	130804-35-2
leconotide	léconotide	2934.99	NC0730B2 Ann. M/6	HSC/31	2003	86	247207-64-3
lecozotan	lecozotan	2934.99	NC1059B2b Ann. O/5	HSC/37	2006	93	434283-16-6
ledaborbactam	lédaborbactam	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	1842397-36-7
ledaborbactam etzadroxil	lédaborbactam étzadroxil	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	1842399-68-1
ledelabricin alfa	lédélabricine alfa	3504.00	NC2930Bc Ann. P/28	HSC/69	2022	122/124	2252176-75-1
ledipasvir	ledipasvir	2933.39	NC2004B1b Ann. O/5	HSC/53	2014	109	1256388-51-8
ledismase	lédismase	3507.90	40.600 Ann. D, par. 6	HSC/18	1996	70	149394-67-2
ledoxantrone	ledoxantrone	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	76	113457-05-9	HSC/21 (2934.90)
lefamulin	léfamuline	2941.90	NC2116B1b Ann. R/4	HSC/55	2015	110	1061337-51-6
lefetamine	léfétamine	2921.46	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	30	7262-75-1
lefitolimod	léfitolimod	2934.99	NC2237B1b Ann. S/9	HSC/57	2016	113	1548439-51-5
leflutrozole	leflutrozole	2933.99	NC2501B1b Ann. M/6	HSC/61	2018	117	143030-47-1
lefradafiban	léfradafiban	2933.79	42.100 Ann. O (IV)	HSC/21	1998	75	149503-79-7
lemalesomab	lémalésomab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	84	250242-54-7	HSC/29 (3002.10)
lemborexant	lemborexant	2933.59	NC2116B1b Ann. R/5	HSC/55	2015	111	1369764-02-2
lemidosul	lémidosul	2930.90	38.100 Ann. Q (No. 400)	HSC/11	1993	52	88041-40-1

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
lemoxinol	lémoxinol	3824.99	NC2116B1b Ann. S/1	HSC/55	2015	70	no mention	HSC/18 (3824.90)
lemuteporfin	lémutéporfine	2933.99	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	215808-49-4
lemzoparlimab	lemzoparlimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2377483-71-9
lenabasum	lénabasum	2932.99	NC2626B1b Ann. O/5	HSC/63	2019	118	137945-48-3
lenacapavir	lénacapavir	2935.90	NC2803Bc Ann. T/3	HSC/67	2021	121	2189684-44-2
lenadogene nolparvovec	lénadogène nolparvovec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	114	1640969-63-6	HSC/59 (3002.90)
lenalidomide	lénalidomide	2933.79	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	191732-72-6
lenampicillin	lénampicilline	2941.10	38.100 Ann. Q (No. 401)	HSC/11	1993	50	86273-18-9
lenapenem	lénapénem	2941.90	40.600 Ann. D, par. 6	HSC/18	1996	73	149951-16-6
lenercept	lénercept	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	72	156679-34-4	HSC/18 (3002.10)
leniolisib	léniolisib	2933.59	NC2373B1b Ann. O/6	HSC/59	2017	114	1354690-24-6
lenomorelin	lénomoréline	2937.19	NC1760B1b Ann. N/8	HSC/49	2012	105	258279-04-8
lenrispodun	lenrispodun	2933.59	NC2930Bc Ann. P/25	HSC/69	2022	124	1160521-50-5
lensiprazine	lensiprazine	2934.99	NC1443B1b Ann. P/6	HSC/43	2009	99	327026-93-7
lenvatinib	lenvatinib	2933.49	NC1760B1b Ann. N/7	HSC/49	2012	104	417716-92-8
lenvervimab	lenvervimab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	2055006-79-4
lenzilumab	lenzilumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	111	1229575-09-0	HSC/55 (3002.10)
lenzumestrocel	lenzumestrocel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	119	no mention	HSC/63 (3002.90)
lepirudin	lépirudine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	73	138068-37-8	HSC/18 (2934.90)
lepunafusp alfa	lépunafusp alfa	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2396411-71-3
lerapolturev	lérapolturev	3002.49	NC2930Bc Ann. P/27	HSC/69	2022	125	2430048-02-3
lerdelimumab	lerdelimumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	83	285985-06-0	HSC/27 (3002.10)
leridistim	leridistim	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	80	193700-51-5	HSC/47 (3002.10)
leriglitazone	lériglitazone	2934.10	NC2626B1b Ann. O/6	HSC/63	2019	119	146062-44-4
lerimazoline	lérimazoline	2933.29	NC2116B1b Ann. R/4	HSC/55	2015	110	54765-26-3
lerociclib	lérociclib	2933.59	NC2803Bc Ann. T/2	HSC/67	2021	120	1628256-23-4
lerodalcibep	lérodalcibep	2934.99	NC2803Bc Ann. T/7	HSC/67	2021	123	2250073-78-8
leronlimab	léronlimab	3002.13	NC2626B1b Ann. O/5	HSC/63	2019	118	674782-26-4
lersivirine	lersivirine	2933.19	NC1604B1b Ann. N/5	HSC/46	2010	101	473921-12-9
lesinidase alfa	lésinidase alfa	3507.90	NC2501B1b Ann. M/5	HSC/61	2018	116	1522433-40-4
lesinurad	lésinurad	2933.99	NC1760B1b Ann. N/8	HSC/49	2012	105	878672-00-5
lesofavumab	lésofavumab	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1807960-57-1
lesogaberan	lésogabéran	2931.59	NC2803Bc Ann. T/4	HSC/67	2021	100	344413-67-8	HSC/44 (2931.00) HSC/59 (2931.39)
lestaurtinib	lestaurtinib	2934.99	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	111358-88-4
letaplimab	létaplimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2283356-07-8
letaxaban	létaxaban	2933.59	NC1760B1b Ann. N/7	HSC/49	2012	104	870262-90-1
leteprinim	létéprinim	2933.59	NC0090B2 Ann. M/5	HSC/23	1999	80	138117-50-7
letermovir	létermovir	2933.59	NC1760B1b Ann. N/7	HSC/49	2012	104	917389-32-3

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
letetresgene autoleucel	letetresgéne autoleucel	3002.51	NC2803Bc Ann. T/3	HSC/67	2021	121	no mention
letolizumab	létolizumab	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1450981-87-9
letrozole	létrozole	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	70	112809-51-5	HSC/18 (2933.90)
leuprorelin	leuproréline	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	47	53714-56-0	HSC/11 (2937.99)
levacetylmethadol	lévacétylméthadol	2922.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	27	34433-66-4
levallorphan	lévallorphane	2933.49	NC2004B1b Ann. O/6	HSC/53	2014	2	152-02-3	HSC/11 (2933.40)
levamfetamine	lévamfétamine	2921.46	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	12	156-34-3
levamlodipine	lévamlodipine	2933.39	NC1310B1b Ann. N/4	HSC/41	2008	97	103129-82-4
levilimab	lévilimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2035008-70-7
levisoprenaline	lévisoprénaline	2922.50	38.100 Ann. Q (No. 404)	HSC/11	1993	10	51-31-0
levmetamfetamine	levmétamfétamine	2939.45	NC2803Bc Ann. T/4	HSC/67	2021	83	33817-09-3	HSC/27 (2921.49) HSC/63 (2939.71)
levobetaxolol	lévobétaxolol	2922.19	40.260 Ann. L/2 (No. 84)	HSC/17	1996	61	93221-48-8
levobunolol	lévobunolol	2922.19	40.260 Ann. L/2 (No. 85)	HSC/17	1996	42	47141-42-4
levobupivacaine	lévobupivacaïne	2933.39	42.100 Ann. O (III)	HSC/21	1998	74	27262-47-1
levocetirizine	lévocétirizine	2933.59	42.750 Ann. O	HSC/22	1998	78	130018-77-8
levodopa	lévodopa	2922.50	38.100 Ann. Q (No. 405)	HSC/11	1993	21	59-92-7
levoglucose	lévoglucose	1702.30	NC1760B1b Ann. N/7	HSC/49	2012	104	921-60-8
levoketoconazole	lévokétoconazole	2934.99	NC2373B1b Ann. O/6	HSC/59	2017	114	142128-57-2
levolansoprazole	lévolansoprazole	2933.39	NC1059B2b Ann. O/5	HSC/37	2006	93	138530-95-7
levomefolic acid	acide lévoméfolique	2936.29	NC1443B1b Ann. P/6	HSC/43	2009	99	31690-09-2
levomequitazine	lévoméquitazine	2934.30	NC1649B3b Ann. R/12	HSC/47	2011	101	88598-74-7
levomethorphan	lévométhorphane	2933.49	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	1	125-70-2
levomilnacipran	lévomilnaciprane	2924.29	NC1443B1b Ann. P/6	HSC/43	2009	99	96847-55-1
levomoprolol	lévomoprolol	2922.19	40.260 Ann. L/2 (No. 86)	HSC/17	1996	58	77164-20-6
levomoramide	lévomoramide	2934.99	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	6	5666-11-5
levonadifloxacin	lévonadifloxacine	2933.39	NC1178B1c Ann. O/5	HSC/39	2007	95	154357-42-3
levonebivolol	lévonébivolol	2932.99	NC1443B1b Ann. P/5	HSC/43	2009	98	118457-16-2
levonorgestrel	lévonorgestrel	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	33	797-63-7	HSC/11 (2937.92)
levophenacylmorphan	lévophénacylmorphane	2933.49	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	9	10061-32-2
levopropoxyphene	lévopropoxyphène	2922.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	7	2338-37-6
levopropylhexedrine	lévopropylhexédrine	2921.30	38.100 Ann. Q (No. 409)	HSC/11	1993	37	6192-97-8
levormeloxifene	lévorméloxifène	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	73	78994-23-7	HSC/18 (2934.90)
levorphanol	lévorphanol	2933.41	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	4	77-07-6
levosalbutamol	lévosalbutamol	2922.50	42.750 Ann. O	HSC/22	1998	78	34391-04-3
levosemotiadil	lévosémotiadil	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	72	116476-16-5	HSC/18 (2934.90)
levosulpiride	lévosulpiride	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	63	23672-07-3	HSC/11 (2935.00)
levotofisopam	levotofisopam	2933.99	NC1004B1b Ann. L/11	HSC/36	2005	92	82059-51-6
lexacalcitol	lexacalcitol	2909.49	42.100 Ann. O (VII)	HSC/21	1998	71	131875-08-6

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
lexanersen	lexanersen	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	2073015-40-2
lexanopadol	lexanopadol	2934.99	NC2004B1b Ann. O/5	HSC/53	2014	109	1357348-09-4
lexaptepid pegol	lexaptépid pégol	3907.29	NC2803Bc Ann. T/4	HSC/67	2021	108	1390631-57-8	HSC/53 (3907.20)
lexatumumab	lexatumumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	95	845816-02-6	HSC/39 (3002.10)
lexibulin	lexibuline	2933.59	NC1760B1b Ann. N/8	HSC/49	2012	105	917111-44-5
lexipafant	lexipafant	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	70	139133-26-9	HSC/18 (2935.00)
liafensine	liafensine	2933.49	NC2004B1b Ann. O/5	HSC/53	2014	109	1198790-53-2
liatermin	liatermine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	81	188630-14-0	HSC/25 (2934.90)
libenzapril	libenzapril	2933.79	38.100 Ann. Q (No. 412)	HSC/11	1993	58	97878-35-8
libivirumab	libivirumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	91	569658-79-3	HSC/35 (3002.10)
libvatrep	libvatrep	2933.59	NC2930Bc Ann. P/25	HSC/69	2022	124	871814-52-7
licaminlimab	licaminlimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	1688648-13-6
licarbazepine	licarbazépine	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	81	29331-92-8	HSC/25 (2933.90)
licofelone	licofélone	2933.99	NC0730B2 Ann. M/6	HSC/31	2003	86	156897-06-2
licogliflozin	licogliflozine	2932.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1291094-73-9
licostinel	licostinel	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	77	153504-81-5	HSC/21 (2933.90)
lidadronic acid	acide lidadronique	2931.49	NC2803Bc Ann. T/4	HSC/67	2021	84	63132-38-7	HSC/29 (2931.00) HSC/59 (2931.39)
lidamidine	lidamidine	2925.29	NC2004B1b Ann. O/6	HSC/53	2014	41	66871-56-5	HSC/11 (2925.20)
lidorestat	lidorestat	2934.20	NC0730B2 Ann. M/7	HSC/31	2003	87	245116-90-9
lifastuzumab vedotin	lifastuzumab védotine	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	110	1401812-88-1	HSC/55 (3002.10)
lifibrol	lifibrol	2918.99	NC2373B1b Ann. O/12	HSC/59	2017	62	96609-16-4	HSC/11 (2918.90)
lificiguat	lificiguat	2934.99	NC1178B1c Ann. O/5	HSC/39	2007	95	170632-47-0
lifileucel	lifileucel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	118	no mention	HSC/63 (3002.90)
lifirafenib	lifirafénib	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1446090-79-4
lifitegrast	lifitegrast	2934.99	NC1874B1b Ann. O/2	HSC/51	2013	107	1025967-78-5
ligelizumab	ligelizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1322627-61-1	HSC/51 (3002.10)
ligufalimab	ligufalimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2428381-55-7
lilopristone	lilopristone	2922.50	38.100 Ann. Q (No. 415)	HSC/11	1993	54	97747-88-1
lilotomab	lilotomab	3002.13	NC2237B1b Ann. T/10	HSC/57	2016	112	1453362-55-4	HSC/57 (3002.10) (S/8)
limiglidole	limiglidole	2933.99	NC1500B1b Ann. K/6	HSC/44	2009	100	64644-54-8
linaclotide	linaclotide	3002.49	NC2803Bc Ann. T/9	HSC/67	2021	96	851199-59-2	HSC/43 (3002.90)
linagliptin	linagliptine	2933.59	NC1443B1b Ann. P/6	HSC/43	2009	99	668270-12-0
linaprazan	linaprazan	2933.99	NC1004B1b Ann. L/11	HSC/36	2005	92	248919-64-4
linerixibat	linérixibat	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1345982-69-5
linetastine	linétastine	2933.39	42.100 Ann. O (III)	HSC/21	1998	74	159776-68-8
linezolid	linézolide	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	76	165800-03-3	HSC/21 (2934.90)
linifanib	linifanib	2933.99	NC1604B1b Ann. N/6	HSC/46	2010	102	796967-16-3

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
linopristin	linopristine	2941.90	NC1553B1b Ann. O/3	HSC/45	2010	98	325965-23-9
linperlisib	linperlisib	2935.90	NC2803Bc Ann. T/3	HSC/67	2021	121	1702816-75-8
linrodostat	linrodostat	2933.49	NC2626B1b Ann. O/6	HSC/63	2019	119	1923833-60-6
linsitinib	linsitinib	2933.49	NC1760B1b Ann. N/7	HSC/49	2012	104	867160-71-2
lintitript	lintitript	2934.10	42.100 Ann. O (III)	HSC/21	1998	74	136381-85-6
lintuzumab	lintuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	76	166089-32-3	HSC/21 (3002.10)
linzagolix	linzagolix	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	935283-04-8
liothyronine	liothyronine	2937.90	NC2004B1b Ann. O/6	HSC/53	2014	6	1823692	HSC/11 (2937.99)
lipegfilgrastim	lipegfilgrastim	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	105	1117844-87-7	HSC/49 (3002.10)
liraglutide	liraglutide	2937.19	NC0845B2 Ann. M/1 (II)	HSC/33	2004	87	204656-20-2
lirametostat	liramétostat	2933.79	NC2803Bc Ann. T/7	HSC/67	2021	123	1621862-70-1
lirentelimab	lirentélimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2283348-97-8
lirequinil	liréquinil	2933.79	40.600 Ann. D, par. 6	HSC/18	1996	72	143943-73-1
lirexapride	lirexapride	2933.39	42.100 Ann. O (III)	HSC/21	1998	74	145414-12-6
lirilumab	lirilumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	107	1000676-41-4	HSC/51 (3002.10)
lirimilast	lirimilast	2932.99	NC0590B2 Ann. L/15	HSC/29	2002	85	329306-27-6
lisadimate	lisadimate	2922.49	40.260 Ann. L/2 (No. 87)	HSC/17	1996	63	136-44-7
lisaftoclax	lisaftoclax	2935.90	NC2930Bc Ann. P/27	HSC/69	2022	125	2180923-05-9
lisavanbulin	lisavanbuline	2934.99	NC2373B1b Ann. O/7	HSC/59	2017	115	1263384-43-5
lisdexamfetamine	lisdexamphétamine	2924.29	NC1178B1c Ann. O/3	HSC/39	2007	94	608137-32-2
lisocabtagene maraleucel	lisocabtagène maraleucel	3002.51	NC2803Bc Ann. T/4	HSC/67	2021	119	no mention	HSC/63 (3002.90)
lisofylline	lisofylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	72	100324-81-0	HSC/18 (2939.50)
lisuride	lisuride	2939.69	NC2004B1b Ann. O/6	HSC/53	2014	25	18016-80-3	HSC/11 (2939.60)
litenimod	liténimod	2934.99	NC1310B1b Ann. N/10	HSC/41	2008	96	852313-25-8
litomeglovir	litoméglovir	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	84	321915-31-5	HSC/29 (2935.00)
litronesib	litronésib	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	101	910634-41-2	HSC/46 (2935.00)
livaraparin calcium	livaraparin calcium	3001.90	NC1553B1b Ann. O/5	HSC/45	2010	85	no mention
lividomycin	lividomycine	2941.90	38.100 Ann. Q (No. 419)	HSC/11	1993	32	36441-41-5
livmoniplimab	livmoniplimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2412004-88-5
livoletide	livolétide	2937.19	NC2626B1b Ann. O/5	HSC/63	2019	118	1088543-62-7
lixadesiran	lixadésiran	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	1152798-49-6
lixazinone	lixazinone	2933.59	38.100 Ann. Q (No. 420)	HSC/11	1993	57	94192-59-3
lixisenatide	lixisénatide	2937.19	NC1760B1b Ann. N/3	HSC/49	2012	99	320367-13-3
lixivaptan	lixivaptan	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	83	168079-32-1	HSC/27 (2933.90)
lobeglitazone	lobéglitazone	2934.10	NC1178B1c Ann. O/5	HSC/39	2007	95	607723-33-1
lobeline	lobéline	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	4	90-69-7	HSC/11 (2939.90) HSC/53 (2939.99)
lobucavir	lobucavir	2933.59	40.600 Ann. D, par. 6	HSC/18	1996	72	127759-89-1
locnartecan	locnartécan	2939.79	NC2930Bc Ann. P/25	HSC/69	2022	124	1472614-83-7

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
lodapolimab	lodapolimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2118349-31-6
lodelcizumab	lodelcizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	108	1355338-54-3	HSC/53 (3002.10)
lodenafil carbonate	carbonate de lodenafil	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	94	398507-55-6	HSC/39 (2935.00)
lodenosine	lodénosine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	78	110143-10-7	HSC/22 (2934.90)
lodoxamide	lodoxamide	2926.90	38.100 Ann. Q (No. 422)	HSC/11	1993	38	53882-12-5
lokivetmab	lokivetmab	3002.13	NC2237B1b Ann. T/10	HSC/57	2016	112	1533403-95-0	HSC/57 (3002.10) (S/8)
lomardexamfetamine	lomardexamfétamine	2925.29	NC2803Bc Ann. T/3	HSC/67	2021	121	1032291-80-7
lometraline	lométraline	2922.29	38.100 Ann. Q (No. 423)	HSC/11	1993	28	39951-65-0
lometrexol	lométrexol	2933.59	38.100 Ann. Q (No. 424)	HSC/11	1993	63	106400-81-1
lomevactone	lomévactone	2932.20	NC2004B1b Ann. O/6	HSC/53	2014	48	81478-25-3	HSC/11 (2932.29)
lomibuvir	lomibuvir	2934.99	NC1874B1b Ann. O/2	HSC/51	2013	107	1026785-55-6
lomifylline	lomifylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	37	10226-54-7	HSC/11 (2939.50)
lomitapide	lomitapide	2933.39	NC1604B1b Ann. N/5	HSC/46	2010	101	182431-12-5
lomtegovimab	lomtégovimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2550869-33-3
lonafarnib	lonafarnib	2933.39	NC0730B2 Ann. M/6	HSC/31	2003	86	193275-84-2
lonapalene	lonapalène	2915.39	38.100 Ann. Q (No. 427)	HSC/11	1993	55	91431-42-4
lonapegsomatropin	lonapegsomatropine	2937.11	NC2501B1b Ann. M/6	HSC/61	2018	117	1934255-39-6
lonaprisan	lonaprisan	2937.29	NC1377E1b Ann. G/17	HSC/42	2008	97	211254-73-8
loncastuximab	loncastuximab	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1875032-68-0
loncastuximab tesirine	loncastuximab tésirine	3002.13	NC2501B1b Ann. M/6	HSC/61	2018	117	1879918-31-6
lonigutamab	lonigutamab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2362015-67-4
lonigutamab ugodotin	lonigutamab ugodotine	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2363754-30-5
lonoctocog alfa	lonoctocog alfa	3002.12	NC2237B1b Ann. T/13	HSC/57	2016	111	1388129-63-2	HSC/55 (3002.10)
lonodelestat	lonodélestat	2933.79	NC2803Bc Ann. T/3	HSC/67	2021	121	906547-89-5
lopinavir	lopinavir	2933.59	NC0090B2 Ann. M/5	HSC/23	1999	80	192725-17-0
lopobutan	lopobutan	2922.50	40.600 Ann. D, par. 6	HSC/18	1996	70	6582-30-5
loprazolam	loprazolam	2933.55	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	44	61197-73-7
loprodiol	loprodiol	2905.59	NC2004B1b Ann. O/6	HSC/53	2014	43	2209-86-1	HSC/11 (2905.50)
loracarbef	loracarbef	2941.90	38.100 Ann. Q (No. 429)	HSC/11	1993	60	76470-66-1
lorajmine	lorajmine	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	34	47562-08-3	HSC/11 (2939.90) HSC/53 (2939.99)
lorazepam	lorazépam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	23	846-49-1
lorcaserin	lorcasérine	2933.99	NC1178B1c Ann. O/5	HSC/39	2007	95	616202-92-7
loreclezole	loréclézole	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	60	117857-45-1	HSC/11 (2933.90)
lorediplon	lorédiplon	2934.99	NC1760B1b Ann. N/8	HSC/49	2012	105	917393-39-6
lorigerlimab	lorigerlimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2416595-46-3
lorlatinib	lorlatinib	2934.99	NC2373B1b Ann. O/6	HSC/59	2017	114	1454846-35-5
lormetazepam	lormétazépam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	38	848-75-9

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
lorpiprazole	lorpiprazole	2933.59	38.100 Ann. Q (No. 432)	HSC/11	1993	60	108785-69-9
lorpucitinib	lorpucitinib	2933.99	NC2803Bc Ann. T/6	HSC/67	2021	122	2230282-02-5
lorukafusp alfa	lorukafusp alfa	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2131168-99-3
lorvotuzumab mertansine	lorvotuzumab mertansine	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	103	1008106-64-6	HSC/47 (3002.10)
losatuxizumab	losatuxizumab	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1801544-27-3
losatuxizumab vedotin	losatuxizumab védotine	3002.13	NC2501B1b Ann. M/5	HSC/61	2018	116	1685249-67-5
losigamone	losigamone	2932.20	NC2004B1b Ann. O/6	HSC/53	2014	61	112856-44-7	HSC/11 (2932.29)
losmapimod	losmapimod	2933.39	NC1604B1b Ann. N/5	HSC/46	2010	101	585543-15-3
losmiprofen	losmiprofène	2918.99	NC2373B1b Ann. O/12	HSC/59	2017	61	74168-08-4	HSC/11 (2918.90)
lotamilast	lotamilast	2933.59	NC2626B1b Ann. O/5	HSC/63	2019	118	947620-48-6
lotazadromcel	lotazadromcel	3002.51	NC2930Bc Ann. P/27	HSC/69	2022	125	no mention
lotilaner	lotilaner	2934.99	NC2116B1b Ann. R/4	HSC/55	2015	110	1369852-71-0
lotilibcin	lotilibcine	2941.90	NC1553B1b Ann. O/7	HSC/45	2010	100	169148-84-9
lotrafiban	lotrafiban	2933.39	42.750 Ann. O	HSC/22	1998	78	171049-14-2
loviride	loviride	2924.29	40.600 Ann. D, par. 6	HSC/18	1996	70	147362-57-0
lovotibeglogene autotemcel	lovotibéglogène autotemcel	3002.51	NC2930Bc Ann. P/27	HSC/69	2022	125	no mention
loxicodegol	loxicodégol	2939.19	NC2501B1b Ann. M/6	HSC/61	2018	117	1211231-76-3
loxoprofen	loxoprofène	2918.30	38.100 Ann. Q (No. 435)	HSC/11	1993	50	68767-14-6
lozilurea	lozilurée	2924.21	38.100 Ann. Q (No. 436)	HSC/11	1993	44	71475-35-9
lubabegron	lubabégron	2934.99	NC2004B1b Ann. O/5	HSC/53	2014	109	391920-32-4
lubazodone	lubazodone	2934.99	NC0730B2 Ann. M/7	HSC/31	2003	87	161178-07-0
lubeluzole	lubéluzole	2934.20	40.600 Ann. D, par. 6	HSC/18	1996	70	144665-07-6
lubiprostone	lubiprostone	2937.50	NC0730B2 Ann. M/7	HSC/31	2003	87	333963-40-9
lucatumumab	lucatumumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	98	903512-50-5	HSC/43 (3002.10)
lucerastat	lucérastat	2933.39	NC1874B1b Ann. O/1	HSC/51	2013	106	141206-42-0
lucimycin	lucimycine	2941.90	38.100 Ann. Q (No. 437)	HSC/11	1993	13	13058-67-8
lucitanib	lucitanib	2933.49	NC1874B1b Ann. O/2	HSC/51	2013	107	1058137-23-7
ludaterone	ludatérone	2937.29	NC2803Bc Ann. T/7	HSC/67	2021	123	124548-08-9
lufepirsen	lufépirsen	2934.99	NC2930Bc Ann. P/27	HSC/69	2022	125	287122-58-1
lufotrelvir	lufotrelvir	2933.79	NC2930Bc Ann. P/27	HSC/69	2022	125	2468015-78-1
luliconazole	luliconazole	2934.99	NC0730B2 Ann. M/6	HSC/31	2003	86	187164-19-8
lulizumab pegol	lulizumab pégol	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	111	1421830-13-8	HSC/55 (3002.10)
lumacaftor	lumacaftor	2934.99	NC1760B1b Ann. N/8	HSC/49	2012	105	936727-05-8
lumasiran	lumasiran	2934.99	NC2501B1b Ann. M/6	HSC/61	2018	117	1834610-13-7
lumateperone	lumatépérone	2933.99	NC2373B1b Ann. O/6	HSC/59	2017	114	313368-91-1
lumefantrine	luméfantrine	2922.19	42.100 Ann. O (VI)	HSC/21	1998	77	82186-77-4
lumicitabine	lumicitabine	2934.99	NC2373B1b Ann. O/7	HSC/59	2017	115	1445385-02-3
lumiliximab	lumiliximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	90	357613-86-6	HSC/35 (3002.10)
luminespib	luminespib	2934.99	NC2004B1b Ann. O/4	HSC/53	2014	108	747412-49-3

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
lumiracoxib	lumiracoxib	2922.49	NC0730B2 Ann. M/7	HSC/31	2003	87	220991-20-8
lumretuzumab	lumrétuzumab	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	111	1448327-63-6	HSC/55 (3002.10)
lunacalcipol	lunacalcipol	2930.90	NC1760B1b Ann. N/5	HSC/49	2012	102	250384-82-8
lupartumab	lupartumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1640971-88-5
lupartumab amadotin	lupartumab amadotine	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1640972-00-4
lupitidine	lupitidine	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	53	83903-06-4	HSC/11 (2934.90)
lurasidone	lurasidone	2934.20	NC0845B2 Ann. M/2	HSC/33	2004	88	367514-87-2
lurbinectedin	lurbinectédine	2939.80	NC2930Bc Ann. P/26	HSC/69	2022	105	497871-47-3	HSC/49 (2934.99)
lurtotecan	lurtotécan	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	74	149882-10-0	HSC/21 (2939.90) HSC/53 (2939.99)
lusaperidone	lusapéridone	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	82	214548-46-6	HSC/27 (2934.90)
luseogliflozin	luséogliflozine	2934.99	NC1760B1b Ann. N/7	HSC/49	2012	104	898537-18-3
luspatercept	luspatercept	3002.13	NC2237B1b Ann. T/13	HSC/57	2016	110	1373715-00-4	HSC/55 (3002.10)
lusupultide	lusupultide	2933.29	NC0250B2 Ann. P/1 (I)	HSC/25	2000	80	200074-80-2
lusutrombopag	lusutrombopag	2934.10	NC1760B1b Ann. N/7	HSC/49	2012	104	1110766-97-6
lusvertikimab	lusvertikimab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2375835-91-7
lutetium (¹⁷⁷Lu) lilotomab satetraxetan	lutécium (¹⁷⁷Lu) lilotomab satétraxétan	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	112	1453362-90-7	HSC/57 (2844.40)
lutetium (177Lu) oxodotreotide	lutécium (177Lu) oxodotréotide	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	116	437608-50-9	HSC/61 (2844.40)
lutetium (¹⁷⁷Lu) vipivotide tetraxetan	lutécium (¹⁷⁷Lu) vipivotide tétraxetan	2844.43	NC2803Bc Ann. T/7	HSC/67	2021	123	1703749-62-5
lutetium (¹⁷⁷Lu) zadavotide guraxet	lutécium (¹⁷⁷Lu) zadavotide guraxét	2844.43	NC2930Bc Ann. P/27	HSC/69	2022	125	2447131-70-4
lutikizumab	lutikizumab	3002.13	NC2373B1b Ann. O/7	HSC/59	2017	115	1791411-57-8
lutrelin	lutréline	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	51	66866-63-5	HSC/11 (2937.99)
lutropin alfa	lutropine alfa	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	71	152923-57-4	HSC/18 (2937.10)
luvadaxistat	luvadaxistat	2933.99	NC2803Bc Ann. T/6	HSC/67	2021	122	1425511-32-5
luxeptinib	luxeptinib	2933.79	NC2930Bc Ann. P/27	HSC/69	2022	125	1616428-23-9
lymecycline	lymécycline	2941.30	38.100 Ann. Q (No. 440)	HSC/11	1993	14	992-21-2
lynestrenol	lynestrénol	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	13	52-76-6	HSC/11 (2937.92)
lypressin	lypressine	2937.19	NC2004B1b Ann. O/6	HSC/53	2014	13	50-57-7	HSC/11 (2937.99)
lysergide	lysergide	2939.69	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	8	50-37-3
macimorelin	macimoréline	2937.90	NC1874B1b Ann. O/3	HSC/51	2013	100	381231-18-1	HSC/45 (2937.40)
macitentan	macitentan	2933.59	NC1443B1b Ann. P/6	HSC/43	2009	99	441798-33-0
macozinone	macozinone	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1377239-83-2
macrogol ester	ester de macrogol	3402.42	NC2803Bc Ann. T/4	HSC/67	2021	34	no mention	HSC/25 (3402.13)
macrosalb (131 I)	macrosalb (131 I)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	33	54182-63-7	HSC/11 (2844.40)
macrosalb (99m Tc)	macrosalb (99m Tc)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	33	54277-47-3	HSC/11 (2844.40)
maduramicin	maduramicine	2941.90	38.100 Ann. Q (No. 446)	HSC/11	1993	55	84878-61-5
maftivimab	maftivimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2135632-36-7

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
magaldrate	magaldrate	2842.90	38.100 Ann. Q (No. 447)	HSC/11	1993	49	74978-16-8
magnesium clofibrate	clofibrate de magnésium	2918.99	NC2373B1b Ann. O/12	HSC/59	2017	31	14613-30-0	HSC/11 (2918.90)
magrolimab	magrolimab	3002.13	NC2803Bc Ann. T/2	HSC/67	2021	120	2169232-81-7
maletamer	malétamère	3911.90	38.100 Ann. Q (No. 449)	HSC/11	1993	14	29535-27-1
maleylsulfathiazole	maléylsulfathiazol	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	1	515-57-1	HSC/11 (2935.00)
malotilate	malotilate	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	44	59937-28-9	HSC/11 (2934.90)
managlinat dialanetil	managlinat dialanétil	2934.10	NC1310B1b Ann. N/10	HSC/41	2008	96	280782-97-0
manelimab	manélimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2168561-26-8
manfidokimab	manfidokimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2428381-56-8
mangafodipir	mangafodipir	2933.39	40.600 Ann. D, par. 6	HSC/18	1996	72	155319-91-8
manifaxine	manifaxine	2934.99	NC0590B2 Ann. L/15	HSC/29	2002	85	135306-39-7
manitimus	manitimus	2926.90	NC1059B2b Ann. O/5	HSC/37	2006	93	202057-76-9
mannitol hexanitrate	hexanitrate de mannitol	2920.90	38.100 Ann. Q (No. 452)	HSC/11	1993	1	15825-70-4
mannosulfan	mannosulfan	2905.49	38.100 Ann. Q (No. 453)	HSC/11	1993	24	7518-35-6
manozodil	manozodil	2934.20	38.100 Ann. Q (No. 454)	HSC/11	1993	47	77528-67-7
mantabegron	mantabégron	2922.19	NC0845B2 Ann. M/2	HSC/33	2004	88	36144-08-8
mapatumumab	mapatumumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	93	658052-09-6	HSC/37 (3002.10)
mapinastine	mapinastine	2933.59	40.600 Ann. D, par. 6	HSC/18	1996	72	140945-32-0
mapracorat	mapracorat	2934.99	NC1649B3b Ann. R/13	HSC/47	2011	102	887375-26-0
maraciclatide	maraciclatide	2934.99	NC1649B3b Ann. R/14	HSC/47	2011	103	489427-17-0
maralixibat chloride	chlorure de maralixibat	2934.99	NC2237B1b Ann. S/8	HSC/57	2016	113	228113-66-4
maraviroc	maraviroc	2933.39	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	376348-65-1
mardepodect	mardépodect	2933.49	NC2501B1b Ann. M/6	HSC/61	2018	117	898562-94-2
margetuximab	margetuximab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	109	1350624-75-7	HSC/53 (3002.10)
maribavir	maribavir	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	80	176161-24-3	HSC/23 (2934.90)
maridomycin	maridomycine	2941.90	38.100 Ann. Q (No. 455)	HSC/11	1993	32	35775-82-7
marimastat	marimastat	2928.00	42.100 Ann. O (IV)	HSC/21	1998	75	154039-60-8
mariptiline	mariptiline	2928.00	38.100 Ann. Q (No. 456)	HSC/11	1993	44	60070-14-6
marizomib	marizomib	2934.99	NC1604B1b Ann. N/6	HSC/46	2010	102	437742-34-2
marnetegragene autotemcel	marnétégragène autotemcel	3002.51	NC2930Bc Ann. P/27	HSC/69	2022	125	no mention
maropitant	maropitant	2933.39	NC0938B2b Ann. O/3 (I)	HSC/35	2005	90	147116-67-4
marstacimab	marstacimab	3002.13	NC2626B1b Ann. O/6	HSC/63	2019	119	1985638-39-8
marzeptacog alfa (activated)	marzeptacog alfa (activé)	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	113	160049-21-4	HSC/57 (3002.10) (S/9)
masilukast	masilukast	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	94	136564-68-6	HSC/39 (2935.00)
masitinib	masitinib	2934.10	NC1310B1b Ann. N/10	HSC/41	2008	96	790299-79-5
masupirdine	masupirdine	2935.90	NC2626B1b Ann. O/6	HSC/63	2019	119	701205-60-9
matuzumab	matuzumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	88	339186-68-4	HSC/33 (3002.10)
mavacamten	mavacamten	2933.59	NC2501B1b Ann. M/5	HSC/61	2018	116	1642288-47-8

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
mavacoxib	mavacoxib	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	94	170569-88-7	HSC/38 (2935.00)
mavatrep	mavatrep	2933.99	NC2004B1b Ann. O/5	HSC/53	2014	109	956274-94-5
mavelertinib	mavélertinib	2933.59	NC2626B1b Ann. O/5	HSC/63	2019	118	1776112-90-3
mavezelimab	mavézélimab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2231068-83-8
mavilimogene ralaplasmid	mavilimogène ralaplasmide	2934.99	NC2626B1b Ann. O/5	HSC/63	2019	118	1977487-95-8
mavoglurant	mavoglurant	2933.99	NC1760B1b Ann. N/7	HSC/49	2012	104	543906-09-8
mavorixafor	mavorixafor	2933.49	NC2626B1b Ann. O/5	HSC/63	2019	118	558447-26-0
mavrilimumab	mavrilimumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	102	1085337-57-0	HSC/46 (3002.10)
maxacalcitol	maxacalcitol	2909.49	42.100 Ann. O (IV)	HSC/21	1998	75	103909-75-7
mazapertine	mazapertine	2933.59	40.600 Ann. D, par. 6	HSC/18	1996	72	134208-17-6
mazindol	mazindol	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	23	22232-71-9
mazipredone	maziprédone	2937.29	38.100 Ann. Q (No. 457)	HSC/11	1993	32	13085-08-0
mazokalim	mazokalim	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	75	164178-54-5	HSC/21 (2934.90)
mazorelvimab	mazorelvimab	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2419087-89-9
mebeverine	mébévérine	2922.50	38.100 Ann. Q (No. 458)	HSC/11	1993	14	3625-06-7
mebolazine	mébolazine	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	21	3625-07-8	HSC/11 (2937.99)
mebutamate	mébutamate	2924.19	NC2004B1b Ann. O/6	HSC/53	2014	12	64-55-1	HSC/11 (2924.10)
mebutizide	mébutizide	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	15	3568-00-1	HSC/11 (2935.00)
mecamylamine	mécamylamine	2921.30	38.100 Ann. Q (No. 462)	HSC/11	1993	6	60-40-2
mecapegfilgrastim	mécapegfilgrastim	3002.13	NC2237B1b Ann. T/11	HSC/57	2016	113	1570067-55-8	HSC/57 (3002.10) (S/9)
mecasermin rinfabate	mecasermine rinfabate	2933.29	NC0938B2b Ann. O/3 (II)	HSC/35	2005	91	478166-15-3
mecillinam	mécillinam	2941.90	38.100 Ann. Q (No. 463)	HSC/11	1993	32	32887-01-7
meclinertant	méclinertant	2933.49	NC0730B2 Ann. M/4 (III)	HSC/31	2003	88	146362-70-1
meclocycline	méclocycline	2941.30	38.100 Ann. Q (No. 464)	HSC/11	1993	14	2013-58-3
mecloqualone	mécloqualone	2933.55	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	12	340-57-8
meclorisone	méclorisone	2937.22	38.100 Ann. Q (No. 467)	HSC/11	1993	40	4732-48-3
mecobalamin	mécobalamine	2936.26	38.100 Ann. Q (No. 468)	HSC/11	1993	26	13422-55-4
medazepam	médazépam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	20	2898-12-6
medifoxamine	médifoxamine	2922.50	40.260 Ann. L/2 (No. 88)	HSC/17	1996	33	32359-34-5
medorinone	médorinone	2933.79	38.100 Ann. Q (No. 470)	HSC/11	1993	54	88296-61-1
medorubicin	médorubicine	2941.90	38.100 Ann. Q (No. 471)	HSC/11	1993	47	64314-52-9
medrogestone	médrogestone	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	15	977-79-7	HSC/11 (2937.92)
medroxyprogesterone	médroxyprogestérone	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	10	520-85-4	HSC/11 (2937.92)
medrylamine	médrylamine	2922.19	40.260 Ann. L/2 (No. 89)	HSC/17	1996	1	524-99-2
mefenorex	méfénorex	2921.46	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	19	17243-57-1
mefeserpine	méféserpine	2939.79	NC2116B1b Ann. S/1	HSC/55	2015	15	3735-85-1	HSC/21 (2939.90) HSC/53 (2939.99)
mefruside	méfruside	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	16	7195-27-9	HSC/11 (2935.00)

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
megalomicin	mégalomicine	2941.90	38.100 Ann. Q (No. 476)	HSC/11	1993	40	28022-11-9
megestrol	mégestrol	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	13	3562-63-8	HSC/11 (2937.92)
meglucycline	méglucycline	2941.30	38.100 Ann. Q (No. 478)	HSC/11	1993	22	31770-79-3
melagatran	mélagatran	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	74	159776-70-2	HSC/21 (2933.90)
meldonium	meldonium	2928.00	NC0730B2 Ann. M/6	HSC/31	2003	86	76144-81-5
melengestrol	mélengestrol	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	13	5633-18-1	HSC/11 (2937.92)
melevodopa	mélévodopa	2922.50	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	7101-51-1
melogliptin	mélogliptine	2933.99	NC1443B1b Ann. P/6	HSC/43	2009	99	868771-57-7
meloxicam	méloxicam	2934.10	38.100 Ann. Q (No. 480)	HSC/11	1993	52	71125-38-7
melphalan flufenamide	melphalan flufénamide	2924.29	NC1760B1b Ann. N/8	HSC/49	2012	105	380449-51-4
melquinast	melquinast	2933.59	38.100 Ann. Q (No. 481)	HSC/11	1993	62	87611-28-7
melredableukin alfa	melrédableukine alfa	3002.13	NC2930Bc Ann. P/27	HSC/69	2022	125	2056881-92-4
melrilimab	melrilimab	3002.13	NC2803Bc Ann. T/7	HSC/67	2021	123	2222865-46-3
meluadrine	méluadrine	2922.50	42.750 Ann. O	HSC/22	1998	78	134865-33-1
menfegol	menfégol	3402.42	NC2803Bc Ann. T/4	HSC/67	2021	36	57821-32-6	HSC/11 (3402.13)
menogaril	ménogaril	2941.90	38.100 Ann. Q (No. 483)	HSC/11	1993	51	71628-96-1
meobentine	méobentine	2925.29	NC2004B1b Ann. O/6	HSC/53	2014	38	46464-11-3	HSC/11 (2925.20)
mephenytoin	méphénytoïne	2933.21	38.100 Ann. Q (No. 485)	HSC/11	1993	1	50-12-4
mepitiostane	mépitiostane	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	34	21362-69-6	HSC/11 (2937.99)
mepolizumab	mépolizumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	81	196078-29-2	HSC/25 (3002.10)
mepramidil	mépramidil	2922.19	40.260 Ann. L/2 (No. 90)	HSC/17	1996	27	23891-60-3
meprobamate	méprobamate	2924.11	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	6	57-53-4
meproscillarin	méproscillarine	2938.90	38.100 Ann. Q (No. 488)	HSC/11	1993	38	33396-37-1
meprylcaine	méprylcaïne	2922.19	38.100 Ann. Q (No. 489)	HSC/11	1993	4	495-70-5
meradimate	méradimate	2922.49	NC0430B2 Ann. Q/1 (II)	HSC/27	2001	83	134-09-8
meralein sodium	méraléine sodique	2932.99	42.100 Ann. O (I)	HSC/21	1998	13	4386-35-0
meralluride	méralluride	3003.49	NC2237B1b Ann. T/12	HSC/57	2016	1	8069-64-5	HSC/11 (3003.40)
merbromin	merbromine	2932.99	42.100 Ann. O (I)	HSC/21	1998	1	129-16-8
mercaptomerin	mercaptomérine	2930.90	42.100 Ann. O (I)	HSC/21	1998	1	20223-84-1
mercumatilin sodium	mercumatiline sodique	3003.49	NC2237B1b Ann. T/12	HSC/57	2016	4	60135-06-0	HSC/11 (3003.40)
mercurophylline	mercurophylline	3003.49	NC2237B1b Ann. T/12	HSC/57	2016	1	8012-34-8	HSC/11 (3003.40)
merestinib	mérestinib	2933.79	NC2237B1b Ann. S/9	HSC/57	2016	113	1206799-15-6
mergocriptine	mergocriptine	2939.69	NC2004B1b Ann. O/6	HSC/53	2014	54	81968-16-3	HSC/11 (2939.60)
meribendan	méribendan	2933.19	38.100 Ann. Q (No. 494)	HSC/11	1993	62	119322-27-9
mericitabine	méricitabine	2934.99	NC1760B1b Ann. N/7	HSC/49	2012	104	940908-79-2
merimepodib	mérimépodib	2934.99	NC0730B2 Ann. M/7	HSC/31	2003	87	198821-22-6
merisoprol (197 Hg)	mérisoprol (197 Hg)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	24	5579-94-2	HSC/11 (2844.40)
meropenem	méropénem	2941.90	38.100 Ann. Q (No. 496)	HSC/11	1993	60	96036-03-2
merotocin	mérotocine	2937.19	NC2116B1b Ann. R/5	HSC/55	2015	111	1190083-57-8

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
mesabolone	mésabolone	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	29	7483-09-2	HSC/11 (2937.99)
mesdopetam	mesdopétam	2930.90	NC2803Bc Ann. T/3	HSC/67	2021	121	1403894-72-3
mesmulogene ancovacivec	mesmulogène ancovacivec	3002.49	NC2930Bc Ann. P/33	HSC/69	2022	114	1246525-59-6	HSC/59 (3002.90)
mesocarb	mésocarb	2934.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	34	34262-84-5
mespiperone (11C)	mespipérone (11C)	2844.43	NC2803Bc Ann. T/4	HSC/67	2021	78	94153-50-1	HSC/22 (2844.40)
mestanolone	mestanolone	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	10	521-11-9	HSC/11 (2937.99)
mesterolone	mestérolone	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	15	1424-00-6	HSC/11 (2937.99)
mestranol	mestranol	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	15	72-33-3	HSC/11 (2937.92)
mesulergine	mésulergine	2939.69	NC2004B1b Ann. O/6	HSC/53	2014	47	64795-35-3	HSC/11 (2939.60)
mesulfamide	mésulfamide	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	41	122-89-4	HSC/11 (2935.00)
mesulfen	mésulfène	2934.99	NC2004B1b Ann. O/6	HSC/53	2014	1	135-58-0	HSC/11 (2934.90)
mesuprine	mésuprine	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	21	7541-30-2	HSC/11 (2935.00)
mesuximide	mésuximide	2925.19	38.100 Ann. Q (No. 505)	HSC/11	1993	6	77-41-8
metaglycodol	métaglycodol	2906.29	38.100 Ann. Q (No. 506)	HSC/11	1993	12	13980-94-4
metahexamide	métahexamide	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	10	565-33-3	HSC/11 (2935.00)
metamfetamine	métamfétamine	2939.45	NC2803Bc Ann. T/4	HSC/67	2021	55	537-46-2	HSC/25 (2939.91) HSC/55 (2939.71)
metaraminol	métaraminol	2939.79	NC2626B1b Ann. E/2	HSC/63	2019	1	54-49-9	HSC/57 (2939.49)
metaterol	métatérol	2922.50	38.100 Ann. Q (No. 510)	HSC/11	1993	43	3571-71-9
metazocine	métazocine	2933.39	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	9	3734-52-9
metelimumab	métélimumab	3002.13	NC2116B1b Ann. S/2	HSC/55	2015	86	272780-74-2	HSC/31 (3002.10)
metenkefalin	métenkéfaline	2930.90	NC1310B1b Ann. N/4	HSC/41	2008	97	58569-55-4
metenolone	méténolone	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	12	153-00-4	HSC/11 (2937.99)
metergoline	métergoline	2939.69	42.100 Ann. O (I)	HSC/21	1998	18	17692-51-2
metergotamine	métergotamine	2939.69	NC2004B1b Ann. O/6	HSC/53	2014	29	22336-84-1	HSC/11 (2939.60)
metescufylline	métescufylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	15	15518-82-8	HSC/11 (2939.50)
metesculetol	métesculétol	2932.20	NC2004B1b Ann. O/6	HSC/53	2014	41	52814-39-8	HSC/11 (2932.29)
metesind	métésind	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	76	138384-68-6	HSC/21 (2935.00)
metformin glycinate	glycinate de metformine	2925.29	NC1649B3b Ann. R/14	HSC/47	2011	103	121369-64-0
methadone	méthadone	2922.31	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	1	76-99-3
methandriol	méthandriol	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	1	521-10-8	HSC/11 (2937.99)
methaqualone	méthaqualone	2933.55	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	10	72-44-6
metharbital	métharbital	2933.54	NC2004B1b Ann. O/6	HSC/53	2014	1	50-11-3	HSC/11 (2933.51)
methazolamide	méthazolamide	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	10	554-57-4	HSC/11 (2935.00)
methdilazine	methdilazine	2934.30	38.100 Ann. Q (No. 519)	HSC/11	1993	90	1982-37-2
methiodal sodium	méthiodal sodique	2904.99	NC2116B1b Ann. S/1	HSC/55	2015	1	126-31-8	HSC/11 (2904.90)
methoprene	méthoprène	2918.99	NC2373B1b Ann. O/12	HSC/59	2017	60	40596-69-8	HSC/11 (2918.90)
methyldesorphine	méthyldésorphine	2939.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	16008-36-9
methyldihydromorphine	méthyldihydromorphine	2939.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	5	509-56-8

Product (En)	Produit (Fr)	Class 2022	HSC Report / CSH Rapport	Session	Year / Année	List / Liste	CAS No	Other
methylergometrine	méthylergométrine	2939.69	NC2004B1b Ann. O/6	HSC/53	2014	1	113-42-8	HSC/11 (2939.60)
methylnaltrexone bromide	bromure de méthylnatrexone	2939.19	NC1310B1b Ann. N/10	HSC/41	2008	96	73232-52-7
methylphenidate	méthylphénidate	2933.33	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	6	113-45-1
methylphenobarbital	méthylphénobarbital	2933.53	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	1	115-38-8
methylrosanilinium chloride	chlorure de méthylrosanilinium	3204.13	38.100 Ann. Q (No. 523)	HSC/11	1993	1	548-62-9
methylsamidorphan chloride	methylsamidorphan chloride	2933.49	NC2004B1b Ann. O/5	HSC/53	2014	109	1118885-67-8
methylthiouracil	méthylthiouracile	2933.59	38.100 Ann. Q (No. 524)	HSC/11	1993	1	56-04-2
methyprylon	méthyprylone	2933.72	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	6	125-64-4
methysergide	méthysergide	2939.69	NC2004B1b Ann. O/6	HSC/53	2014	11	361-37-5	HSC/11 (2939.60)
metipirox	métipirox	2933.39	38.100 Ann. Q (No. 526)	HSC/11	1993	26	29342-02-7
metipranolol	métipranolol	2922.19	40.260 Ann. L/2 (No. 91)	HSC/17	1996	38	22664-55-7
metkefamide	metkéfamide	2930.90	38.100 Ann. Q (No. 527)	HSC/11	1993	44	66960-34-7
metogest	métogest	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	33	52279-58-0	HSC/11 (2937.92)
metopon	métopon	2939.19	E.N. Chap. 29 – List I-I (Narcotic	HSC/25	2000	1	143-52-2
metoprolol	métoprolol	2922.19	40.260 Ann. L/2 (No. 92)	HSC/17	1996	30	37350-58-6
metoquizine	métoquizine	2933.19	38.100 Ann. Q (No. 529)	HSC/11	1993	17	7125-67-9
metralindole	métralindole	2933.59	40.260 Ann. L/2 (No. 28)	HSC/17	1996	42	54188-38-4
metreleptin	métréleptine	2937.19	NC0590B2 Ann. L/10	HSC/29	2002	82	186018-45-1
metribolone	métribolone	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	17	965-93-5	HSC/11 (2937.99)
metynodiol	métynodiol	2937.23	NC2004B1b Ann. O/6	HSC/53	2014	27	23163-42-0	HSC/11 (2937.92)
mevidalen	mévidalène	2933.49	NC2930Bc Ann. P/25	HSC/69	2022	124	1638667-79-4
mevociclib	mévociclib	2933.59	NC2803Bc Ann. T/3	HSC/67	2021	121	1816989-16-8
mexafylline	mexafylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	48	80294-25-3	HSC/11 (2939.50)
mexrenoate potassium	mexrénoate potassique	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	33	43169-54-6	HSC/11 (2937.99)
mezacopride	mézacopride	2933.39	38.100 Ann. Q (No. 534)	HSC/11	1993	56	89613-77-4
mezagitamab	mézagitamab	3002.13	NC2803Bc Ann. T/3	HSC/67	2021	121	2227490-52-8
mezigdomide	mézigdomide	2933.79	NC2930Bc Ann. P/27	HSC/69	2022	125	2259648-80-9
mezilamine	mézilamine	2933.59	38.100 Ann. Q (No. 535)	HSC/11	1993	36	50335-55-2
mibampator	mibampator	2935.90	NC2116B1b Ann. S/1	HSC/55	2015	103	375345-95-2	HSC/47 (2935.00)
mibavademab	mibavadémab	3002.13	NC2930Bc Ann. P/25	HSC/69	2022	124	2305770-44-7
mibefradil	mibéfradil	2933.99	NC2004B1b Ann. O/6	HSC/53	2014	72	116644-53-2	HSC/18 (2933.90)
mibenratide	mibenratide	2934.99	NC2116B1b Ann. R/5	HSC/55	2015	111	1239011-83-6
mibolerone	mibolérone	2937.29	NC2004B1b Ann. O/6	HSC/53	2014	27	3704-09-4	HSC/11 (2937.99)
micafungin	micafongine	2941.90	NC0730B2 Ann. M/4	HSC/31	2003	84	235114-32-6
midafotel	midafotel	2933.59	NC0090B2 Ann. M/1 (II)	HSC/23	1999	79	117414-74-1
midaglizole	midaglizole	2933.39	38.100 Ann. Q (No. 537)	HSC/11	1993	57	66529-17-7
midaxifylline	midaxifylline	2939.59	NC2004B1b Ann. O/6	HSC/53	2014	79	151159-23-8	HSC/27 (2939.50)
midazolam	midazolam	2933.91	E.N. Chap. 29 – List I-II (Psycho	HSC/25	2000	40	59467-70-8
midomafetamine	midomafétamine	2932.99	NC2501B1b Ann. M/5	HSC/61	2018	116	42542-10-9

t t

Customs Tax Experts Kenya

Find Us

Recent Posts

NEW IMPORT DUTY RATES JUNE 2024

Tax Appeals Tribunal Decision HS Classification of Andolex Medicated Mouthwash

Kenya Revenue Authority HS Classification 2023 to 2024

HOW TO UNDERSTAND AND NAVIGATE SUBHEADINGS IN THE HS NOMENCLATURE

JANRON CONSULT LIMITED PROFILE

TAX APPEALS TRIBUNAL DECISION HS CLASSIFICATION EUCALYPTUS OIL 80/85

Follow Me

WCO WHO HS Classification of Active Pharmaceutical Ingredients>> HS Code HS Classification

Like this:

Related

Quick Links

Contact

Customs Tax Experts Kenya

Find Us

Recent Posts

NEW IMPORT DUTY RATES JUNE 2024

Tax Appeals Tribunal Decision HS Classification of Andolex Medicated Mouthwash

Kenya Revenue Authority HS Classification 2023 to 2024

HOW TO UNDERSTAND AND NAVIGATE SUBHEADINGS IN THE HS NOMENCLATURE

JANRON CONSULT LIMITED PROFILE

TAX APPEALS TRIBUNAL DECISION HS CLASSIFICATION EUCALYPTUS OIL 80/85

Follow Me

WCO WHO HS Classification of Active Pharmaceutical Ingredients>> HS Code HS Classification

Share this if post if you like It

Like this:

Related